Empowered by Pipeline and Forged by Technology: Mabwell Successfully Lists on the Main Board of HKEX

HONG KONG, Apr 28, 2026 - (ACN Newswire via SeaPRwire.com) - Driven by the continuous innovation in global biopharmaceutical technology, the steady rollout of favorable policies, and escalating clinical demands, the biopharmaceutical industry is ushering in a golden cycle of development. As a representative enterprise in China's innovative pharmaceutical sector, Mabwell (Shanghai) Bioscience Co., Ltd. (“Mabwell” or the “Company”, stock code: 02493.HK) has seized industry development opportunities by leveraging its profound R&D foundation, integrated whole-industry-chain advantages, and forward-looking global layout. Today, it officially listed on the Main Board of the Hong Kong Stock Exchange (HKEX), joining the biopharmaceutical sector of the Hong Kong stock market and opening a brand-new chapter in its international development.Reportedly, founded in 2017, Mabwell is a leading domestic innovative pharmaceutical enterprise, possessing premier innovative drug R&D capabilities and end-to-end whole-industry-chain capabilities that span from drug discovery to commercial sales. Since its establishment, the Company has been deeply engaged in therapeutic areas for major diseases such as oncology, immunology, ophthalmology, and orthopedics, and is committed to providing safer and more efficient innovative treatment solutions for patients worldwide.Rich and Diversified Product Pipeline Builds Core Competitive BarriersA rich and promising product portfolio serves as the core pillar for Mabwell’s steady development, as well as its key advantage in seizing first-mover opportunities in the market. With a long-term, deep-rooted presence in the innovative drug sector, the Company has built a diversified product pipeline featuring multiple categories and tiers. As of now, Mabwell has 4 commercialized products and 10 drug candidates: 1 in NDA stage,, 1 in preclinical stages, covering multiple high-potential therapeutic areas and supporting long-term growth.Mabwell’s self-developed core product, 9MW2821, fully demonstrates the Company’s leading edge in the ADC field. 9MW2821 is the most advanced among all Nectin-4-targeting ADCs for urothelial carcinoma (“UC”) in China in terms of clinical development progress, and only second to the globally blockbuster drug Padcev. Meanwhile, it is also the first Nectin-4-targeting ADC globally to enter the pivotal Phase III clinical trials for cervical cancer (“CC”), and triple-negative breast cancer (“TNBC”), boasting extensive market potential.Beyond 9MW2821, Mabwell continues to advance the R&D of ADC candidates targeting other novel targets and has built a comprehensive ADC pipeline portfolio. Its pipeline includes 7MW3711, an ADC specifically targeting B7-H3 (an immune checkpoint protein), and 7MW4911, an ADC specifically targeting CDH17. This layout further diversifies the Company’s footprint in oncology treatment and steadily consolidates its leading advantages in the ADC track.Notably, Mabwell has also strategically prioritized the layout of product pipelines covering monoclonal antibodies (“mAbs”), TCE bispecific antibodies, fusion proteins and small molecule drugs, fostering a pattern of coordinated development across multiple product categories. Its R&D portfolio includes: 9MW3811, a humanized monoclonal antibody targeting IL-11 for the treatment of fibrosis -related diseases and cancers; 9MW1911, the first domestically developed drug candidate approved for clinical development in China targeting ST2; 9MW3011, a recombinant humanized TMPRSS6 targeting mAb among the leading TMPRSS6-targeting therapies in terms of development status globally; and 6MW5311, the world’s first LILRB4/CD3-targeted TCE bispecific antibody filed for clinical trials. These candidates keep expanding the boundaries of the Company’s innovative drug research and development.Outstanding commercialization capabilities, expanding a global market footprintLeveraging its fully integrated industry chain capabilities and forward-looking commercialization strategy, Mabwell (Shanghai) Bioscience Co., Ltd. has continued to deliver tangible commercialization outcomes. In 2025, the Company’s Junmaikang® obtained marketing approval in Indonesia, while Mailisheng® and Maiweijian were approved for commercialization in Pakistan, marking steady progress in its international commercialization efforts.Since 2022, the Company has actively expanded overseas collaborations, entering into multiple landmark international partnership agreements and securing corresponding revenue-sharing arrangements. It has successfully penetrated emerging markets including Brazil, Indonesia, Saudi Arabia, and countries along the Belt and Road Initiative, establishing an extensive global commercial network.In terms of global partnerships, Mabwell has further deepened its international presence. In January 2023, the Company entered into an exclusive licensing agreement with Disc Medicine for 9MW3011, under which it is entitled to receive up to US$412.5 million in upfront payments, milestone payments, and royalties. In June 2025, it reached an exclusive licensing agreement with Calico Life Sciences for 9MW3811, with total potential consideration exceeding US$600 million, including upfront, milestone, and royalty payments. In October 2025, the Company signed an exclusive licensing agreement with Kalexo Bio for a novel dual-target siRNA candidate drug, further expanding the breadth and depth of its international market collaborations.Powerful Technology Platforms Lay a Solid Foundation for Innovation-Driven GrowthPowerful technology platforms serve as the core engine for sustained innovation at Mabwell, and are also pivotal to building differentiated competitive advantages. With deep commitment to technological R&D, the Company has established four core ADC technologies for which we possess proprietary intellectual property rights, providing strong support for the development of innovative drugs.Among these, DARfinity is a self-developed site-specific conjugation process that enables precise drug molecule conjugation; IDconnect is an optimized design of linker molecules that enhances the stability of the linkage between the antibody and toxins; Mtoxin is a class of camptothecin-based novel toxic molecules that are used as the “warhead” in the ADC to kill the targeted cells, providing more potent target cell killing effects; LysOnly is an innovative structure that allows conditional release of toxins, effectively improving the overall safety and efficacy of ADC drugs.These four proprietary technologies serve as the core pillars of our site-specific conjugation ADC development platform, synergistically enabling the Company to develop ADC products with better uniformity, stability, purity, and a superior efficacy and safety profile. This significantly improves pipeline R&D efficiency, allows rapid response to clinical and market demands, and continuously consolidates the Company's leading position in the ADC field.In addition, Mabwell continues to develop and upgrade other core technology platforms, forming a multi-technology synergistic development system. These platforms include the integrated high-efficiency antibody discovery platform and the T-cell engager (TCE)-based bi/tri-specific antibody development platform, among others. The TCE-based bi/tri-specific antibodies developed on these platforms can simultaneously and specifically bind to tumor-associated antigens and the T-cell CD3 epitope, thereby laying a solid technical foundation for the Company's strategic positioning in the field of immunotherapy.From an industry perspective, the global biopharmaceutical sector, as a core segment, has continued to gain momentum in recent years. The global oncology drug market grew from US$143.5 billion in 2019 to US$253.3 billion in 2024 with a CAGR of 12.0%, and is expected to further increase to US$375.9 billion, and US$548.2 billion in 2028, and 2032 respectively, with CAGRs of 10.4% from 2024 to 2028 and 9.9% from 2028 to 2032, respectively. This trend presents substantial growth opportunities for leading industry players like Mabwell, which possess core technologies and a globalized footprint.Driven by in-house R&D, supported by integrated end-to-end capabilities across the entire industry chain, and guided by a long-term global strategy, Mabwell continues to advance steadily in the innovative pharmaceutical sector. Leveraging a robust product pipeline, strong technological expertise, and well-established commercialization capabilities, the Company has built a solid competitive position. Its successful listing in Hong Kong will further accelerate the development of its core products, enhance its commercialization strategy, and strengthen its core competitiveness. This, in turn, is expected to position the Company at the forefront of the biopharmaceutical wave, with strong long-term growth potential that merits close market attention. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

51WORLD Grants 940,200 RSUs for the First Time via Share Repurchase

HONG KONG, Apr 28, 2026 - (ACN Newswire via SeaPRwire.com) - Beijing 51WORLD Digital Twin Technology Co., Ltd. (“the Company”, Stock Code: 6651.HK) announced on 27 April 2026 the first grant of 940,200 restricted share units (RSUs) to 303 employees under its 10-year RSU Scheme, representing approximately 0.23% of the Company’s total issued shares.The underlying shares will be sourced from existing H Shares acquired by the Trust on the secondary market and/or treasury H Shares repurchased by the Company using its own funds. Vesting of the award shares shall be 25% after 12 months from acceptance, and the remaining 75% shall vest in 12 quarterly instalments at 6.25% each until fully vested.The RSU Scheme is intended to align the interests of the core team with the long-term development of the Company and enhance the incentive mechanism for talent attraction and retention. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Buffalo Potash Announces Preliminary Economic Assessment for Disley Project with After-Tax NPV of US$1.1B and IRR of 30%; Releases Results from Maiden 43-101 Mineral Resource Estimate

Saskatoon, Saskatchewan--(ACN Newswire via SeaPRwire.com - April 27, 2026) - Buffalo Potash Corporation (TSXV: BUFF) (OTCQB: BLPTF) (the "Company" or "Buffalo") is pleased to announce the completion of a Preliminary Economic Assessment ("PEA") and concurrent release of its maiden 43-101 Mineral Resource Estimate for its 100%-owned Disley Potash Project (the "Disley Project"), located in Saskatchewan, Canada.The PEA has been filed and can be found under the Company's profile on SEDAR+ (www.sedarplus.ca) and on the Company's website (www.buffalopotash.ca).PEA & Mineral Resource Estimate Highlights Total production of 1,000,000 tonnes per annum (TPA) of K62 granular-grade Muriate of Potash (MOP) and 125,000 TPA of K62 soluble grade MOPAfter-tax NPV(1)(8) of US$1.1B and IRR(1) of 30%US$639M initial CAPEX estimate, including US$128M in contingencyEstimated US$55/t MOP OPEX (Table 4)Measured and indicated tonnage of 1,671.5 million metric tonnes at an average grade of 34.8% KCl, yielding 582 million tonnes of KClOver 50 years of mine life at 1,125,000 TPA based on current resource estimate (Table 2)(2)The advancement of a Feasibility Study ("FS") for Disley East and Disley West (the "HLD Mines") will run concurrent with Initial Production Module ("IPM") construction, with FS completion representing the key decision gate for proceeding to construction of Disley East and Disley West(3)(2) Based on Measured and Indicated resource estimate of 582Mt at 34.8% KCl.(3) The PEA does not constitute a feasibility study and does not demonstrate economic viabilityMr. Steve Halabura P.Geo., Buffalo Chief Executive Officer, commented: "Since founding Buffalo Potash in 2018, the team and I have invested years of disciplined work — geological, technical, and strategic — to systematically unlock the potential of modular selective solution potash mining in Saskatchewan, the key being Buffalo's Disley Project. Having spent my career working in Saskatchewan potash, I had a strong conviction from the beginning that Disley had a substantial resource endowment, and this Mineral Resource Estimate confirms exactly that. The PEA illustrates both low capex per tonne and operating cost per tonne, as well as setting a new environmental standard for how potash production should look in the 21st century — no tailings stored on surface and minimal freshwater usage." Mr. Halabura continued: "The team and I believe the Disley Project represents the next generation of Saskatchewan potash solution mining and are excited to begin development of the Initial Production Module, which will be the first leg of this buildout and is expected to bring soluble-grade potash production online within the next 12 months. During the development of the Initial Production Module, we will also test our patent-pending Vortex Crystallizer, alongside an industry standard crystallizer, which has the potential to significantly reduce the capex of the Initial Production Module and further potential build-outs. With global attention turning to the security of critical supply chains, the urgency to bring reliable, jurisdiction-stable potash production online has never been greater. This is a proud moment for our team, our shareholders, and the stakeholders that have supported us along the way — and we are just getting started."Table 1: PEA SummaryLine ItemUnitsTotal Project Production Rate MOPTPA1,000,000Production Rate Soluble GradeTPA125,000Total Initial CAPEXUS$ million639CAPEX per Tonne CapacityUS$/tonne568Average Unit OPEXUS$/tonne55MOP Price (25-year avg.)US$/tonne393.6(4)Soluble Grade Price (25-year avg.)US$/tonne373.6(5)Pre-Tax NPV(1) (8%)US$ million1,534.67Pre-Tax IRR(1)%35Post-Tax NPV(1) (8%)US$ million1,085.47Post-Tax IRR(1)%30Steady-State Annual RevenueUS$ million442.5Steady-State Annual EBITDAUS$ million251.0 (4) LoM average price of Granular MOP, produced by Disley East and Disley West(5) LoM average price of Soluble Grade MOP, produced by IPMThe PEA is preliminary in nature and includes inferred mineral resources, which are considered too speculative geologically to have the economic considerations applied to them that would enable them to be categorized as mineral reserves. There is no certainty that the PEA will be realized.PEA & Mineral Resource Estimate OverviewThe PEA was prepared by Micon International Co Limited ("Micon") in accordance with National Instrument 43-101 Standards of Disclosure for Mineral Projects and evaluates the development of the Disley Project as a phased potash solution mining operation. The PEA has an effective date of April 15, 2026 and is based on a Mineral Resource Estimate ("MRE") developed concurrently by Micon with an effective date of April 15, 2026, incorporating historical assay data from legacy drilling programs as well as results from Buffalo Potash's 2026 confirmation drill program. The PEA contemplates a phased development approach across three production facilities on the Disley property:The Initial Production Module ("IPM") - is a low-capital entry point designed to bring 125,000 tonnes per year of soluble grade MOP to market;Disley East - a full-scale HLD Mine on the east segment of the Disley Project, with a production capacity of 500,000 tonnes per year of granular MOP; andDisley West - a full-scale HLD Mine on the west segment of the Disley Project, with a production capacity of 500,000 tonnes per year of granular MOP.Successful construction of the IPM is anticipated to provide technical data used in the completion of the concurrent FS and would, subject to the results from the FS and a positive construction decision, be followed by the potential concurrent development of the Disley East and Disley West HLD solution mines. If fully developed, the Disley Project is designed to have the capacity to produce 1,000,000 TPA of granular MOP and 125,000 TPA of soluble grade MOP ("Full Production Capacity").The MRE indicates a resource base that substantially exceeds the project's current design requirements, which, if successfully developed, would position the Disley Project as a long-life asset. This is consistent with the generational mine lifecycles typically associated with Saskatchewan potash operations, though there is no certainty that resources will be converted to reserves or that any particular mine life will be achieved.Table 2: Mineral Resource EstimateCategoryTonnage (Mt) Avg KCl GradeAvg K2O GradeKCl (Mt)K2O (Mt)Measured399.734.82%22.00%139.287.9Indicated1,267.434.84%22.01%441.5278.9Inferred2,663.234.96%22.08%930.9588.1 Table 2 Notes:The effective date of this MRE is April 15, 2026.Dr. Ryan Langdon, Ph.D, CGeol, of Micon is the QP responsible for this MRE.The MRE has been classified in the Measured, Indicated and Inferred categories.An average specific gravity (SG) value of 2.08 g/cm3 was used.Conversion between KCl and K2O was made using the formula KCl = K2O * 1.583The MRE used economic assumptions for HLD mining. A deduction was made to account for the presence of mining anomalies not detected by existing drill holes and seismic lines. The values used are 5% for Measured, 9% for Indicated and 25% for Inferred.The block model supporting the resource is orthogonal and has a block size of 50 m x 50 m x 0.9 m.The mineral resources described above have been prepared in accordance with the current Canadian Institute of Mining, Metallurgy and Petroleum Standards and Practices.Numbers have been rounded to the nearest million tonnes. Differences may occur in totals due to rounding.Mineral Resources are not Mineral Reserves as they do not have demonstrated economic viability. The quantity and grade of reported Inferred Mineral Resources are uncertain in nature and there has been insufficient exploration; however, it is reasonably expected that a significant portion of Inferred Mineral Resources could be upgraded into Indicated Mineral Resources with further exploration.Micon's QP has not identified any legal, political, environmental, or other factors that could materially affect the potential development of the mineral resource estimate.Figure 1: Core Samples from the 7-10 Hole on the Disley ProjectTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/12107/294332_592822e3642ebbb0_001full.jpgMining MethodBuffalo intends to develop the Project using solution mining, a well-established approach that has been successfully deployed across Saskatchewan for more than 50 years. Solution mining is widely recognized as a reliable and efficient technique for extracting potash from laterally continuous deposits, notably used at both neighboring properties of the Disley Project — the K+S Bethune mine and the Mosaic Belle Plaine mine.Building on this proven foundation, Buffalo holds a patent on an enhanced solution mining approach known as Horizontal-Line-Drive Selective Solution Mining ("HLD Mining"), which is the installation of commercially proven oil and gas injection systems within horizontal wells. This method is designed to optimize efficiency, reduce overall capital intensity, and significantly limit freshwater requirements, while remaining grounded in the principles of traditional solution mining.Following underground dissolution, potash-rich brine is recovered to surface and processed through crystallization, drying, and compaction to produce a finished potash product ready for local delivery or export via existing road and rail infrastructure that currently runs adjacent to the Disley Property.Initial Capital Expenditure (CAPEX) The initial capital cost estimate has been prepared in line with the Class 4 definition outlined by AACE International standards, with a contingency of 25% applied to the IPM, Disley East, and Disley West components.Mechanical equipment represents the largest component of initial capital expenditure at approximately 38% of Total Project initial CAPEX. For Disley East and Disley West, the mechanical scope encompasses the full processing train required to produce export-grade granular MOP, including crystallization, debrining and drying, compaction and glazing, soluble product screening, and product storage and loading. For the IPM, the mechanical scope includes a crystallizer, pumps, tanks, pipework, centrifuge, dryer, and baghouse. Total initial capital expenditure across all three facilities is US$639 million, as summarized in the table below.Table 3: Initial CAPEX SummaryDescription IPMDisley EastDisley WestTotal Project(US$ million)(US$ million)(US$ million)(US$ million)Site Works0.711.311.323.3Concrete-5.65.611.2Structural Steel1.29.39.319.9Mechanical15.1113.3113.3241.7Piping0.214.914.930.0Electrical-15.015.029.9Instrumentation0.12.92.95.9Architecture0.019.619.639.2Minor Mechanical4.72.42.49.4General Construction1.413.313.328.0Indirects-36.136.172.3Contingency5.860.960.9127.7Total Capital Expenditure(6)29.2304.7304.7638.6  (6) For modelling purposes, the total capital expenditure estimate for the PEA assumes use of an industry standard crystallizer instead of Buffalo's patent-pending Vortex Crystallizer.Sustaining capital of US$483 million (US$17/t MOP) over the life of mine comprises an annual provision of 2% of original fixed plant and surface infrastructure costs, plus US$10/t MOP for the drilling, completion and tie-in of replacement wells — the dominant component of sustaining capital — based on each set of three wells yielding 500,000 tonnes over an approximate 5-year useful life.Operating Expenses (OPEX)Buffalo Potash's estimated operating cost of US$55/t MOP reflects the structural advantages of operating in Saskatchewan, a mature potash jurisdiction with competitive industrial energy rates, an established skilled workforce, and existing road and rail infrastructure adjacent to the Disley Property enabling low-cost delivery to both domestic and export markets. Buffalo management anticipates these fundamentals position the Disley Project to be among the lowest-cost potash producers upon reaching full production.Table 4: OPEX SummaryItemDescription1,125,000 TPA(US$ million)IPM Contingency$14.49/t applied to IPM production only1.8Wellfield Power500 Hp at $0.063/kWh1.8Processing Power19,356 Hp at $0.063/kWh18.0Drilling$25,000/day; 45 days/yr0.1Pipes, Pumps, ValvesSteaming & general maintenance0.8InstrumentationMonitoring & controls0.4Labour32 staff7.8Natural Gas$386/1000m³ incl. carbon tax19.6Maintenance5% of major equipment capital5.4ReagentsDedust oil & anticake amines2.0Water$2.20/m³; 45 m³/hr1.3General & Admin SupervisionManagement & safety1.9Admin SuppliesOffice & admin supplies0.8Total Annual OPEX61.7OPEX US$/t MOP55 / tonne Economic AssumptionsThe economic analysis evaluates the Disley Project as a phased development consisting of the IPM to establish early cash flow, followed by the full-scale HLD Mine comprising Disley West and Disley East. The IPM was evaluated as a standalone project, with the HLD Mine (Disley East and Disley West) assessed on an incremental basis and in combination with the IPM as an overall project. A Discounted Cash Flow ("DCF") model was constructed with the following assumptions:All costs and revenues are expressed in constant, first quarter 2026 money terms, with no provision for escalation or inflation;Capital and operating cost estimates denominated in Canadian dollars have been converted to US dollars at an exchange rate of CAD 1.38 per USD;A discount rate of 8% has been applied on an all-equity basis;The pre-tax results presented include the Saskatchewan Potash Production Tax (PPT) and royalties but exclude federal and provincial corporate income tax. The after-tax results include corporate income tax (Saskatchewan 12%, Federal 15%);The IPM ramps up over 3 months at 50% of nominal capacity; Disley West and Disley East have a 6-month ramp-up period at 50% of capacity, with the Disley East being deferred by a 3-month offset from the West Section;It is assumed the IPM is scheduled to begin construction July 2026 with commercial operations starting January 2027;It is assumed that a positive construction decision will be reached on Disley West and Disley East. Disley West is scheduled to begin construction July 2027, with operations beginning July 2029. Construction at Disley East is scheduled to be the final facility developed, with construction beginning October 2027 and operations beginning October 2029;Soluble grade MOP produced by the IPM is sold locally, incurring a transport cost of US$10/t compared to US$43/t for export grade granular MOP railed FOB Vancouver; soluble grade MOP is priced at a US$20/t discount to granular, reflecting a life-of-mine average of US$373.6/t versus US$393.6/t FOB Vancouver;In addition to MOP, the IPM will produce 50,000 m³ per year of KCl brine that may be attractive to regional oilfield services customers at an average transport cost of US$10/m³;Payback period is measured from the start of construction to the point at which cumulative cash flow turns positive; andAlthough the project's mine life is anticipated to extend beyond a 25-year time frame, the NPV(1) and IRR(1) calculations reflect a 25-year "LoM" period.The primary input parameters for the DCF model are outlined in the table below.Table 5: Summary of Inputs for Economic AnalysisInput ParametersUnitValueEvaluation Base Date - IPMDate2026-07-01Evaluation Base Date - Disley East & Disley WestDate2027-07-01Sales: HLD Mine MOP Sales (granular)TPA1,000,000Sales: IPM MOP (soluble)TPA125,000Sales: KCl Brinem3/yr50,000Price: Granular MOP (FOB Vancouver) 25-year averageUS$/t394Price: Soluble MOP 25-year averageUS$/t374Price: KCl BrineUS$/m343Transport Costs: Granular MOPUS$/t43Transport Costs: Soluble MOPUS$/t10Transport Costs: KCl BrineUS$/m310Corporate Tax (Sask. + Canada)%27%Contingency for CAPEX%25%Discount Rate%8%NPV calculationYears25 The Disley East and Disley West mines have a start date of construction later than that of the Initial Production Module, and their IRR(1), NPV(1) and Payback periods are all calculated from that later date, while the overall Project results reflect the start date of the IPM. The individual IPM phase has a payback period of 1.1 years, while Disley East and Disley West each respectively have payback periods of 2.9 years. The total Project payback of 4.7 years reflects an earlier calculated start date at the time of first production at the IPM, prior to first production from Disley East and Disley West.Table 6: Summary of OutputsMetricUnitTotal ProjectInitial CAPEXUS$ million639OPEXUS$55 / tonnePre-Tax NPV(1) (8)US$ million1,534Pre-Tax IRR(1)%35%Post-Tax NPV(1) (8)US$ million1,085Post-Tax IRR(1)%30% The Disley ProjectThe Disley Project is located approximately 50km northwest of Regina and covers 10,610 hectares (Crown and Freehold mineral rights). The property is situated immediately adjacent to the east of the K+S Bethune potash solution mine and north of the Mosaic Belle Plaine potash solution mine — both of which are amongst the largest producing potash solution mines in the world. In the opinion of management, the Disley Project is in one of the most favorable areas of Saskatchewan for potash solution mining (see Figure 2) as evidenced by the success of these neighboring projects(6).Figure 2: The Disley Property Situated Amongst Major Potash Solution Mines(7)To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/12107/294332_592822e3642ebbb0_002full.jpgAbout Buffalo PotashBuffalo Potash is an emerging Saskatchewan-based potash developer pursuing a modular approach to selective solution mining through its patented Horizontal Line-Drive (HLD) technology. Buffalo is advancing the Disley Project — located next to several of the most prominent currently producing potash solution mines in the world — with the objective of establishing capital-efficient, lower-impact potash production in one of the world's leading potash jurisdictions.Qualified PersonThe scientific and technical information contained in this news release has been reviewed and approved by Douglas F. Hambley, PhD, PE, P.Eng., PG, an independent consultant of the Company and Qualified Person as defined under NI 43-101 Guidelines. Dr. Hambley is a globally recognized expert in potash geology and mine development and has assisted Micon in their preparation of the MRE and PEA.All related and pertinent information has also been reviewed for this news release by Jared Galenzoski, P.Geo, FIMMM as an independent consultant and Qualified Person as defined under NI 43-101. Mr. Galenzoski is also an expert in several potash-related fields and has assisted Micon in their preparation of the MRE and PEA.Technical Report and Qualified PersonsFor more information in respect of the Disley Project, including with respect to key assumptions, parameters, and methods used to estimate the MRE, data validation and QA/QC procedures, and the basis, qualifications and assumptions for the PEA, please refer to the entirety of the Technical Report prepared by Ryan Langdon, PhD, P.Geol.; Jack Nagy, PEng; Christopher Jacobs, CEng., MIMMM; and Richard Thompson, CEng, MiChemE. Each of the aforementioned persons is considered a "Qualified Person" for the purposes of NI 43-101 and has reviewed and approved the scientific and technical disclosure contained in this news release. No limitations were imposed on their verification process. Readers are cautioned to review the entirety of the PEA as it contains additional disclosures material to the matters discussed in this press release.Notes(7) The K+S Bethune potash solution mine and north of the Mosaic Belle Plaine potash solution mine (together, the "Adjacent Properties") may each be considered an "adjacent property" (within the meaning of NI 43-101) to the Company's Disley Project. The Company does not have any interest in either of the Adjacent Properties. The Company believes this context is useful in illustrating the proven endowment of the district, while noting that mineralization on adjacent or nearby properties is not indicative of mineralization on the Company's Disley Project. There is no guarantee that the Disley Project will yield comparable results to any of these mines.ContactSteve Halabura, P.Geo. | Chief Executive Officer & DirectorEmail: steve@buffalopotash.ca | Phone: 1-306-220-7715(1) Non-GAAP Financial MeasuresNet Present Value ("NPV") and internal rate of return ("IRR") are forward-looking financial measures used by management to evaluate the economic potential of the Disley Project, as estimated in the PEA. These measures do not have standardized definitions under IFRS and may not be comparable to similar measures disclosed by other issuers.NPV represents the sum of discounted future after-tax cash flows projected over the 25-year evaluation period at a discount rate of 8%, net of initial and sustaining capital expenditures. The most comparable IFRS measure is net income (loss); however, NPV is a forward-looking measure that reflects projected future cash flows and cannot be directly reconciled to historical net income. IRR represents the discount rate at which NPV equals zero across the project's projected cash flows.These measures should not be construed as alternatives to net income, comprehensive income, or cash flows from operations as determined in accordance with IFRS. Readers are cautioned that these measures reflect PEA-level estimates and are subject to the risks and uncertainties disclosed under "Forward-Looking Information" below.Forward-Looking InformationThis news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking information") within the meaning of applicable Canadian securities legislation and the United States Private Securities Litigation Reform Act of 1995. Forward-looking information is generally identifiable by the use of words such as "believes," "may," "plans," "will," "anticipates," "intends," "could," "estimates," "expects," "forecasts," "projects," "targets," "schedules," or similar expressions, and the negative of such expressions.Forward-looking information in this news release includes, but is not limited to, statements regarding: the results, assumptions, and projections contained in or derived from the PEA and Mineral Resource Estimate for the Disley Project, including projected production rates, capital and operating costs, NPV, IRR, payback periods, and mine life; the anticipated timing and phasing of construction and commercial production for the IPM, Disley East, and Disley West; the Company's ability to secure permitting, financing, and all necessary regulatory approvals; the anticipated cost and technical performance of the HLD Mining method; expectations regarding MOP and soluble grade potash pricing, transportation costs, and market access; and the Company's broader development plans and strategy for the Disley Project.Forward-looking information is based on management's reasonable assumptions, estimates, analysis, and opinions made in light of its experience and perception of historical trends, current conditions, and expected future developments, as well as other factors that management believes are relevant and reasonable in the circumstances as of the date such statements are made. Key assumptions underlying the forward-looking information include, but are not limited to: the accuracy of the Mineral Resource Estimate and PEA, including geological, engineering, and cost assumptions; no material adverse changes to commodity prices, exchange rates, or tax and royalty regimes; the availability of financing on acceptable terms; the Company's ability to obtain necessary permits and approvals on anticipated timelines; and the continued availability of equipment, personnel, and infrastructure.Forward-looking information is subject to known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied, including: the inherent uncertainty of PEA-level studies and the possibility that actual capital costs, operating costs, and production rates differ materially from estimates; changes in potash or fertilizer market prices; fluctuations in currency exchange rates, particularly the Canadian dollar relative to the US dollar; the risk that permitting, financing, or regulatory approvals are not obtained on anticipated timelines or at all; risks related to the development, commissioning, and operation of novel mining technology; risks inherent to solution mining operations; and general business, economic, competitive, political, and social risks and uncertainties.A PEA is preliminary in nature and includes Inferred Mineral Resources that are considered too speculative geologically to have the economic considerations applied to them that would enable them to be categorized as Mineral Reserves. There is no certainty that the PEA will be realized. Mineral Resources that are not Mineral Reserves do not have demonstrated economic viability.Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated, or intended. The forward-looking information contained herein is made as of the date of this news release, and the Company disclaims any obligation to update or revise such information except as required by applicable securities laws.Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/294332 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Standard Chartered GBA Business Confidence Indices highlight resilience of GBA corporates despite Middle East uncertainties

HONG KONG, Apr 27, 2026 - (ACN Newswire via SeaPRwire.com) - Standard Chartered and the Hong Kong Trade Development Council (HKTDC) jointly released the latest Standard Chartered Greater Bay Area Business Confidence Index (GBAI), revealing that business sentiment among companies in the Greater Bay Area (GBA) remained stable in the first quarter of 2026 despite ongoing geopolitical and trade headwinds, notably oil price shocks and continued repercussions from the Middle East conflict.Maintaining Momentum Amid HeadwindsThe Q1 findings largely captured activity and business sentiment since the Middle East conflict began in late February, which has remained highly uncertain and weighed on overall business and market sentiment.Despite a reduced appetite for expansion amid persistent geopolitical uncertainties, business sentiment remained steady across the GBA. The “current performance” index for business activity in Q1 edged down marginally to 49.9 from 50.3 in the previous quarter, while the “expectation” index moderated to 50.4 from 51. Both indices hovered around the 50-neutral mark, indicating GBA corporates’ resilience, supported by favourable policies announced by the Chinese Government aimed at boosting the domestic economy, which in turn would partially offset the fallout of the Middle East conflict.The “current performance” index came down mainly driven by “raw material inventory”, “fixed asset investment” and “financing scale”. The latter two readings were believed to reflect more cautious sentiment among businesses in light of the Middle East conflict. Meanwhile, “production/ sales”, “prices of finished goods/ services” and “profits” all experienced quarter-on-quarter expansion.The “expectations” index remained modestly positive, despite heightened external uncertainties. “New orders” held steady at 51.5, while “prices of finished good/ services” rose to 58.5. However, “profits” fell below the 50-watershed level, implying surveyed companies did not view price increases as sufficient to offset a likely rise in energy and material costs.Hong Kong to Sustain a Still-solid Growth PaceBy city, Hong Kong is expected to maintain a solid performance going forward. Although both the “current” and “expectation” sub-indices edged down to 52.7, these readings still comfortably stayed in expansionary territory, supported by improvements in “financial services” and “innovation and technology” sectors.Tommy Wu, Senior Economist, Greater China and North Asia, Standard Chartered, said: “In addition to the initial impact of surging global energy and freight costs, there are concerns about second-round impacts, such as higher input costs and weaker global demand. This is aligned with the latest reading, which shows a 2.3-point decline in “new export orders” to 47.5 for “current performance”, indicating a more cautious outlook for export demand. With the prolonged Middle East conflict, we anticipate global energy prices to be higher for longer and the second-round effects to become more visible in the coming months. These will likely weigh on business sentiment and appetite on making fixed investment. Nevertheless, Hong Kong has once again demonstrated its resilience amid market turbulence, and such resilience is expected to attract more global capital into HKD and Renminbi assets as safe-haven allocation.”Demand-boosting Measures Favour GBA BusinessesThe survey also investigated the impacts of a series of supportive policies from the Chinese government aimed at stimulating domestic demand in its thematic section. Among the new policy measures introduced by the Ministry of Finance in January, most respondents cited “loan interest subsidies for small, medium and micro-sized enterprises” (38.4%), “large-scale equipment upgrade subsidies” (36.9%) and “consumer goods trade-in subsidies” (31.7%) as the top domestic demand-boosting policies likely to have the most positive impact on their business.Wing Chu, Deputy Director of Research, HKTDC, said: “Demand-boosting stimulus is generating tangible benefits for GBA companies, helping to cushion external challenges amid the Middle East conflict. Targeted support, including loan interest subsidies, alongside measures aimed at stimulating consumer spending, is underpinning demand and supporting business activity across the GBA. Overall, policy-led demand support continues to serve as a meaningful tailwind for GBA businesses. While cost pressures and market competition remain key concerns, respondents are considering stepping up investment in talent and market promotion to sustain further business growth.”While many respondents believe stimulative policies could benefit their businesses by boosting online sales (36.6%) and reducing operating costs (33.8%), challenges faced by GBA corporates remain. Specifically, 54.9% of respondents identified labour costs as the biggest pressure point for their businesses, followed by rental costs (41.7%) and market competition (33.3%). Zooming into Hong Kong respondents, market competition was viewed as a more pressing challenge than rental costs, likely due to the increase in cross-border travel and change in consumption behaviours in recent years. In these circumstances, 38.7% would prioritise their investment in talent recruitment, followed by market promotion (38.1%) and personnel training (36.7%).About the GBAIThe GBAI is the first forward-looking quarterly survey in the market that looks at the business sentiment and synergistic effects in cities and industries across the GBA. It is compiled based on a survey of more than 1,000 companies in the GBA covering the manufacturing and trading, retail and wholesale, financial services, professional services and innovation and technology sectors. The index enables investors and businesses to better understand the current business climate, gauge future performance prospects and formulate their market strategies for the GBA.Related materialsStandard Chartered GBA Business Confidence Index Report: https://www.sc.com/hk/gba/gba-index-report/HKTDC Research: https://research.hktdc.com/en/article/MjMwNjM2MTgxMQReport and photos download: https://bit.ly/4u3izEMWing Chu, Deputy Director of Research, HKTDC (right), and Tommy Wu, Senior Economist, Greater China and North Asia, Standard Chartered (left), announced the latest GBA Business Confidence Index (GBAI) on 27 April 2026.Media enquiriesCorporate Affairs DepartmentStandard Chartered Bank (Hong Kong) Limited Flora Chiu Tel: (852) 3843 2285 Email: flora.chiu@sc.com   Communications & Public Affairs DepartmentHKTDC Christy LeeClayton Lauw Tel: (852) 2584 4369Tel: (852) 2584 4472Email: christy.wn.lee@hktdc.orgEmail: clayton.y.lauw@hktdc.orgAbout Standard CharteredWe are a leading international banking group, with a presence in 54 of the world’s most dynamic markets. Our purpose is to drive commerce and prosperity through our unique diversity, and our heritage and values are expressed in our brand promise, here for good.Standard Chartered PLC is listed on the London and Hong Kong stock exchanges.The history of Standard Chartered in Hong Kong dates back to 1859. It is currently one of the Hong Kong SAR’s three note-issuing banks. Standard Chartered incorporated its Hong Kong business on 1 July 2004, and now operates as a licensed bank in Hong Kong under the name of Standard Chartered Bank (Hong Kong) Limited, a wholly owned subsidiary of Standard Chartered PLC.For more stories and expert opinions please visit Insights at sc.com. Follow Standard Chartered on X, LinkedIn, Instagram and Facebook.About HKTDCThe Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Follow us on  @hktdc and  LinkedIn Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

貿發局七大時尚創意及授權盛事 今日盛大揭幕

香港, 2026年4月27日 - (亞太商訊 via SeaPRwire.com) - 香港貿易發展局(香港貿發局)七大時尚生活產品及授權盛事今日揭幕,包括於今天至4月30日在灣仔香港會議展覽中心舉行的香港禮品及贈品展(禮品展)、香港時尚家品及家紡展(Home InStyle)、香港時裝節(Fashion InStyle),以及於亞洲國際博覽館舉行的香港國際印刷及包裝展(印包展)和香港奢侈品包裝展。而香港國際授權展(授權展)及亞洲授權業會議則由今天至4月29日在灣仔會展舉行。六項展覽共吸引來自超過30個國家及地區、約5,600家展商參與。香港貿發局總裁張淑芬表示:「香港一直是環球企業通往中國內地的主要門戶,擔當連接中國內地龐大市場與世界各地間的『超級聯繫人』和『超級增值人』的角色。香港憑藉穩固的優勢、完善的創新生態系統及知識產權基建,是企業拓展業務、實現創新發展,及將成果商業化的理想地。」創意禮品及家品薈萃 禮品展及Home InStyle成新品發佈平台禮品展與Home InStyle為買家帶來多元化禮品及家品選擇,產品涵蓋文化及創意、可持續發展、創新物料、樂齡科技等範疇。部份焦點內容集中於會展五樓展覽廳的全新Reimagine主題樓層,讓買家一站式掌握環球最新時尚家品及禮品方案,啟發業界想像未來產品的更多可能,帶來新視角及靈感。兩展亦吸引展商作發佈新產品平台。禮品展展商唯一冷熱水壺廠(展位:1E-D02)首次推出由香港插畫師 Pen So 與香港當代藝術家曹志豪設計的MINI20保溫杯盲盒。適逢其駱駝牌品牌與李小龍誕辰同樣迎來85周年,該展商亦推出另一聯乘保溫壺款式。Home InStyle展商百隆人工智能 (展位:5E-C20)首次展出防感染流動廁所,免安裝、無需用水,使用前後均無需重複消毒和接觸排泄物,更提供健康監測方案,將專業護理無縫融入現代家居。禮品展主打設計精品及訂製禮品禮品展於會展一樓展覽廳的卓越廊雲集超過100家本地及環球展商,主打高端及具設計特色的產品,涵蓋文具、家居用品及配備嶄新科技的智能精品。星光實業(展位:1C-G03)帶來紅 A「香港製造」迷你系列盲盒,以經典家品喚起1960至1990年代香港生活記憶。滙賢集團有限公司(展位:1C-E05)則展示為匹克球愛好者而設的 Napier Coded 背包,採用回收物料製成,結合運動與環保元素。Home InStyle引領家居新趨勢由創新科技署資助的樂齡科技及創新物料館(展位:5E-C20)設於Home InStyle,匯聚超過20家本地企業,展示樂齡科技產品、智能生活方案及創新物料家品。Scan Infinity Ltd帶來 TechFitX 智能運動訓練系統,透過切換組件及遊戲形式訓練, 讓長者輕鬆在家建立運動習慣。聯合國嶺南大學人道創新及科技中心展出 IntuCREW 智慧動力輔助解決方案,減輕照顧者推輪椅的體力負擔。其他產品包括聖諾盟 (Sinomax) 的仿生音波哄睡寶、德國寶 (German Pool) 的自然養生機,以及雅芳婷 (Afontane) 的自動清潔床上用品。創新物料方面,德塘瑞華國際股份有限公司展示以蓮花莖製成的可生物分解餐具及餐盒,以及蓮花纖維除臭貓砂; Editecture展出以回收塑膠瓶及瓶蓋碎片製成的 reEDIT 升級再造椅;Mush Composites則展示以農業副產品及菌絲體製成的生物基瓷磚,可應用於裝飾表面。Home InStyle另一焦點文創體驗區集合來自超過10個國家及地區、逾110家設計機構及文化品牌參與。當中包括印尼展商 PT MANAMU ANAIA SUMBA(展位:5E-C09A)帶來巴諾拉手鐲、捷克展商Izaak Reich Crystal s.r.o. (展位:5E-A14)展示超過150年歷史的手工玻璃、英國展商Block Design(展位:5E-C09B)的雙面造型玻璃花瓶、台灣展商Karari(展位:5E-A18)的線香器物、以及澳門展商(展位:5E-A16)的3D打印產品等。大會再度聯乘Pantone,以 2026 年度代表色「雲上舞白」為主題,打造不同家居陳列場景,幫助買家了解如何運用色彩配搭塑造時尚家居。Fashion InStyle展示環球時尚物料創新應用由香港貿發局主辦、香港特別行政區政府「文創產業發展處」資助的焦點展區NEXT@Fashion InStyle (NEXT)今年再度登場,展示時裝界如何通過創新物料引領產業變革、實踐永續發展。今年特別邀請菲律賓作為合作夥伴,並得到菲律賓駐香港貿易投資中心(PTIC-HK)及國際貿易展覽和代表團中心(CITEM)全力支持。而NEXT展區匯聚超過60家環球展商,覆蓋地域廣闊,當中有來自比利時的 Bloom Biotech (展位:3F-F09),展出微藻皮革,是首款採用可擴展綠色科技製的碳中和皮革替代品;而來自芬蘭的 Spinnova PLC(展位:3F-E04)展示以木材或廢棄纖維素製成的 SPINNOVA(R)新一代紡織纖維,適用於傳統紡織工藝,並可與棉纖維無縫混紡,為服裝及其他領域提供可擴展、可循環利用的紡織解決方案;而來自越南的 Thai Son S.P Co., Ltd.(展位:3F-F03)帶來多款織物,包括已有3000多年歷史的苧麻纖維不僅具有優異性能,更具有天然抗菌特性。NEXT展區還有來自香港、中國内地、泰國、印尼、冰島、瑞典、美國等地的展商展出各種創新物料。今年NEXT繼續邀請當代時尚品牌 Self-Portrait 創辦人兼創意總監 Han Chong 擔任項目顧問,帶領六組本地設計師及品牌組合,從八家物料供應商精選前瞻物料,傾力打造跨界企劃。今年更會首次利用香港及中國内地以外的物料進行設計,為時尚物料帶來新衝擊。如設計品牌WILSONKAKI將由法國供應商Chargeurs PCC提供的全球最輕H2物料、印尼供應商MYCL提供的菌絲皮革和香港供應商Texwinca提供的天然纖維糅合,透過層壓及黏合工藝,製作出兼具輕盈防護與自然觸感的日常單品。各組設計成品將在明天(4月28日)的時裝巡禮亮相。Fashion InStyle亦設有更多展區,包括設計師舞台、輔料及布料、時尚配飾、女裝、新娘禮服及晚裝、運動時尚等,展示各款成衣及配飾設計。Glory G International Limited(展位:3G-B31)展出「柔韌」系列輕質猄皮丹寧,打破牛仔褸沉重刻板印象;香港海源有限公司(展位:3G-F18)展出兼具裝飾性與實用性,可掛在手袋、鑰匙等物件作日常配搭的流蘇掛飾;來自烏茲別克的 Bibi Hanum(展位:3F-G29)則帶來具傳統特色的絲綢伊卡拼接裹身裙。印包展及奢侈品包裝展呈現綠色方案與高端工藝由貿發局和華港國際展覽有限公司主辦的印包展及香港奢侈品包裝展,展示創新、環保及高端印刷包裝方案。印包展展商環亞印刷包裝有限公司(展位:3-E01)推出的FSC無塑料纖維素膜包裝及FSC半透明紙袋,主打無塑膠及可回收,充分體現環保理念。寶紳國際香港有限公司(展位:3-E02)則帶來RFID(無線射頻識別)標籤,其內層以紙為原材料,兼顧永續設計。廣州市星啟元貿易有限公司 (展位:3-E11) 展示以農業廢料為原料的環保濕壓紙塑包裝,兼具實用性與環保價值。至於奢侈品包裝展,雅雋商務拓展(展位:3-A05)帶來立體旋轉音樂盒及復古留聲機禮盒,結合音樂播放、收納功能及高端包裝。美新隆(集團)有限公司(展位:3-A08)的紙燈籠花鳥罐採用一罐兩用設計,延長產品使用週期;亦帶來維港日夜光影禮盒,結合光影效果和收納功能,用於精緻食品包裝。授權展首設知識產權及電子商貿支援服務專區 拓展線上商機香港國際授權展匯聚來自香港、中國內地及亞洲各地超過 330 家參展商,展示超過 600 個品牌及知識產權項目,涵蓋藝術及文化、動畫與角色、品牌延伸、娛樂及體育授權等多個領域。展會首設知識產權及電子商貿支援服務專區,以配合特區政府積極提升港商在跨境電商平台競爭力的政策方向。專區匯聚多家電商平台、KOL、營銷及公關公司,包括電商平台Digitify Online Growth (展位:5G-E04)及營銷公司Matrix Promotion Limited (展位:5G-F01),支援品牌及知識產權項目把握電商發展帶來的新機遇。各大電商商會在展會期間舉辦包括搭建電商平台、透過電商平台「出海」和直播帶貨等相關的工作坊,協助業界掌握先機。授權展焦點 IP 包括 9GAG Limited 的 Potatoz(展位:5G-D20)、Toyzeroplus Limited 的 罐頭豬LULU(展位:5G-A24)、Yogurt Studio Ltd. 的 Café de Bollo(展位:5F-G20),以及來自中國內地的 乖巧寶寶(展位:5G-A22)、韓國的 LOTTY FRIENDS (展位:5F-G36)和泰國的 Warbie Yama(展位:5G-A51)等。由創意創業會主辦,香港特區政府文創產業發展處贊助的「香港設計授權‧支援計劃」在香港國際授權展續設「DLAB香港館」,雲集近40家展商,展示多個香港原創品牌及IP。大會亦再次與香港恒生大學、香港浸會大學及香港理工大學合作,並加入香港知專設計學院,舉辦香港授權新力量展區,展示本港新晉創意人才的創意設計。與展會同期舉行的亞洲授權業會議,邀請業界領袖探討多項市場焦點議題,當中今天會議邀請國際授權業協會行政總裁Maura Regan分享「2026年全球授權業趨勢展望」。適逢世界盃於今年舉行,會議亦邀請到國際足球協會(FIFA)高級授權經理Alessandro Villa及香港山成集團創辦人兼行政總監陳華俊分享成功體育授權後的商業策略。COVER株式會社執行副總裁兼銷售本部長毛延熙,將在明天探討虛擬 YouTubers (VTubers) 如何透過具策略性的社交媒體互動,與 Z 世代建立連結。研討會論壇探索市場新機遇為協助業界掌握最新發展趨勢,展會期間將舉辦約60場主題研討會、買家論壇、產品推廣及發佈會。內容聚焦銀髮經濟、市場趨勢、文化與創新,以及永續發展等熱門主題。其中,印包展及奢侈品包裝展其中一場研討會由貿發局與香港數碼印刷協會合辦,以「從指令到現實:生成式AI與數碼印刷的創意視覺革命」為題,分享生成式人工智能與數碼印刷如何推動創新轉型。禮品展與Home InStyle將舉行「循環再禮:永續家居與禮品設計的趨勢與突破」研討會,探討可持續設計的新方向。Fashion InStyle則會舉辦「文化融合×生活設計:『流行紋化』的超現實美」研討會,為業界帶來最新市場分析、創新思維及實踐策略。圖片下載:https://bit.ly/4vQE39E香港貿發局舉辦的香港禮品及贈品展、香港時尚家品及家紡展(Home InStyle)、香港時裝節(Fashion InStyle)、香港國際印刷及包裝展、香港奢侈品包裝展,以及香港國際授權展及亞洲授權業會議今天在香港會議展覽中心揭幕,六個展覽項目匯聚來自超過30個國家及地區、約5,600家展商。香港貿發局總裁張淑芬今早(4月27日)出席香港國際授權展與亞洲授權業會議開幕典禮,並為活動致開幕辭。(左起)文創產業發展處文創產業專員黎細明、亞洲旅遊交流中心主任張棟、香港貿發局總裁張淑芬、香港特區政府文化體育及旅遊局常任秘書長沈鳳君、泰國文化部Plan and Policy Analyst Expert Level Narathorn Parndee及國際授權業協會行政總裁Maura Regan共同主持開幕儀式。禮品展內的卓越廊雲集高端且具設計特色的禮品,涵蓋文具、家居用品及配備嶄新科技的智能精品。Home InStyle的樂齡科技及創新物料館,匯聚超過20家本地企業,展示樂齡科技產品、智能生活方案及多款可應用於家品及家紡市場的創新物料。文創體驗區集中展示環球文創家品,匯聚具有文化創意及獨特風格的設計師品牌。Fashion InStyle今年設有焦點展區NEXT@Fashion InStyle,項目合作夥伴菲律賓帶來超過25家展商展出當地時尚物料。NEXT@Fashion InStyle項目顧問Han Chong(中)帶領六組本地設計師及品牌打造多款選用精選環球創新物料的時裝設計。於印包展亮相的寶紳國際香港有限公司展示RFID(無線射頻識別)標籤,內層以紙為原材料,兼顧功能與永續設計。美新隆(集團)有限公司於奢侈品包裝展帶來維港日夜光影禮盒,結合光影效果和收納功能,用於精緻食品包裝。香港國際授權展今年首設知識產權及電子商貿支援服務專區。香港貿發局新聞中心:http://mediaroom.hktdc.com/tc香港禮品及贈品展:http://www.hktdc.com/event/hkgiftspremiumfair/tc香港時尚家品展 (Home InStyle):https://www.hktdc.com/event/homeinstyle/tc香港國際家用紡織品展 :www.hktdc.com/event/hkhometextilesfair/tc香港時裝節 (Fashion InStyle):www.hktdc.com/event/fashioninstyle/tc香港國際印刷及包裝展:https://www.hktdc.com/event/hkprintpackfair/tc香港國際授權展:https://www.hktdc.com/event/hklicensingshow/tc亞洲授權業會議:https://www.hktdc.com/event/hklicensingshow/tc/programme?category=all&date=all傳媒查詢新聞界如有查詢,請聯絡:香港時尚家品及家紡展(Home InStyle)、香港時裝節(Fashion InStyle)、香港禮品及贈品展、香港國際印刷及包裝展及香港奢侈品包裝展:Pandagon公關公司:  李彥煒電話:6083 5623電郵:pandagon.limited@gmail.com   香港貿發局傳訊及公共事務部:  劉茸電話:2584 4472電郵:clayton.y.lauw@hktdc.org香港國際授權展及亞洲授權業會議:言十公關公司:  劉碧思電話:6187 7786電郵:molisalau@raconteur.hk謝媛彰 電話:9742 7338電郵:betsytse@raconteur.hk   香港貿發局傳訊及公共事務部:  簡惠宜電話:2584 4055電郵:winnie.wy.kan@hktdc.org香港貿易發展局簡介香港貿易發展局(香港貿發局)今年慶祝成立60周年!成立於1966年,香港貿發局是負責促進、協助和發展香港貿易的法定機構。香港貿發局在世界各地設有超過50個辦事處,其中13個設於中國內地,致力推廣本港作為雙向環球投資及商業樞紐。 香港貿發局通過舉辦國際展覽會、會議及商貿考察團,為企業(尤其是中小企)開拓內地和環球市場的機遇。香港貿發局亦通過研究報告和數碼資訊平台,提供最新的市場分析和產品資訊。有關香港貿發局的其他資訊,請瀏覽www.hktdc.com/aboutus/tc。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

康哲藥業就已上市原研藥靜脈鐵劑莫諾菲和科莫非簽訂獨家商業化與供應協議

深圳, 2026年4月27日 - (亞太商訊 via SeaPRwire.com) - 康哲藥業控股有限公司(867.HK/8A8.SG)("康哲藥業")欣然宣佈,近期,康哲藥業通過其全資附屬公司與Pharmacosmos A/S就異麥芽糖酐鐵注射液("莫諾菲(R)")和右旋糖酐鐵注射液("科莫非(R)")簽訂獨家商業化與供應協議("協議")。根據協議,康哲藥業獲得了在中華人民共和國(就本協議而言,不含香港特別行政區、澳門特別行政區、臺灣地區)獨家商業化產品的權利,Pharmacosmos A/S繼續負責生產、供應產品。合作期限為協議約定的生效之日起十五年,到期前雙方可友好協商延長。本次合作的兩款靜脈鐵劑均為原研藥,已在中國獲批上市並納入國家醫保目錄。其中,莫諾菲(R)為獨家藥,是中國首款獲批上市的第三代靜脈鐵劑,具有更穩定的創新矩陣式納米結構,安全性更優[1],可一次足量補鐵,顯著減少輸注次數、更快提升血紅蛋白水平,提高臨床便捷性。另一款產品科莫非(R)為目前中國唯一被納入國家醫保目錄甲類,也是唯一被納入國家基本藥物目錄的靜脈鐵劑,臨床應用多年,其有效性與安全性已得到累積的臨床經驗和已發表數據的支持。上述兩款產品將形成覆蓋全渠道、全場景的靜脈補鐵產品矩陣,可滿足不同層級醫療機構、不同類型缺鐵性貧血患者的臨床需求,為患者提供更多元化、安全、高效的治療選擇。鐵缺乏症/缺鐵性貧血患者廣泛分佈於消化、心內、腎內、婦產、骨科等多個科室,均為康哲藥業的優勢專科領域,兩款產品的加入將與其現有在售產品的專家資源、學術推廣網絡高效協同,進一步強化康哲藥業在貧血治療領域的整體競爭力,並預期對其業績產生積極正面影響。關於莫諾菲(R)的更多信息莫諾菲(R)已於2021年1月30日獲批,用於治療口服鐵劑無效、無法口服補鐵或臨床需快速補鐵時的缺鐵狀況。2023年被納入《國家基本醫療保險、工傷保險和生育保險藥品目錄》(醫保目錄)乙類醫保。莫諾菲(R)由納米顆粒組成,其結構穩定、呈基質樣,由鐵原子層與短鏈線性异麥芽糖碳水化合物層交替構成。該結構可實現可控的鐵釋放,游離鐵含量更低,從而有助於形成良好的安全性特徵,包括較低的超敏反應和低磷血症風險。莫諾菲(R)可實現單次高劑量靜脈輸注給藥1000mg或更高劑量,而較早的療法(如蔗糖鐵)通常需要多次給藥,每次僅100至200 mg。因此莫諾菲(R)一次治療即可實現足量補鐵,减少輸注次數,減輕醫患負擔,並提升輸注能力。同時,其低磷血症風險較低,有助於避免骨折等併發症,並支持改善疲勞症狀(缺鐵性貧血關鍵症狀之一)。關於科莫非(R)的更多信息科莫非(R)為第二代低分子量右旋糖酐鐵注射液,於2003年在中國大陸獲批上市,用於無法口服鐵劑的缺鐵病人(如不耐受或口服鐵劑治療不滿意),同樣可實現單次大劑量足量補鐵。科莫非(R)憑藉多年臨床應用積累,其有效性與安全性已得到累積的臨床經驗和已發表數據的支持,其甲類醫保與基藥的雙重資質,支持其基層臨床補鐵的核心地位。關於鐵缺乏症和缺鐵性貧血鐵缺乏症(iron deficiency,ID)和缺鐵性貧血(iron deficiency anemia,IDA)是普遍影響兒童、停經前女性(尤其是孕婦)及老年人的全球性健康問題,可對多系統器官功能造成損害,引發生長發育遲緩、行為障礙、認知功能損傷、體能受損、圍產期及圍手術期併發症等一系列健康問題,亦會嚴重影響消化系統疾病、慢性腎臟疾病、心力衰竭及腫瘤等慢性疾病的預後[2]。超過10億人患有缺鐵性貧血[3],使其成為全球疾病負擔的主要因素之一[4]。中國第4次營養調查數據顯示,居民IDA患病率為20.1%[5],但醫患雙方重視程度不足,輕度貧血獲診治者不足20%,極重度貧血者亦僅50%獲診治,ID/IDA存在明顯診斷不及時及治療率偏低的情況[2]。補鐵為ID/IDA的常規治療方式,分為口服補鐵與靜脈補鐵,其中靜脈鐵劑是口服鐵劑不耐受、口服鐵劑療效不佳、臨床需快速補鐵、患者希望1-2次補足鐵量等情境下的重要手段[1,2,6]。但因對IDA重視不足、服藥依從性、住院時間、輸液便利性等條件限制,加上對靜脈鐵劑安全性的顧慮導致靜脈鐵劑使用較為保守。中國真實世界研究顯示,IDA患者蔗糖鐵使用總劑量均值為511mg,遠未達目標劑量1000mg[2]。臨床亟需安全性高、補鐵療效佳、可一次足量補鐵的靜脈鐵劑產品。莫諾菲(R)與科莫非(R)構建覆蓋全場景的靜脈補鐵產品矩陣,為缺鐵性貧血患者提供分層診療選擇。關於Pharmacosmos A/SPharmacosmos A/S為碳水化合物化學及缺鐵與缺鐵性貧血創新治療領域的全球領先企業。公司憑藉在碳水化合物化學與細胞週期生物學的深厚專業積累,致力於針對未被滿足的患者需求開發創新療法,重點關注鐵代謝及血液相關疾病。公司成立於1965年,總部位於丹麥,團隊由來自英國、愛爾蘭、北歐、德國、美國、加拿大及中國的700多名專家組成。憑藉優異的產品質量與臨床價值,核心鐵劑產品已於全球多個國家及地區獲批上市並廣泛應用,積累深厚技術實力與優質市場口碑。關於康哲藥業康哲藥業是一家鏈接醫藥創新與商業化,把控產品全生命週期管理的開放式平臺型企業,致力於提供有競爭力的產品和服務,滿足尚未滿足的醫療需求。康哲藥業專注於全球首創(FIC)及同類最優(BIC)的創新產品,並高效推進創新產品臨床研究開發和商業化進程,賦能科研成果向診療實踐的持續轉化,造福患者。康哲藥業聚焦專科領域,擁有被驗證的商業化能力,廣泛的渠道覆蓋和多疾病領域專家資源,核心在售產品已獲領先的學術與市場地位。康哲藥業圍繞優勢專科領域不斷縱深發展,以鞏固心腎代謝/消化/眼科/皮膚健康業務競爭力,帶來專科規模效率,其中皮膚健康業務(德鎂醫藥)已成為其細分領域的龍頭企業,並擬於聯交所獨立上市。同時,康哲藥業持續推動研產銷全產業鏈在東南亞及中東區域運營發展,以獲取新興市場的增量,助力集團實現高質量可持續發展。參考文獻/資料1. 中國藥理學會藥源性疾病學專業委員會. 廣東省藥學會. 靜脈鐵劑的臨床應用和藥學監護專家共識(2024)[J]. 藥物不良反應雜誌, 2025, 27(3): 129-141. DOI: 10.3760/cma.j.cn114015⁃20240929⁃000702. 廖敏婧, 張連生. 鐵缺乏及缺鐵性貧血規範化診治[J]. 中華內科雜誌, 2023, 62(6): 722-727. DOI: 10.3760/cma.j.cn112138-20230210-00074.3. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME); 2020. Available from http://ghdx.healthdata.org/gbd-results-tool.4. Pasricha SR, Tye-Din J, Muckenthaler MU, Swinkels DW. Iron deficiency. Lancet. 2021 Jan 16;397(10270):233-248.5. 李莉娟, 張連生. 缺鐵性貧血規範化診治的若干問題[J]. 中華醫學雜誌, 2021, 101(40): 3266-3270. DOI: 10.3760/cma.j.cn112137-20210609-01319.6. 中華醫學會血液學分會紅細胞疾病(貧血)學組. 鐵缺乏症和缺鐵性貧血診治和預防的多學科專家共識(2022年版)[J]. 中華醫學雜誌, 2022, 102(41): 3246-3256. DOI: 10.3760/cma. j.cn112137-20220621-01361.康哲藥業免責與前瞻性聲明本新聞無意向您做任何產品的推廣,非廣告用途。本新聞不對任何藥品和醫療器械和/或適應症作推薦。若您想了解具體疾病診療信息,請遵從醫生或其他醫療衛生專業人士的意見或指導。醫療衛生專業人士作出的任何與治療有關的決定應根據患者的具體情況並遵照藥品說明書。由康哲藥業編制的此新聞不構成購買或認購任何證券的任何要約或邀請,不形成任何合約或任何其他約束性承諾的依據或加以依賴。本新聞由康哲藥業根據其認為可靠之資料及數據編制,但康哲藥業並無進行任何說明或保證、明述或暗示,或其他表述,對本新聞內容的真實性、準確性、完整性、公平性及合理性不應加以依賴。本新聞中討論的若干事宜可能包含涉及康哲藥業的市場機會及業務前景的陳述,該等陳述分別或統稱為前瞻性聲明。該等前瞻性聲明並非對未來表現的保證,存在已知及未知的風險、不明朗性及難以預知的假設。康哲藥業並不採納本新聞包含的第三方所做的任何前瞻性聲明及預測,康哲藥業對該等第三方聲明及預測不承擔責任。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

CMS (867.HK/8A8.SG) Signed An Exclusive Commercialization and Supply Agreement for Marketed Originator Intravenous Iron Products Monofer(R) and Cosmofer(R)

SHENZHEN, Apr 27, 2026 - (ACN Newswire via SeaPRwire.com) - China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that, the Group through its wholly-owned subsidiary entered into an exclusive commercialization and supply agreement (the “Agreement”) with Pharmacosmos A/S for Iron Isomaltoside Injection (“Monofer®”) and Iron Dextran Injection (“Cosmofer®”) recently. In accordance with the Agreement, the Group has obtained an exclusive right to commercialize the products in the People’s Republic of China (for the purpose of this Agreement, excluding the Hong Kong Special Administrative Region, the Macau Special Administrative Region and Taiwan region). Pharmacosmos A/S will continue to manufacture and supply the products. The cooperation term shall be fifteen years from the effective date stipulated in the Agreement, which may be extended upon mutual agreement between the parties prior to expiry.The two intravenous iron therapies under this cooperation are both originator products that have been approved for marketing in China and included in the China’s National Reimbursement Drug List (NRDL). Among them, Monofer® is an exclusive drug and the first third-generation intravenous iron therapy approved for marketing in China. It features an innovative and more stable matrix-like nanostructure and provides a superior safety profile[1]. Its single-dose full iron replenishment significantly reduces the number of infusions, enables faster improvement in hemoglobin levels and enhances clinical convenience. Another product, Cosmofer®, is currently the only intravenous iron therapy included in Category A of the NRDL and also the only one included in the National Essential Medicines List (NEML). With many years of accumulated clinical use, its efficacy and safety have been supported by accumulated clinical experience and published data.The above two products will form a comprehensive intravenous iron product portfolio covering all channels and treatment scenarios, which can support meeting the clinical needs of different levels of healthcare institutions and different types of iron deficiency anemia (IDA) patients, providing more diversified, safe and effective treatment options for patients. Patients with iron deficiency (ID) and IDA are widely distributed across multiple clinical departments, including gastroenterology, cardiology, nephrology, obstetrics and gynecology, and orthopedics, which are all key specialty areas of the Group. The addition of the two products will generate efficient synergies with the Group’s existing marketed products in expert resources and academic promotion network, further strengthening the Group’s overall competitiveness in the field of anemia treatment, and is expected to have a positive impact on the Group’s performance.More information about Monofer®Monofer® was approved on 30 January 2021 for the treatment of iron deficiency in patients where oral iron preparations are ineffective, cannot be used, or where there is a clinical need for rapid iron supplementation. In 2023, Monofer® was included in the NRDL as a Category B reimbursable drug. Monofer® consists of nanoparticles with a stable, matrix-like structure composed of interchanging layers of iron atoms and short, linear isomaltose carbohydrates. This structure enables controlled iron release with low levels of labile iron, contributing to a favourable safety profile, including a low risk of hypersensitivity reactions and hypophosphatemia. Monofer® can be administered as a high-dose infusion of 1,000 mg or more in a single visit, whereas older therapies such as iron sucrose typically require repeated administrations of 100 to 200 mg. This enables full iron repletion in one treatment, reducing the need for multiple infusions, lowering the burden on patients and healthcare systems, and increasing infusion capacity. At the same time, the low risk of hypophosphatemia helps avoid complications such as fractures and supports recovery from fatigue, a key symptom of iron deficiency anaemia.More information about Cosmofer®Cosmofer® is a second-generation low-molecular-weight iron dextran injection. It was approved for marketing in Mainland China in 2003 and is indicated for patients with iron deficiency who cannot take oral iron preparations (such as those who are intolerant to oral iron or have unsatisfactory therapeutic outcomes). Cosmofer® also allows single-dose high-dose iron repletion. With many years of accumulated clinical use, its efficacy and safety have been supported by accumulated clinical experience and published data. Its dual status as a Category A NRDL-listed product and NEML supports its core role in iron supplementation in primary healthcare settings.About Iron Deficiency and Iron Deficiency AnemiaID and IDA are global health issues that commonly affect children, premenopausal women (particularly pregnant women) and the elderly. These conditions may impair the function of multiple organ systems, leading to a series of health problems such as growth retardation, behavioral disorders, cognitive impairment, reduced physical capacity, and peri-natal and peri-operative complications. They also significantly affect the prognosis of chronic diseases such as gastrointestinal diseases, chronic kidney disease, heart failure and tumors[2]. More than 1 billion people live with iron deficiency anaemia[3], making it one of the leading contributors to the global burden of disease[4]. Data from the Fourth National Nutrition Survey in China indicate that the prevalence of IDA among Chinese residents is 20.1%[5]. However, both patients and healthcare professionals have insufficient awareness of the disease. Less than 20% of patients with mild anemia receive diagnosis and treatment, while only about 50% of patients with severe anemia receive appropriate diagnosis and treatment[2]. This indicates significant underdiagnosis and undertreatment of ID/IDA. Iron supplementation is the standard treatment for ID/IDA and includes oral iron therapy and intravenous iron therapy. Intravenous iron therapy is an important option for patients who cannot tolerate oral iron, have inadequate response to oral therapy, require rapid iron repletion, or prefer full iron supplementation within one to two administrations[1,2,6]. However, due to insufficient awareness of IDA, patient adherence issues, hospitalization constraints, infusion convenience, and safety concerns regarding intravenous iron therapies, the clinical use of intravenous iron in China remains relatively conservative. A Chinese real-world study shows that the average total dose of iron sucrose used in IDA patients was approximately 511 mg, which was significantly lower than the target dose of 1,000 mg[2]. There is therefore a significant clinical need for intravenous iron therapies that offer high safety, strong demonstrated efficacy and single-dose full iron repletion. Monofer® and Cosmofer® together establish a comprehensive intravenous iron product portfolio covering multiple treatment scenarios, providing tiered treatment options for patients with iron deficiency anemia.About Pharmacosmos A/SPharmacosmos A/S is a global leader in carbohydrate chemistry and innovative treatments for iron deficiency and iron deficiency anemia. Leveraging its deep expertise in carbohydrate chemistry and cell cycle biology, the company is committed to developing innovative therapies to address unmet patient needs, with a particular focus on iron metabolism and hematology-related diseases. Pharmacosmos A/S was founded in 1965 and is headquartered in Denmark, and employs more than 700 specialists from the United Kingdom, Ireland, the Nordic countries, Germany, the United States, Canada and China. With excellent product quality and strong clinical value, its core iron therapy products have been approved and widely used in multiple countries and regions worldwide, establishing strong technological capabilities and a solid market reputation.About CMSCMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardiovascular-kidney-metabolic/gastroenterology/ophthalmology/skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.Reference:1. Chinese Pharmacological Society Professional Committee of Drug‑induced Diseases, Guangdong Pharmaceutical Association. Expert consensus of clinical application and pharmaceutical care for intravenous iron agents (2024) [J]. Adverse Drug Reactions Journal, 2025, 27(3): 129-141. DOI: 10.3760/cma.j.cn114015⁃20240929⁃000702. Liao Minjing, Zhang Liansheng. Standardized diagnosis and treatment of iron deficiency and iron‑deficiency anemia [J]. Chinese Journal of Internal Medicine, 2023, 62(6): 722-727. DOI: 10.3760/cma.j.cn112138-20230210-00074.3. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME); 2020. Available from http://ghdx.healthdata.org/gbd-results-tool.4. Pasricha SR, Tye-Din J, Muckenthaler MU, Swinkels DW. Iron deficiency. Lancet. 2021 Jan 16;397(10270):233-248.5. Li Lijuan, Zhang Liansheng. Considerations on the standardized diagnosis and treatment of iron‑deficiency anemia [J]. National Medical Journal of China, 2021, 101(40): 3266-3270. DOI: 10.3760/cma.j.cn112137-20210609-01319.6. Red Blood Cell Disease (Anemia) Group, Chinese Society of Hematology, Chinese Medical Association. Multidisciplinary expert consensus on the diagnosis, treatment and prevention of iron deficiency and iron deficiency anemia (2022 edition) [J]. National Medical Journal of China, 2022, 102(41): 3246-3256. DOI: 10.3760/cma. j.cn112137-20220621-01361.CMS Disclaimer and Forward-Looking StatementsThis press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Kincora Investor Webinar Invitation

Vancouver, British Columbia--(ACN Newswire via SeaPRwire.com - April 27, 2026) - Copper-gold explorer and hybrid project generator Kincora Copper Limited (ASX: KCC) (TSXV: KCC) (Kincora or the Company) is pleased to announce that it will be holding an Investor Webinar Presentation and Discussion on the afternoon of Tuesday April 28th Pacific Standard Time (PST) and morning of Wednesday 29th Australian Eastern Standard Time (AEST).President & Chief Executive Officer, Mr Sam Spring, will update the market on recent and upcoming drill programs, exploration activities and corporate developments across the project portfolio.Both Kincora shareholders and interested investors are invited to attend the webinar and participate in the accompanying Q&A session.Kincora Copper Investor Webinar Details: Canada(Vancouver)US(Dallas)Australia(East Coast)Date28-Apr-202628-Apr-202629-Apr-2026Time4.00PM PST6.00PM CT9.00AM AEST Please note: Registration is required to attend this Zoom format investor webinar.Please register in advance for the Zoom webinar using the following link:https://us02web.zoom.us/webinar/register/WN_IE079ntuTbmoCUiWm6_O5QAfter registering, you will receive a confirmation email containing information about joining the webinar.Questions can be submitted in advance of the webinar to Julia Maguire of The Capital Network via the following email address: julia@thecapitalnetwork.com.auA replay of the webinar will be available on Kincora's website on the following page:https://kincoracopper.com/interviews/About Kincora: Kincora Copper Limited (ASX: KCC) (TSXV: KCC) is an emerging Australia-focused gold-copper explorer with a hybrid project generator strategy.The Company is successfully proving up the prospectivity of its extensive project portfolio, which includes multiple district-scale landholdings and scalable drill ready targets. These assets are located in Australia's Lachlan Fold Belt and Mongolia's Southern Gobi, two of the globe's leading porphyry belts, and the historical Condobolin mining field within the Cobar basin in NSW.The Company has already unlocked over $100 million of potential partner funding for multiple earlier stage and/or non-core porphyry projects. These initial deals have supported over 18,000 metres of drilling and over A$9m of partner funded exploration since late 2024, with management fees and exploration ramping up.Partner discussions are ongoing for its remaining 100% owned flagship projects that are all situated within existing porphyry camps containing over 20-million-ounce gold equivalent resource inventory.By having a significant portfolio of partner funded large porphyry projects, and a very focused capital efficient programs at the Condobolin and other sole funded projects, the Company is seeking to position Kincora as a leading institutional grade explorer in the public Australian and Canadian markets, and the leading project generator on the ASX.The Company's website is: www.kincoracopper.comThis announcement has been authorised for release by the Board of Kincora Copper Limited (ARBN 645 457 763)For further information please contact:Sam Spring, President and Chief Executive Officersam.spring@kincoracopper.com or +61431 329 345 Laurie Thomas, Strategic Advisor laurie.thomas@kincoracopper.com or +1306 341 3826 Media contactJulia Maguire, Managing Director, The Capital Networkjulia@thecapitalnetwork.com.au or +61 2 7257 7338Executive office Subsidiary office Australia 400 - 837 West Hastings Street C/- JM Corporate ServicesVancouver, BC V6C 3N6, Canada Level 6, 350 Collins StreetTel: 1.604.283.1722 Melbourne, VIC, Australia 3000 Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) or the Australian Securities Exchange accepts responsibility for the adequacy or accuracy of this release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/294246 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HKTDC’s seven flagship lifestyle and licensing events open today

HONG KONG, Apr 27, 2026 - (ACN Newswire via SeaPRwire.com) - The Hong Kong Trade Development Council (HKTDC) today officially opened its seven flagship lifestyle and licensing events. The Hong Kong Gifts & Premium Fair, Home InStyle and Fashion InStyle are being held at the Hong Kong Convention and Exhibition Centre (HKCEC), while the Hong Kong International Printing & Packaging Fair and DeLuxe PrintPack Hong Kong at AsiaWorld-Expo, from today until 30 April. The Hong Kong International Licensing Show and Asian Licensing Conference are running concurrently from today until 29 April, also at HKCEC. Together, the six trade fairs have attracted some 5,600 exhibitors from over 30 countries and regions. HKTDC Executive Director Sophia Chong said: "Hong Kong has long served as the key gateway for global businesses connecting with the Chinese Mainland, playing the role of super connector and super value-adder that bridges the Chinese Mainland's vast market with the rest of the world. Backed by its solid strengths, well developed innovation ecosystem and robust intellectual property infrastructure, Hong Kong is the ideal base for companies to grow their businesses, pursue creativity and innovation, and bring them to commercial fruition."Creative gifts and home products converge; Gifts & Premium Fair and Home InStyle serve as platforms for new product launchesThe Gifts & Premium Fair and Home InStyle continue to offer buyers a diverse range of gifts and home products spanning cultural creativity, sustainability, innovative materials and gerontechnology. Selected highlights from both fairs are brought together on the new "Reimagine" themed floor at HKCEC Hall 5, giving buyers a one-stop overview of the latest global trends in lifestyle homeware and gifting products, while inspiring the industry to envision future product possibilities with fresh perspectives and inspiration.Both fairs are also attracting exhibitors to unveil latest products. Wei Yit Vacuum Flask Manufactory (Booth: 1E-D02), an exhibitor at the Gifts & Premium Fair, is debuting the Camel Brand MINI20 thermos blind box, created by Hong Kong illustrator Pen So and Hong Kong contemporary artist Jerry Cho. With the Camel Brand celebrating its 85th anniversary – the same year as Bruce Lee’s 85th birth anniversary - the exhibitor is also launching another special co-branded thermos.   Home InStyle exhibitor PREN Ltd (Booth: 5E-C20) is making its first-ever public introduction of an infection-prevention mobile toilet — an installation-free, waterless unit requiring no repeated disinfection and no direct contact with waste before and after use, incorporating health monitoring capabilities that seamlessly bring professional care into modern households.Gifts & Premium Fair spotlights design-led giftsThe Hall of Fine Designs at the Gifts & Premium Fair, located at HKCEC Hall 1, once again gathers over 100 local and international exhibitors, featuring premium, design-led products ranging from stationery and home accessories to smart collectibles incorporating the latest technologies. Star Industrial Co., Ltd (Booth: 1C-G03) presents the Red A "Made in Hong Kong" mini-series blind boxes, evoking nostalgic memories of Hong Kong daily life from the 1960s to the 1990s through iconic household items. Moral Team Holdings Ltd (Booth: 1C-E05) introduces the Napier Coded backpack designed for pickleball enthusiasts, crafted from recycled materials and combining sports with sustainability elements.Home InStyle shapes the future of home livingFunded by the Innovation and Technology Commission, Home InStyle this year presents the Gerontech and Innovative Material Pavilion (Booth: 5E-C20), showcasing over 20 local enterprises to feature gerontechnology products, smart living solutions and home products made from innovative materials.Scan Infinity Ltd presents the TechFitX Smart Sports Training System, which uses interchangeable modules and gamified training to help seniors easily build an exercise routine at home. The United Nations University Hub on Humanitarian Innovation and Technology at Lingnan University showcases IntuCREW, a smart power-assist solution designed to reduce the physical burden on caregivers when maneuvering wheelchairs. Other highlights include Sinomax's bionic ultrasonic sleep soother, German Pool's Natural Wellness Machine, and Afontane's self-cleaning bedding system.On the innovative materials front, Lotux International Holdings Co., Limited’sbiodegradable tableware and food containers are made from lotus stems alongside lotus fibre deodorising cat litter; Editecture showcases the reEDIT upcycled chair made from recycled plastic bottles and bottle cap fragments; and Mush Composites presents bio-based tiles produced from agricultural by-products and mycelium for decorative surface applications.Another focal point of Home InStyle, the Cultural and Creative Avenue, gathers design institutions and culturally inspired brands from over 10 countries and regions. Highlights include Indonesia's PT MANAMU ANAIA SUMBA (Booth: 5E-C09A) with its Banoura bracelets; Czech exhibitor Izaak Reich Crystal s.r.o. (Booth: 5E-A14), featuring handcrafted glass with over 150 years of heritage; UK exhibitor Block Design (Booth: 5E-C09B) with double-sided sculptural glass vases; Taiwan exhibitor Karari (Booth: 5E-A18) with incense accessories; and a Macao exhibitor (Booth: 5E-A16) featuring 3D-printed creations. Pantone returns as colour partner, presenting home décor trends through the PANTONE 2026 Colour of the Year "Cloud Dancer".Fashion InStyle showcases global innovation in fashion materialsThe highlighted zone NEXT@Fashion InStyle (NEXT), organised by the HKTDC and sponsored by the HKSAR Government's the Cultural and Creative Industries Development Agency (CCIDA), returns this year to demonstrate how material innovation is driving industry transformation and advancing sustainability across the fashion sector. The Philippines joins as the featured partner, powered by the Philippine Trade and Investment Centre – Hong Kong (PTIC-HK) and the Center for International Trade Expositions and Missions (CITEM). NEXT brings together over 60 exhibitors from across the globe.Exhibitors include Belgium's Bloom Biotech (Booth: 3F-F09), showcasing microalgae leather, the world's first carbon-neutral leather alternative produced through scalable green technology; At Booth: 3F-E04, Finland's Spinnova PLC’s SPINNOVA® is a next-generation textile fibre derived from wood or waste cellulose, and compatible with conventional textile processes and seamlessly blendable with cotton to deliver scalable, recyclable solutions for apparel and beyond; and Vietnam's Thai Son S.P Co., Ltd. (Booth: 3F-F03), has a range of fabrics that includes ramie fabric, a material with over 3,000 years of history and celebrated for its outstanding performance and natural antibacterial properties. The NEXT zone also features exhibitors from Chinese Mainland, Hong Kong, Iceland, Indonesia, Sweden, Thailand, and the United States, among others.Returning as project ambassador, Han Chong, founder and creative director of internationally acclaimed brand self-portrait, leads six local designer brands, each drawing on forward-looking materials selected from eight participating material suppliers to create cross-disciplinary collections. In a first for the project, materials sourced from beyond Hong Kong and Chinese Mainland are incorporated this year, bringing fresh creative momentum to the field of fashion material innovation. For example, design label WILSONKAKI fuses the world's lightest H2 fabric from French supplier Chargeurs PCC, mycelium leather from Indonesian supplier MYCL-Mycotech Lab, and natural fibres from Hong Kong supplier Texwinca Holdings Ltd, to craft everyday pieces that balance lightweight protection with a natural tactile quality through lamination and bonding techniques. The full design collection will be unveiled at tomorrow's NEXT fashion parade.Fashion InStyle also features dedicated zones including the Designer Spotlight, Materials Bazaar, Fashion Accessories, Women in Style, Bridal & Evening Wear, and Athleisure, presenting a rich selection of ready-to-wear and accessories. Glory G International Limited (Booth: 3G-B31) presents its "Resilience" collection  of lightweight suede denim, challenging the conventional perception of heavy denim outerwear; Hong Kong Haiyuan Limited (Booth: 3G-F18) showcases decorative and functional tassel ornaments designed to be attached to handbags, keys and everyday accessories; while Bibi Hanum from Uzbekistan (Booth: 3F-G29) brings traditional silk ikat patchwork wrap skirts.Printing & Packaging Fair and DeLuxe PrintPack Hong Kong present green solutions and high-end craftsmanshipThe Hong Kong International Printing & Packaging Fair and DeLuxe PrintPack Hong Kong,co-organised by the HKTDC and CIEC Exhibition Company (HK) Limited, continue to highlight innovative, eco-friendly and premium printing and packaging solutions. Elements Printing and Packaging Limited (Booth: 3-E01) introduces FSC Transparent Non-plastic packaging products and FSC Glassine Paper Bag, championing plastic-free, recyclable design principles. BSN International Hong Kong Limited (Booth: 3-E02) offers radio frequency identification (RFID) () labels incorporating paper-based inner layers for sustainable design. Guangzhou Xingqiyuan Trading Co., Ltd. (Booth: 3-E11) presents eco-friendly wet-press paper-pulp packaging made from agricultural waste.At DeLuxe PrintPack Hong Kong, Ijen Enterprises Ltd. (Booth: 3-A05) presents 3D rotating music boxes and vintage phonograph gift packaging that integrate music, storage and packaging. Marshallom (Holdings) Limited (Booth: 3-A08) showcases a floral-and-bird paper lantern canister with a dual-purpose design that extends the product lifecycle, alongside the "Victoria Harbour Day & Night" gift box combining light and shadow effects with storage and premium food packaging.Licensing Show launches IP and e-Commerce Support Services zone for the first timeThe Hong Kong International Licensing Show welcomes more than330 exhibitors from Hong Kong, Chinese Mainland and across Asia, showcasing more than 600 brands and intellectual property (IP) projects spanning arts and culture, animation and characters, brand extension, lifestyle, entertainment and sports licensing.  In line with direction of the HKSAR Government's policy to strengthen Hong Kong businesses' competitiveness on cross-border e-commerce, the fair introduces for the first time a dedicated IP and e-Commerce Support Services zone. The zone unites e-commerce platforms, KOLs, marketing and PR firms — including e-commerce platform Digitify Online Growth (Booth: 5G-E04) and marketing firm Matrix Promotion Limited (Booth: 5G-F01) — to support brands and IPs in capitalising on the new opportunities generated by e-commerce growth. Throughout the fair, e-commerce associations will conduct workshops on topics including establishment of e-commerce platforms, global market expansion via e-commerce channels, and livestreaming commerce, equipping the industry to stay ahead of the curve.Headline IPs at the Licensing Show include Potatoz by 9GAG Limited (Booth: 5G-D20), LuLu the Piggy by Toyzeroplus Limited (Booth: 5G-A24), Café de Bollo by Yogurt Studio Ltd. (Booth: 5F-G20), along with Chinese Mainland IP Quby (Booth: 5G-A22), Korean IP LOTTY FRIENDS (Booth: 5F-G36) and Thai IP Warbie Yama (Booth: 5G-A51). Organised by the Innovative Entrepreneur Association (IEA) and sponsored by Cultural and Creative Industries Development Agency (CCIDA) of the HKSAR Government, the Design Licensing and Business (DLAB) Support Scheme again stages the DLAB Hong Kong Pavilion at the Hong Kong International Licensing Show, featuring close to 40 exhibitors showcasing a diverse portfolio of Hong Kong original brands and IPs. The HKTDC also continues its collaboration with the Hang Seng University of Hong Kong, Hong Kong Baptist University and The Hong Kong Polytechnic University, with Hong Kong Design Institute joining as a new partner this year, to present the Hong Kong Licensing Force Showcase, spotlighting the creativity of Hong Kong's emerging talents.The concurrent Asian Licensing Conference invites industry leaders to examine key market developments. Today's programme features Maura Regan, President and CEO of Licensing International, presenting the "Global Licensing Trends to Watch in 2026".  With the FIFA World Cup taking place this year, the conference also welcomes Alessandro Villa, Senior Licensing Manager of FIFA, and Ivan Chan, Founder and CEO of Promotional Partners Worldwide to share the commercial strategies underpinning successful sports licensing. Mark Mao, Executive Vice President and Head of Sales at COVER Corporation will explore how Virtual YouTubers forge connections with GenZ through strategic social media engagement on the next day.Industry seminars and forums explore emerging market opportunitiesTo help industry professionals keep pace with the latest developments, around 60 thematic seminars, buyer forums, product presentations and launch events will be held throughout the fairs, covering trending topics including the silver economy, market trends, culture and innovation, and sustainability.Among the seminar highlights, the Printing & Packaging Fair and DeLuxe PrintPack Hong Kong will present a seminar co-organised by the HKTDC and the Hong Kong Digital Printing Association, titled “From Prompt to Reality: Revolutionizing Visual Design and Printing with Generative AI and Digital Printing”, examining how generative AI and digital printing are driving innovative transformation across the industry. The Gifts & Premium Fair and Home InStyle will host “Re-Gifted: Trends and Triumphs in Sustainable Home & Gift Design”, exploring new directions in sustainable design. Fashion InStyle will stage the seminar “Cultural Fusion in Lifestyle Design: The Surreal Aesthetics of Motifx”, offering the industry the latest market insights, innovative thinking and practical strategies.Photo Download: https://bit.ly/4vQE39EOrganised by HKTDC, the Hong Kong Gifts & Premium Fair, Home InStyle, Fashion InStyle, Hong Kong International Printing & Packaging Fair, Deluxe PrintPack Hong Kong, Hong Kong International Licensing Show and Asian Licensing Conference open today, with the six trade fairs bringing together some 5,600 exhibitors from more than 30 countries and regionsHKTDC Executive Director Sophia Chong delivered the welcome remarks at the opening ceremony of the Hong Kong International Licensing Show and Asian Licensing Conference this morning (27 April)(From left) Commissioner for Cultural and Creative Industries of CCIDA, Drew Lai; Director, Asia Tourism Exchange Centre, Zhang Dong; HKTDC Executive Director, Sophia Chong; Permanent Secretary for Culture, Sports and Tourism, HKSAR Government, Sum Fong Kwang, Vivian; Plan and Policy Analyst Expert Level, Ministry of Culture, Thailand, Narathorn Parndee; and President and CEO of Licensing International, Maura Regan, officiated the opening ceremonyThe Hall of Fine Designs at the Gifts & Premium Fair showcases a premium selection of design-led gifts, including stationery, home products and smart lifestyle items featuring innovative technologyAt Home InStyle, the Gerontech and Innovative Material Pavilion features more than 20 local exhibitors showcasing gerontech products, smart living solutions and innovative materials applied to the homeware and home textilesThe Cultural & Creative Avenue showcases cultural and creative home products from around the world, presenting distinctive brands and designs that celebrate diverse cultural heritagesFashion InStyle this year presents the spotlight zone NEXT@Fashion InStyle, with featured partner the Philippines bringing over 25 exhibitors to showcase local fashion materialsNEXT@Fashion InStyle project ambassador Han Chong (centre) leads six local designer brands in creating fashion collections incorporating selected innovative global materialsBSN International Hong Kong Limited showcases radio frequency identification (RFID) labels with paper-based inner layers at the Printing & Packaging Fair, highlighting both functionality and sustainable designAt DeLuxe PrintPack Hong Kong, Marshallom (Holdings) Limited presents its “Victoria Harbour Day & Night” gift box, a multifunctional design combining decorative lighting, food packaging and storage, inspired by the changing scenery of Victoria HarbourThe Hong Kong International Licensing Show this year introduces for the first time the dedicated IP & e-Commerce Support Services zoneWebsitesHKTDC Media Room: https://mediaroom.hktdc.com/enHong Kong Gifts & Premium Fair: https://www.hktdc.com/event/hkgiftspremiumfair/enHome InStyle: https://www.hktdc.com/event/homeinstyle/enFashion InStyle: https://www.hktdc.com/event/fashioninstyle/enHong Kong International Printing & Packaging Fair: https://www.hktdc.com/event/hkprintpackfair/enDeLuxe PrintPack Hong Kong: https://www.hktdc.com/event/deluxeprintpackhk/enHong Kong International Licensing Show and Asian Licensing Conference: https://www.hktdc.com/event/hklicensingshow/enMedia enquiriesFor enquiries, please contact:Home InStyle, Fashion InStyle, HK Gifts & Premium Fair, HK International Printing & Packaging Fair and DeLuxe PrintPack Hong KongPandagon:Fraser LiTel: 6083 5623Email: pandagon.limited@gmail.comHKTDC’s Communications & Public Affairs Department:Clayton LauwTel: 2584 4472Email: clayton.y.lauw@hktdc.org   HK International Licensing Show and Asian Licensing ConferenceRaconteur:  Molisa LauTel: 6187 7786Email: molisalau@raconteur.hkBetsy TseTel: 9742 7338Email: betsytse@raconteur.hkHKTDC’s Communications & Public Affairs Department:Winnie KanTel: 2584 4055Email: winnie.wy.kan@hktdc.orgHKTDC Newsroom: http://mediaroom.hktdc.com/enAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus.  Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

周大福人壽推出「匠心 – 飛越」儲蓄保險計劃

香港, 2026年4月27日 - (亞太商訊 via SeaPRwire.com) - 周大福人壽今日宣布推出「匠心 - 飛越」儲蓄保險計劃(「計劃」),旨在為客戶提供一個穩健兼具長遠財富增值潛力與靈活自主的一站式財富管理方案,並設有整付及定期保費繳付模式可供選擇。計劃結合領先市場的回報速度,透過一筆過整付的美元保單,預期總內部回報率(IRR)於第20年可達6.5%,屬全港最快及市場最高1 讓客戶有機會更早獲取可觀的潛在回報。市場特有2的「財富增值調配選項」3,讓客戶透過3個調配選項(「增進」、「均衡」及「保守」)作出靈活調配,配合不時的理財目標。另外,計劃的「貨幣轉換選項」4,5、「保單分拆選項」6及多項產品優勢,可全面滿足客戶在不同人生階段的財務需求及環球規劃藍圖。周大福人壽憑藉穩健的投資策略及財務實力,分紅美元保單非保證積存年利率連續第14年維持4.25%7。同時,三大皇牌產品系列8更連續10年9達到分紅實現率100%或以上,充分體現公司在兌現客戶回報的承諾上的穩定性和可靠性。截至2025年12月31日,周大福人壽在香港保險業風險為本資本基準下的償付能力充足率高達282%10,領先行業11並遠超100%的最低監管要求,為客戶的財富增值提供堅實後盾。客戶於指定日期內成功投保此計劃可享首兩年保費折扣優惠高達24%總保費折扣及預繳保費保證利率優惠*。全新「匠心-飛越」儲蓄保險計劃反映出周大福人壽對客戶需求的深刻洞察,不僅提供市場領先的財富增值潛力,更融入多項靈活自主的選項和創新的傳承服務,讓客戶在每個人生階段規劃財富時更得心應手。計劃的優越特點及特設服務包括:1. 「財富增值調配選項」3:在保單生效時,客戶可透過市場特有2匠心設計的調配選項,於第10個保單週年日及其後的保單週年日,輕鬆以「增進」、「均衡」及「保守」這三個預設的調配選項,靈活挑選「穩健資產戶口」12  價值與復歸紅利13之現金價值(如有)及終期分紅14之現金價值(如有)分配比例。2. 自由轉換保單貨幣:於第3個保單週年日當日或其後任何一個保單週年日及保單生效時,可申請行使「貨幣轉換選項」4,5於保單週年日將原保單之基本計劃的保單貨幣轉換至一個不同的貨幣(如美元、港元、人民幣、澳元、加元、歐元、英鎊或新加坡元),而毋需提供任何可保證明。3. 保單分拆選項6:於保單有效期內及受保人仍然生存期間,由第3個保單年度完結後或保費繳付年期完結後起(以較遲者為準),客戶可將原保單分拆,把原保單的基本計劃的部分投保單位分配至一份甚至多份獨立分拆保單。保單分拆選項亦適用於分拆保單,極致發揮資產分配功能。4. 多項創新傳承優勢:客戶可於保單第 6 個保單週月日起無限次轉換受保人15。而計劃更特設「保單延續選項」16,讓指定受益人可於受保人身故後成為新保單持有人及延續新受保人保障期。行使此兩個選項後,保障期亦將調整至新受保人 128 歲,更靈活配合客戶傳承安排,讓財富延續至後代。5. 靈活保單價值提取:保單持有人除可選擇為自己設定常行指示作定期提取17,更可直接支付予指定收款人(例如家人、醫院、安老院或慈善機構),而「匠心預設保單服務」與此產品相輔相成,透過多元化的特設安排,為客戶帶來更靈活的提取安排與便捷性。6. 長達8年之保費假期18:萬一保單持有人不幸確診指定受保疾病(包括癌症、嚴重心臟病發作或中風),保費假期年期亦可獲免費加倍延長,讓客戶可獲更充裕的財務緩衝。7. 自選身故賠償19/ 全數退保20支付方式:客戶可為每位受益人從多種選項中選擇其中一項身故賠償支付方式,其中包括一筆過支付、固定分期支付19、遞增分期支付19,亦可以選部份以一筆過支付後餘額以遞增分期方式支付,或者自訂指定年期或於受益人指定的年歲開始以定額或遞增分期支付,讓每位受益人獲得最合適的安排。8. 市場首創的「自選人生大事」選項21:配合適用之分期支付身故賠償方式及「人生大事選項」,客戶可選擇於主要受益人在結婚、置業等九項預設人生大事時支付身故賠償,更可透過市場首創的「自選人生大事」選項21,自由訂制於具意義的人生時刻以一筆過形式支付金額。而且可為每名主要受益人指定多於一項人生大事,讓保障更具心意與彈性。9. 靈活供款選項:「匠心 - 飛越」儲蓄保險計劃提供整付、 5年及12年保費繳付年期以供選擇,5年保費繳付年期更可於投保時選擇一筆過預繳保費22,助客戶以較低的成本完成保費供款,而預繳之保費22更可獲享利息23(如有)。註:*投保申請遞交日期為 2026 年 4 月 27 日至 2026 年 6 月 30 日(包括首尾兩天)。詳情請參閱宣傳單張:https://www.ctflife.com.hk/pdf/tc/home/premium_offer_flyer.pdf1預期總內部回報率於第20年達6.5%適用於符合最低保費要求的整付美元保單,並假設未曾作任何提取、退保或行使保單選項。截至2026年3月31日,全港最快及最高之預期總內部回報率指於第20年達6.5%最高總內部回報率及3.5倍總回報(即預期總現金價值除以已繳總保費)),乃根據現時假設投資回報而計算,並非保證, 並以四捨五入顯示;及均為本公司比較香港主要人壽保險公司同類主要儲蓄保險產品後所得出之結果。2「市場特有」之計劃特點為比較香港主要人壽保險公司同類主要儲蓄保險產品後所得出之結果,截至2026年4月27日。3財富增值調配選項及其分配比例:調配選項「穩健資產戶口」分配比例復歸紅利之現金價值(如有)及終期分紅之現金價值(如有)分配比例「增進」0%100%「均衡」40%60%「保守」80%20%「 穩健資產戶口分配比例」 =「 穩健資產戶口」價值 ÷ (復歸紅利之現金價值(如有)及終期分紅之現金價值(如有) + 穩健資產戶口價值之總額) x 100%。於第10個保單週年日及其後的保單週年日前或之後的30日內,在符合本公司當時的通行規則下,您可行使財富增值調配選項以達至您所選擇之調配選項的相應穩健資產戶口分配比例,惟須符合特定條件,請參閱保單條款以了解更多關於財富增值調配選項之詳情。4於第3個保單週年日當日或其後任何一個保單週年日及保單生效時,客戶可將原保單之基本計劃的保單貨幣轉換至一個不同的貨幣(「新保單貨幣」),即透過將原保單之基本計劃轉換至可供選擇及由本公司決定並以新保單貨幣列值之指定新計劃(「指定計劃」)而毋須提供任何可保證明,惟須符合特定條件。請參閱保單條款以了解更多關於貨幣轉換選項之詳情。5於貨幣轉換生效日期起,原保單之基本計劃將會轉換為以新保單貨幣列值之指定計劃。原保單的保單生效日期及保單年度將於貨幣轉換後維持不變;原保單之基本計劃的現時及未來之投保單位、保證現金價值、到期及應繳保費(如有)、已繳付保費總額、復歸紅利及終期分紅之面值及現金價值(如有)、穩健資產戶口之累積價值(如有)將由本公司根據不同因素而釐定及調整;及原保單下任何附加保單及附加契約將於貨幣轉換後保留在原保單繼續生效。如任何附加保單及附加契約不接受保留在原保單,該附加保單及附加契約將於貨幣轉換生效日期起自動終止。6於計劃有效期内及由第3個保單年度終結後起,保單持有人可行使保單分拆選項以建立一份或多份獨立的保單(「分拆保單」),從原保單的基本計劃中分配某部分的投保單位至分拆保單而毋須提供可保證明,惟須符合特定條件。分拆保單只會在其保單條款及保單資料說明發出後生效。請參閱保單條款以了解更多關於保單分拆選項之詳情。7利率並非保證,並會不時作出調整。8三大皇牌產品系列包括(i)「盛世」/「傳家寶」系列 (「匠心」系列同類型產品 )、(ii)「守護168」系列 (「守護家倍198」同類型產品 )及(iii)「愛豐盛」系列 (「榮耀世代」同類型產品 ) 。9上述產品系列在2015年至2024年度生效的保單於每個保單生效年份之週年紅利/復歸紅利/終期紅利/終期分紅的分紅實現率均達到100%或以上。請瀏覽周大福人壽網站了解上述或其他產品的最新分紅實現率資料。10資料來源: 周大福創建有限公司2025-2026年中期報告。於2025年12月31日,周大福人壽在香港保險業風險為本資本基準下的償付能力充足率為282%。11與於2025年9月公布2024年度總保費收入最高的15間保險公司就償付能力充足率所作的分析及比對。該等資料為截至2024年12月31日,相關保險公司按保險業監管局公眾披露法規要求所公佈的數據。12根據財富增值調配選項條款所定的戶口,其長期目標資產配置為100%放於固定收入類別證券。穩健資產戶口之價值將會按我們不時公佈的利率積存生息。惟並非保證,且可能會在任何年度為0%。13復歸紅利之面值及現金價值並非保證。然而一經公佈,該公佈之復歸紅利之面值便成為保證,並會永久附加於保單。請參閱保單條款以了解更多關於復歸紅利之詳情。14由第1個保單週年日起,本公司可就此計劃公佈非保證終期分紅,且本公司對決定是否派發該非保證終期分紅及其金額有唯一的酌情決定權。終期分紅之現金價值將會相等於或少於終期分紅之面值。15轉換受保人須符合指定條件和當時的行政規定。投保單位、保證現金價值、累積復歸紅利之面值(如有)、終期分紅之面值(如有)、任何穩健資產戶口之累積價值、保單日期及保單年度將在轉換受保人生效日期當日保持不變,而期滿日將更改為轉換新受保人128歲生日當天或緊接其後的保單週年日(以適用者為準)。請參閱保單條款以了解更多關於轉換受保人選項之詳情。16於受保人身故時,若保單持有人(仍在生)與受保人非同一人,受益人將成為延續新受保人。若保單持有人同時身故或保單持有人與受保人為同一人,受益人將成為新保單持有人及延續新受保人,惟該受益人須符合當時公司的行政規定。於行使此選項後,投保單位、已繳付保費總額、保證現金價值、累積復歸紅利之面值(如有)、終期分紅之面值(如有)及穩健資產戶口之累積價值(如有)、保單日期和保單年度將在保單延續生效日期當日維持不變,但保單的基本計劃之計劃期滿日將調整至延續新受保人128歲生日當天或緊接其後的保單週年日(以適用者為準)。請參閱保單條款以了解更多關於保單延續選項之詳情。17保單價值提取需符合本公司最低投保單位要求及有關條款及細則。就定期提取支付予指定收款人而言,合資格之指定收款人關係需符合本公司之規定,而周大福人壽有權隨時要求提交關係證明文件,並可因應需要不時調整相關條款及細則。保單價值提取乃屬於其他保單服務,詳情請參閱相關之服務申請書及「保單服務確認通知書」。18保費假期不適用於整付保費繳付年期之保單。不論於保費繳付年期內曾否有轉換保單持有人,如保單持有人確診受保疾病,於本公司在收到保單持有人所提供指定的表格及其主診醫生提供的醫療證明後,其保單的保費假期年期可根據保費繳付年期獲延長。請參閱保單條款以了解更多關於保費假期及受保疾病的定義之詳情。19須符合特定條件,請參閱保單條款以了解更多關於身故賠償支付選項之詳情。20須符合特定條件,請參閱保單條款以了解更多關於全數退保之詳情。21「市場首創」之服務特點為比較香港主要人壽保險公司同類主要保單服務後所得出之結果,截至2025年12月4日。有關條款及細則,請參閱相關服務申請書及「保單服務確認通知書」。22預繳保費選項只適用於年繳保費模式的保單。預繳之保費將會存入保費儲存戶口,已存於保費儲存戶口之款項會按當時本公司所給付之利率獲派利息(現時年利率為2%),保單持有人可以全數提取保費儲存戶口內之預繳保費,但所得之利息會被收回。如保費儲存戶口之款項由於利率下降而不足以繳付保費及保費徵費,保單持有人需補回有關保費差額(包括保費徵費),否則保單會被終止或被執行自動保費貸款。如受保人身故,保費儲存戶口內的餘額(如有)會給付保單持有人,並不會收取手續費。23此利息現時為年利率2%且為非保證的。重要提示:- 本新聞稿乃資料摘要,僅供參考之用。詳情請參閱有關產品小冊子、宣傳單張、保單文件、有關保單服務宣傳單張、相關服務申請書及「保單服務確認通知書」。有關周大福人壽「匠心 - 飛越」儲蓄保險計劃詳情,均以保單合約之條款及細則作準。- 本新聞稿的產品資料不包含「匠心 - 飛越」儲蓄保險計劃的完整條款、產品主要風險及所有不保事項的詳情,有關完整條款載於保單文件中。上述「匠心 - 飛越」儲蓄保險計劃可作為獨立保單而無須捆綁式地與其他種類的保險產品一併購買。敬請務須參閱有關「匠心 - 飛越」儲蓄保險計劃之主要產品推銷刊物、保單條款及由閣下的持牌保險中介人所陳述之說明文件以全面了解關於以上定義、收費、產品特點、不保事項及賠償給付條件等之詳情及完整條款 及細則。- 有關「匠心 - 飛越」儲蓄保險計劃產品小冊子,請瀏覽:https://www.ctflife.com.hk/pdf/tc/mywealth-beyond-savings-insurance-plan-brochure.pdf - 有關匠心預設保單服務,請瀏覽: https://www.ctflife.com.hk/pdf/tc/artisanal-default-policy-service-flyer.pdf  - 如欲查詢,歡迎致電周大福人壽客戶服務熱線:+852 2866 8898。- 本新聞稿只適宜於香港分發,不應被詮釋為在香港以外地區提供周大福人壽的任何產品,或就其作出要約或招攬。如在香港境外之任何司法管轄區的法律下提供或出售或游說購買任何周大福人壽的產品屬違法,周大福人壽在此聲明無意在該司法管轄區提供或出售或游說購買該產品。關於周大福人壽周大福人壽保險有限公司(「周大福人壽」)扎根香港 40 年,為周大福創建有限公司(「周 大福創建」)(香港股份代號:659)的全資附屬公司,也是香港最具規模的壽險公司之一。作為周大福企業成員,周大福人壽緊扣鄭氏家族(「周大福集團」或「集團」)生態圈的雄厚資源,致力為客戶及其摯愛於「生活、 成長、健康、傳承」的人生旅程中, 提供個人化的匠心規劃、終身保障及優質體驗。憑藉集團財務實力及環球投資佈局,周大福人壽矢志成為亞太區領先的保險公司,持續開創保險新價值。周大福人壽保險有限公司(於百慕達註冊成立之有限公司) Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

6 Ways to Avoid Hidden Fees When Spending Overseas

SINGAPORE, Apr 27, 2026 - (ACN Newswire via SeaPRwire.com) - Travelling overseas often feels exciting until unexpected charges appear on your card statement after returning home. Many travellers from Singapore rely on overseas credit cards for convenience, rewards, and security, but international transactions can sometimes include hidden costs that are easy to overlook. From currency conversion markups to foreign transaction fees, these charges can quietly increase overall travel expenses. Understanding how these charges work can help travellers manage spending better and make more informed payment choices while abroad.Below are practical ways that can help minimise hidden fees when using credit cards overseas while keeping travel spending smooth and predictable.Understand foreign transaction fees before travellingForeign transaction fees are among the commonly overlooked charges linked to overseas spending. Many cards issued in Singapore charge a fee of around 3.25% per foreign currency transaction, which may not seem significant at first glance. However, on a holiday budget of SGD 4,000, this fee alone can add SGD 130 to total expenses without obvious visibility during purchases.Reviewing the fee structure of an overseas card before travelling can help travellers estimate actual costs more accurately. Some cards offer reduced or promotional foreign transaction charges, which can help manage overall travel budgets more effectively. Knowing these details in advance may also help travellers decide when card payments make financial sense compared to alternative payment methods.Consider paying in local currency instead of SGDWhen paying overseas, merchants sometimes offer the option to charge the amount directly in Singapore dollars. This feature, known as Dynamic Currency Conversion (DCC), may appear convenient because it shows the final amount immediately. However, exchange rates used in DCC transactions often include markups, which can exceed standard bank conversion fees.Choosing to pay in the local currency allows the overseas card network to process the exchange instead. Card networks typically apply more competitive rates compared to merchant-set conversions. Over multiple transactions, such as dining, shopping, and transport, this can help reduce unnecessary markups.Check card currency conversion ratesExchange rates used by card issuers fluctuate daily and may differ slightly from rates seen on currency apps or news platforms. While the difference per transaction might appear minor, frequent purchases abroad can still affect total spending. For example, a 1% difference on SGD 2,500 worth of spending can translate into roughly SGD 25 in additional costs.Reviewing how an overseas card calculates exchange rates can provide better transparency. Some banks publish their rate calculation methods, allowing travellers to estimate expected charges more accurately.Avoid overseas ATM withdrawals when possibleWithdrawing cash abroad using a credit card can trigger multiple layers of fees simultaneously. These may include cash advance fees, overseas ATM operator charges, and immediate interest accrual starting from the withdrawal date. In Singapore, cash advance fees commonly range between 6% and 8% of the withdrawn amount, with minimum charges around SGD 15.Using an overseas card mainly for purchases rather than cash withdrawals can help reduce these compounded costs. Carrying a modest amount of exchanged currency from Singapore or using debit-based solutions for cash needs may help travellers avoid high-interest situations linked to credit card withdrawals overseas.Watch for hotel and car rental pre-authorisation chargesHotels and car rental companies frequently place temporary holds on credit cards as security deposits. These pre-authorisation amounts can be significant depending on location and booking type. Although not permanent charges, they temporarily reduce available credit limits and sometimes involve conversion adjustments once released.Understanding how pre-authorisation works can help travellers avoid confusion when reviewing statements. Using an overseas card with sufficient credit limits may reduce the likelihood of declined transactions during travel. Checking release timelines with merchants can also help travellers track when funds become available again after checkout.Choose a Travel Credit Card designed for overseas spendingNot all credit cards function the same way internationally. Some overseas card options available in Singapore include travel-focused features, such as lower foreign currency fees, travel rewards, or complimentary insurance coverage. These features can help offset certain costs associated with overseas spending when used strategically.Comparing card benefits based on travel frequency, spending habits, and destinations can help travellers identify options aligned with their lifestyle. A well-matched overseas card may also offer added value through rewards or travel-related privileges, making international spending more predictable overall.Final thoughtsFor Singapore travellers, using an overseas card thoughtfully, alongside awareness of currency conversion practices and transaction structures, can help make international payments more transparent. With a few informed habits, overseas spending can remain convenient while reducing the likelihood of unexpected costs appearing after the journey ends.Disclaimer: This content is published by iQuanti Singapore Pte. Ltd., an external marketer engaged and compensated by UOB Ltd.Contact Information:Name: Sonakshi MurzeEmail: Sonakshi.murze@iquanti.comJob Title: ManagerSOURCE: iQuanti Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

China Chunlai Announces 2026 Interim Results

HONG KONG, Apr 27, 2026 - (ACN Newswire via SeaPRwire.com) - China Chunlai Education Group Co., Ltd. ("China Chunlai" or the "Company", together with its subsidiaries and its consolidated affiliated entities, the "Group", Stock Code: 1969) is pleased to announce the unaudited consolidated interim results of the Group for the six months ended 28 February 2026 (the "Reporting Period").For the Reporting Period, the Group continued to increase the number of students enrolment, and recorded a revenue of RMB956.3 million, representing an increase of 7.4% compared with the same period of last year; gross profit recorded RMB511.6 million, representing an increase of 2.4% compared with the same period of last year; profit recorded RMB429.8 million, representing an increase of 5.7% compared with the same period of last year.During the Reporting Period, the Group recorded tuition fees of RMB874.1 million, representing an increase of 7.4%, boarding fees recorded RMB82.2 million, representing an increase of 6.9%. Besides, the revenue of Group's schools increased: Anyang University recorded a revenue of RMB232.5 million, representing an increase of 12.3% compared with the same period of last year; Jingzhou College recorded a revenue of RMB191.7 million, representing an increase of 12.0% compared with the same period of last year; Jiankang College recorded a revenue of RMB76.1 million, representing an increase of 10.5% compared with the same period of last year; Shangqiu University Kaifeng Campus recorded a revenue of RMB138.0 million, representing an increase of 6.1%;Shangqiu University recorded a revenue of RMB217.7 million, representing an increase of 5.8% compared with the same period of last year.As of 28 February 2026, the number of students enrolled was 116,784, representing an increase of 5.3% compared with the same period of last year. Among which, Jingzhou College had a total enrollment of 21,643, representing an increase of 11.0% compared with the same period of last year; Jiankang College had a total enrollment of 10,808, representing an increase of 10.2% compared with the same period of last year; Anyang University had a total enrollment of 28,897, representing an increase of 9.4% compared with the same period of last year; Shangqiu University Kaifeng Campus had a total enrollment of 16,280, representing an increase of 4.8%;Shangqiu University had a total enrollment of 27,051, representing an increase of 1.8% compared with the same period of last year.The educational philosophies of the Group’s schools and well-developed curricula as well as its high graduate employment rates enable the Group to attract high-quality students who are seeking a pathway to satisfactory employment. For the 2025/2026 school year, the overall yield of five colleges that offer bachelor’s degree programmes (being Shangqiu University, Shangqiu University Kaifeng Campus, Anyang University, Anyang University Yuanyang Campus and Jingzhou College) was 91.55%.The Board of China Chunlai Education Group Co., Ltd. said: “In recent years, private higher education in China has continued to improve, and the number of students in schools has continued to increase. We have seized the opportunity to continuously improve and optimize the curriculum system, build an excellent teacher team, strive to expand the enrollment scale, and promote sustained and steady growth in performance. In the future, we expect to enlarge the capacity of the colleges progressively, continue to increase the total number of enrolled students, and hire teachers with a strong command of their respective subject areas who are open to innovative teaching methods and a caring heart toward students’ well-being, and continuously improve the high-quality curriculum system. With Tianping College becoming a consolidated affiliated entity of the Company, our future performance is expected to maintain steady growth.”About China Chunlai Education Group Co., Ltd.:China Chunlai Education Group Co., Ltd. (1969.HK), is a leading provider of private higher education in China. In September 2018, the Group was listed on the main board of the Hong Kong Stock Exchange. Since the Group was established in 2004, it has grown to operate four colleges in Henan Province and two colleges in Hubei Province, participate in the operation of one college in Jiangsu Province. For the past two decades, the schools under the Group have provided tens of thousands of graduates and talents for construction for the country and socialist society. With a strong passion for education, the Group has seen continuous improvements in educational standards across its curriculum. The Group’s unique educational traits and overall excellence have been widely accredited by authorities and society. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

中國春來公佈二零二六年中期業績

香港, 2026年4月27日 - (亞太商訊 via SeaPRwire.com) - 中國春來教育集團有限公司(「中国春来」,連同其附屬公司及併表聯屬實體統稱「本集團」,股份代號:1969.HK)宣佈本集團截至2026年2月28日止六個月(「報告期」)之未經審核綜合中期業績。報告期內,本集團持續擴大招生規模,錄得收入人民幣956.3百萬元,同比增長7.4%;毛利人民幣511.6百萬元,同比增長2.4%;期內利潤人民幣429.8百萬元,同比增長5.7%。報告期內,本集團學費收入錄得人民幣874.1百萬元,同比增長7.4%,住宿費收入錄得人民幣82.2百萬元,同比增長6.9%。此外,本集團期內旗下多所學院收入實現增長:安陽學院錄得收入人民幣232.5百萬元,同比增長12.3%;荊州學院錄得收入人民幣191.7百萬元,同比增長12.0%;健康學院錄得收入人民幣76.1百萬元,同比增長10.5%;商丘學院應用科技學院錄得收入人民幣138.0百萬元,同比增長6.1%;商丘學院錄得收入人民幣217.7百萬元,同比增長5.8%。截止2026年2月28日,在校學生人數116,784人,較上一年同期增長5.3%。其中,荊州學院在校人數錄得21,643人,同比增長11.0%;健康學院在校人數錄得10,808人,同比增長10.2%;安陽學院在校人數錄得28,897人,同比增長9.4%;商丘學院應用科技學院在校人數錄得16,280人,同比增長4.8%;商丘學院在校人數錄得27,051人,同比增長1.8%。本集團院校之教育理念和完善的課程及其畢業生的高就業率使本集團得以吸引尋求通往良好就業機會之康莊大道的優秀學生。於2025/2026學年,本集團五所提供本科課程的院校(即商丘學院、商丘學院應用科技學院、安陽學院、安陽學院原陽校區及荊州學院)的總入學率為91.55%。中國春來教育集團有限公司董事會表示:「近年中國民辦高等教育不斷向好,在校人數持續增長。我們抓住機遇,通過不斷完善優化課程體系,建設優秀教師團隊,努力擴大招生規模,推動業績實現持續穩健的增長。未來,我們將逐步增加學院容量,持續加大入學學生總數,並招聘在其各自教授的學科中表現卓越、對創新教學方法持開放態度且關心學生利益的教師,不斷完善優質課程體系,同時隨著天平學院納入公司報表,未來業績有望保持穩定增長。」中國春來教育集團有限公司簡介:中國春來教育集團(1969.HK)為中國民辦高等教育的領先提供商。2018年9月,集團於香港聯交所主板上市。自2004年成立起,本集團已在河南省經營四所院校,在湖北省經營兩所院校並參與江蘇省一所院校的運營。辦學二十餘年來,集團下屬各校為國家和社會輸送了數以萬計的畢業生和社會主義建設人才,春來人滿懷著對教育事業的熱忱,集團的辦學實力、辦學水準不斷提升,辦學特色和辦學成效進一步彰顯,贏得了上級主管部門和社會各界的廣泛認可。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Peer To Peer Network (OTC: PTOP) Targets Revenue Inflection Point with MOBICARD 1.8 Launch Expected Within 30 Days

BOSTON, Apr 25, 2026 - (ACN Newswire via SeaPRwire.com) - Peer To Peer Network, Inc. (OTC: PTOP), the first publicly traded digital business card company, today announced that its highly anticipated MOBICARD™ 1.8 platform—featuring integrated revenue-generating capabilities—is expected to be released to app stores within the next 30 days.This upcoming release marks a major turning point for the company as MOBICARD™ transitions from a pure networking tool into a monetized digital ecosystem designed to generate recurring revenue across both consumers and businesses.Built for Revenue — Designed for ScaleMOBICARD™ 1.8 introduces multiple revenue streams, including:Subscription Model for Consumers - Free version supported by adsPremium ad-free version at $1.99/monthAnnual premium plan at $20/yearEnterprise-Level Business Monetization - Paid promotional placements within the appTiered business subscriptions enabling companies to advertise directly to usersLead generation tools for enterprise clientsIn-App Engagement Monetization - Trackable card sharing and user engagement analyticsIncreased visibility for businesses through promoted placementsThese features position MOBICARD as more than just a digital card—it becomes a revenue engine driven by user activity, business adoption, and scalable subscription growth.In addition to monetization, MOBICARD 1.8 includes major upgrades designed to increase engagement and sharing:Seamless one-click sharing functionalityAirdrop abilityFully optimized QR code distributionImproved card navigation and discovery featuresEnhanced UI/UX for a cleaner, more professional lookStreamlined “Share This Card” experience to drive viral growthThe platform is being refined to ensure users can easily connect, share, and expand their networks—while businesses gain powerful tools to reach those users“By integrating subscription models and enterprise tools directly into the user experience, we are building a foundation for scalable growth and long-term value creation,” stated Nicholis Santana Team Technology Leader for Peer To Peer Network.PTOP believes that MOBICARD™ 1.8 represents a critical inflection point, as the platform begins to:Convert user activity into recurring revenue streamsProvide scalable monetization opportunities for businessesIncrease overall platform engagement and retentionWith monetization now integrated into the core user experience, Peer To Peer Network is positioning MOBICARD™ to compete at scale within the rapidly growing digital identity and networking market.“This is the version that begins turning MOBICARD™ into a true revenue-generating platform,” said Joshua Sodaitis, Chairman & CEO of Peer To Peer Network. “We’ve focused on building a system where both users and businesses can participate in the ecosystem—driving growth, engagement, and ultimately revenue.”The Company is currently finalizing development and preparing for submission to major app stores, with launch anticipated within the next 30 days.OutlookThe Company is currently finalizing development and preparing for submission to the Apple App Store and Google Play Store. While no assurances can be given, management anticipates launch within the next 30 days.About Peer To Peer Network (OTC: PTOP)Peer To Peer Network, Inc. (OTC: PTOP) is a technology company developing platforms that enhance communication, transparency, and connectivity between individuals and organizations.For more information, visit https://ptopnetwork.com. Contact Information:Peer To Peer Network, Inc.Investor RelationsEmail: info@freemobicard.comPhone: 617-481-1971Website: www.ptopnetwork.com Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

EQIBank expands global, regulated Banking-as-a-Service platform for cross-border banking across fiat and digital assets

George Town, Cayman Islands, Apr 24, 2026 - (ACN Newswire via SeaPRwire.com) -�EQIBank today announced the expansion of its global Banking-as-a-Service (BaaS) platform, strengthening its infrastructure and onboarding capabilities to enable organisations to launch licensed banking services globally in as little as 10 weeks.��EQIBank's BaaS platform allows organisations to offer regulated banking services under their own brand without building or licensing a bank. It supports service delivery across more than 180 countries and over 100 currencies through a single banking infrastructure.Available services include multi-currency accounts, international payments, cards, lending, custody, escrow services, foreign exchange and OTC trading. Digital asset capabilities are fully integrated into the platform, enabling fast crypto-to-fiat and fiat-to-crypto conversions supported by deep liquidity and institutional-grade trading infrastructure.EQIBank provides the banking licence, compliance framework and infrastructure, while partners remain in control of their brand and client relationships.Built on a regulated banking foundation, EQIBank combines global reach with a strong compliance and risk framework. The platform includes integrated anti-money laundering, know-your-customer and transaction monitoring systems, supported by a strong regulatory track record. Its compliance framework is specifically designed to support complex cross-border and digital asset activity at scale, alongside established relationships with global correspondent banking partners."Most organisations don't want to become banks, but they do want to offer banking services as part of their business," said Jason Blick, Chairman of EQIBank. "The challenge has always been regulatory complexity and infrastructure. We remove both barriers. Our platform allows partners to launch quickly, operate globally from day one and deliver services across fiat and digital assets within a fully regulated environment."EQIBank's BaaS platform is designed for organisations with international client bases, including digital asset firms, financial institutions, family offices and other globally focused businesses.Since launching its BaaS offering, EQIBank has onboarded new partners each month, with some partners scaling to over 100,000 users within their first year.About EQIBankEQIBank is a global digital bank providing accounts, payments, cards, custody, lending and investment services to businesses, institutions and high-net-worth clients across more than 180 countries. Through its Banking-as-a-Service platform, EQIBank enables organisations to offer licensed banking services under their own brand using regulated infrastructure and global technology systems.Media enquiriesBrand: EQIBankContact: Media teamWebsite: https://baas.eqibank.com/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

FastX Announces Its Launch, a New Generation Global Trading Exchange

NEW YORK, Apr 24, 2026 - (ACN Newswire via SeaPRwire.com) - FastX today announces the official launch of its platform, a next-generation exchange built for professional and active traders who require institutional‑grade tools without surrendering custody or control of their assets. FastX goes live globally on 5 May, with traders able to access the platform directly at fastx.co.FastX combines deep on‑chain liquidity, multi‑asset perpetual futures markets, and an advanced copy-trading engine designed to bridge the gap between traditional finance and the decentralized digital asset ecosystem. By leveraging blockchain technology, the platform delivers low‑latency mirroring of trades across major decentralized networks worldwide—while keeping users in full control of their own wallets and risk."FastX was created by traders for traders," said Adelene, Chief Executive Officer of FastX. "We've spent our careers on Wall Street desks and in crypto markets, and we've seen the same problems repeat: opaque execution, misaligned incentives, and copytrading systems that ask users to blindly outsource decisions. FastX is our answer—a decentralised, transparent infrastructure layer where traders keep custody, and technology works to augment, not replace, their edge."Backed by a team of veteran traders with more than 50 years of combined experience across top Wall Street institutions and leading crypto trading firms, FastX is built from the ground up as a decentralised protocol. Users connect their own wallets, maintain self‑custody at all times, and interact with smart contracts that execute trades on‑chain, rather than relying on a centralised broker or custodial exchange.At launch, FastX will offer:Deep, on‑chain liquidity across a wide range of perpetual markets, designed to support serious position sizes with tight spreads and minimal slippage.A fast, intuitive trading interface accessible directly via fastx.co, allowing traders to plug in with their preferred wallet and start trading in minutes.A transparent affiliate and points system that shares a meaningful portion of platform fees with the community and rewards traders and partners who help grow liquidity and volume.The flagship feature of FastX is its next‑generation copytrading system. Unlike traditional social trading products that mirror orders on a single venue with unpredictable delays, FastX's engine is designed to route and synchronise copy trades across major decentralised exchanges, layering those capabilities on top of FastX's own liquidity.The result is a copytrading experience that aims to:Minimise latency between lead and follower execution.Mitigate structural risks such as slippage, desync, and obvious forms of manipulation.Exploit decentralised advantages, such as transparent on‑chain track records and programmable risk controls, without turning the platform into a centralised black box."Copytrading has always been typecast as a blind, autonomous disaster waiting to happen," Adelene added. "FastX takes the opposite stance. We use technology to bring more transparency, not less—on‑chain track records, built‑in risk parameters, and infrastructure that reduces front‑running and execution games wherever possible. Over time, our goal is to layer AI‑driven intelligence on top of this foundation so that users can benefit from advanced analytics and risk management, rather than just 'follow and hope'."FastX is currently seed‑funded by a network of angels deeply embedded in the global crypto trading ecosystem. These backers share a common view that the next generation of markets will be built on open, verifiable rails and that traders deserve better, more transparent instrumentation for expressing and managing risk. FastX is assembling a strong advisory board of experienced traders, market makers, and technologists to guide the exchange through its next phase of growth.As a decentralised protocol, FastX does not take custody of user funds and does not operate as a traditional broker. All positions, liquidations, and fee flows are visible on‑chain, giving traders clear, verifiable insight into how the system behaves under all market conditions."Our vision is simple," said Adelene. "We want professional‑grade perpetuals and intelligent copytrading to live where they belong: on transparent, decentralised infrastructure, not in a black box. Launching FastX on 5 May is the first step. From here, we'll continue to ship faster execution, smarter tooling, and AI‑enhanced copytrading that helps traders survive and thrive in 24/7 markets."Traders can learn more and access the exchange at https://fastx.co.About FastXFastX focuses on building decentralised financial infrastructure and tools for professional traders and sophisticated market participants. The company backs products that prioritise self‑custody, transparency, and robust risk management in rapidly evolving digital asset markets.Media ContactBrand: FastX Perpetuals ExchangeContact: Ella HuangWebsite: https://fastx.co/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

CMS (867.HK; 8A8.SG): NDA for the Seasonal Allergic Rhinitis Indication of Class 1 Innovative Drug MG-K10 Accepted in China

SHENZHEN, Apr 23, 2026 - (ACN Newswire via SeaPRwire.com) - China Medical System Holdings Limited (the “Group” or “CMS”) is pleased to announce that the New Drug Application (NDA) in China for the Seasonal Allergic Rhinitis (SAR) indication of MG-K10 (generic name: Comekibart Injection, “MG-K10” or the “Product”), a Class 1 innovative drug anti-IL-4Rα humanized monoclonal antibody injection, for which the Group holds co-development rights (excluding the indication of atopic dermatitis (AD)) and exclusive commercialization rights, was accepted by the National Medical Products Administration of China (NMPA) on 23 April 2026. The Product is proposed for the treatment of adult patients with moderate-to-severe seasonal allergic rhinitis whose symptoms remain inadequately controlled after treatment with intranasal corticosteroids.The acceptance of the NDA represents an important milestone for the Group’s ophthalmology business, CMS Vision, as it expands its therapeutic focus from ophthalmology into the field of otolaryngology (ENT). It also marks another significant milestone in the Group’s research and development progress in the field of type 2 inflammatory diseases. If the Product is successfully approved for marketing, the Group will leverage its strong academic promotion capabilities and extensive commercialization network to accelerate the commercialization of the Product. It is also expected to further enhance the academic brand influence of CMS Vision in the relevant specialty areas and provide new momentum for the Group’s business growth.BIC Potential: Dosing once every 4 weeks; Phase III study met the primary endpoint with a favorable safety profileMG-K10 is an innovative long-acting anti-IL-4Rα humanized monoclonal antibody that simultaneously blocks the signaling pathways of the key type 2 inflammatory cytokines IL-4 and IL-13, thereby exerting immunomodulatory effects. It is being developed for the treatment of type 2 inflammatory diseases, including seasonal allergic rhinitis, asthma, atopic dermatitis (AD), prurigo nodularis, chronic obstructive pulmonary disease (COPD), chronic spontaneous urticaria (CSU), chronic rhinosinusitis with nasal polyps, and eosinophilic esophagitis. Currently marketed anti-IL-4Rα therapies require administration once every two weeks. MG-K10, with its longer half-life, enabling a once-every-four-weeks dosing regimen. It therefore has the potential to become the first long-acting anti-IL-4Rα monoclonal antibody to be marketed globally, with the potential to be best-in-class. MG-K10 has met the primary endpoint in a multicenter, randomized, double-blind, placebo-controlled Phase III clinical trial in adult patients with moderate-to-severe seasonal allergic rhinitis. The results of the Phase III study demonstrated that the primary endpoint achieved statistical significance, with significantly superior efficacy compared with the placebo group, and a favorable safety profile.Focusing on Unmet Needs: ~250 million patients; 62% of moderate-to-severe patients remain inadequately controlled; long-acting breakthrough brings new treatment opportunitiesAllergic rhinitis is a chronic inflammatory disease of the nasal mucosa mediated by IgE, with type 2 inflammation as the core pathogenic mechanism. It occurs in susceptible individuals upon exposure to environmental allergens such as pollen and dust mites. In recent years, the prevalence of the disease in China has increased from 11.1% to 17.6%, affecting approximately 250 million people[1], among whom 52.2% are patients with persistent moderate-to-severe disease[2]. The disease burden is significant and has become an important public health issue. Current standard treatments, including intranasal corticosteroids and antihistamines, have notable limitations. 62% of patients with moderate-to-severe disease remain inadequately controlled[3]. Long-term use of intranasal corticosteroids may lead to adverse reactions such as epistaxis[4], while antihistamines are often associated with side effects such as drowsiness[5], indicating significant unmet clinical needs. As a biologic therapy targeting IL-4Rα, MG-K10 can block the type 2 inflammatory pathway at its source. Compared with currently approved biologics targeting the same pathway (which require dosing once every two weeks), MG-K10 achieves a differentiated breakthrough in dosing frequency with its long-acting property allowing administration once every four weeks, thereby significantly extending dosing intervals. This may help improve patient treatment adherence and reduce the time and economic burden associated with frequent hospital visits. The Product has the potential to provide a new treatment option for patients with moderate-to-severe disease who respond poorly to conventional therapies, thereby reducing the individual and socio-economic burden associated with the disease.On 24 January 2025, the Group through subsidiaries of the Company entered into a Collaboration Agreement (“Agreement”) with Hunan Mabgeek Biotech Co., LTD and its subsidiary for MG-K10. In accordance with the Agreement and supplementary agreements, the Group has obtained the co-development rights (excluding AD) and exclusive commercialization rights for the Product in Mainland China, Hong Kong Special Administrative Region, Macao Special Administrative Region, Taiwan Region and Singapore; its subsidiary Dermavon Holdings Limited has obtained, through its subsidiary, the co-development rights (excluding AD) and exclusive commercialization rights for the Product in the field of dermatological indications in Mainland China.About CMSCMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the Cardiovascular-Kidney-Metabolic/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.Reference1. Cheng L, Chen J, Fu Q, et al. Chinese Society of Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis. Allergy Asthma Immunol Res. 2018;10:300‑353.2. Zheng, Ming et al. “Clinical characteristics of allergic rhinitis patients in 13 metropolitan cities of China.” Allergy vol. 76,2 (2021): 577-581. doi:10.1111/all.145613. White, P et al. “Symptom control in patients with hay fever in UK general practice: how well are we doing and is there a need for allergen immunotherapy?” Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology vol. 28,3 (1998): 266-70. doi:10.1046/j.1365-2222.1998.00237.x4. Rosenblut, A et al. “Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis.” Allergy vol. 62,9 (2007): 1071-7. doi:10.1111/j.1398-9995.2007.01521.x5. Bernstein, Jonathan A et al. “Allergic Rhinitis: A Review.” JAMA vol. 331,10 (2024): 866-877. doi:10.1001/jama.2024.0530CMS Disclaimer and Forward-Looking StatementsThis press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Smart Lighting Expo and Lighting Fair conclude successfully

HONG KONG, Apr 23, 2026 - (ACN Newswire via SeaPRwire.com) - The 3rd Smart Lighting Expo and the 17th Hong Kong International Lighting Fair (Spring Edition), organised by the Hong Kong Trade Development Council (HKTDC), successfully concluded today at the Hong Kong Convention and Exhibition Centre. The four-day fairs brought together some 900 exhibitors and attracted some 13,000 buyers from 114 countries and regions for on-site visits and sourcing. Buyer numbers recorded growth, including those from Asian markets such as Malaysia and the Philippines; European markets including France, Germany, the Netherlands, Russia and Türkiye; and North and South American markets, including Brazil, Canada and the US, highlighting Hong Kong’s role as a key global hub for lighting products and technology exchange.Jenny Koo, Deputy Executive Director of the HKTDC, said: "This year’s two lighting fairs attracted industry-leading enterprises who showcased cutting-edge high-performance, smart lighting and sustainable products and solutions. The events also attracted quality buyers from global markets. This helps companies diversify supply chains, explore new markets, and underscores Hong Kong’s strength as an ‘International Exhibition Capital’ which boosts efficient business platforms. The fairs are the preferred platform for the industry to showcase innovation, connect with global buyer networks and accelerate business development.”Survey findings: Respondents were most optimistic about the India and Australia marketsTo keep abreast of the latest industry developments, the HKTDC conducted an on-site survey during the fairs, interviewing 450 exhibitors and buyers. The findings show that overall confidence among exhibitors and buyers in future business development has shown a general increase.Key market outlook and product trend findings:49.1% of respondents expect overall sales to increase in the next 12 to 24 months, while 47.6% expect sales to remain stable.Respondents consider India (73.4%), Australia (71%), ASEAN countries (70.4%), and Japan (68.1%) to be promising or very promising target sales markets for lighting products over the next two years in terms of growth.In terms of new market development, exhibitor respondents are actively exploring Middle East (31.8%), Europe (29.5%), ASEAN countries (23.9%), Latin America (17.6%) and North America (14.8%).In the smart lighting segment, respondents identified home automation and intelligent lighting control systems (48.2%), energy saving lighting control solutions (38.2%), and outdoor smart security lighting systems (31.1%) as having the greatest growth potential over the next two years.Compared with conventional lighting products, respondents indicated that consumers are willing to pay an average premium of 29% for lighting products equipped with smart functions.Scenario-based displays and new zones enhance sourcing effectiveness, with positive trade outcomesThe newly launched “Light Lab” features various scenario-based and immersive designs, integrating lighting products into landscape, sports, cultural and artistic application settings. Shanghai Sansi Electronic Engineering showcased plant clamp lights and compact downlights suitable for museum applications. Guoli Zhu, Deputy Chief Engineer of the company said: “The Light Lab has effectively enhanced the presentation of our products, enabling buyers to more intuitively and swiftly grasp product features and their real-world application scenarios. This has successfully attracted buyers from Argentina, Canada, Germany, India, Japan and the US to visit our booth for in-depth discussions. We expect this to result in orders worth over US$1 million.”The Smart Lighting Expo also debuted the “Smart Display and Stage Lighting & Sound Zone” which displayed a wide range of intelligent display solutions. Industry leader Absen participated in the fair for the first time. Benjamin Tang, Senior Sales Engineer, said: “The new zone has effectively enhanced product visibility, attracting buyers from Eastern Europe, Oceania, North America, South America, and South Asia to our booth. These inquiries came from new clients across key sectors such as cultural tourism and stage engineering. We have also successfully engaged in several promising collaboration discussions with potential clients from the Dominican Republic, Hong Kong and Thailand, further strengthening the company’s market expansion plan. We estimate the value of orders from the expo will amount to US$930,000. Riding on this momentum, we have decided to join the Hong Kong International Lighting Fair (Autumn Edition) this year.”The newly launched “Leisure Lighting Zone” has injected new momentum into the Spring Lighting Fair. Rebecca Seo, CFO of NIZ, a first-time exhibitor from Korea, said: “The fair has provided us with an excellent platform to connect with international buyers. We have successfully connected with buyers from Denmark, Germany, Japan, and the US, and a well-known Japanese homeware retailer has already placed an on-site order. Thanks to the strong traffic generated by the new zone, we expect the fair to bring up to US$70 million in orders for our company this year."Supported by Zhongshan as the Special Partner City, the fairs featured the Zhongshan Guzhen Pavilion and Zhongshan Henglan Pavilion under the Zhongshan Smart Home Zone, presenting the manufacturing strength and competitiveness of the region’s lighting industry while supporting enterprises in “going global”. Merry Liu, Manager of Bairan Lighting, an industrial enterprise above designated size in Henglan, Zhongshan, said: “The two lighting fairs provide Zhongshan enterprises with an efficient ‘go-global’ gateway, enabling us to connect directly with buyers from Europe, the Middle East, South America, and Southeast Asia. This helps drive our products and brand onto the international stage. We expect to achieve US$2 million in sales.”During the fair, the HKTDC organised a buying mission to Zhongshan for the first time, visiting several lighting factories and participating in business matching meetings. This initiative aimed to deepen exchange and cooperation within the Zhongshan lighting supply chain. The visit successfully facilitated several substantive business collaborations; New Zealand buyer Spark100 Ltd established a connection with a Zhongshan lighting supplier, with a potential order value estimated between US$100,000 and US$300,000.This year’s exhibition also attracted buyers from the Middle East. Patrick Zhang, VP of sales of Tecnon Lighting Technology from the Shenzhen Pavilion, stated: “At this year’s fair, a buyer from the United Arab Emirates and a US buyer from a leading women’s fashion brand are likely to become our cooperation partners. We expect to generate US$2 million in sales turnover for our company.”As construction projects in the ASEAN region accelerate, market demand for smart lighting solutions continues to expand. Sambath HK, Manager of RS Decoration from Cambodia, stated, “I travelled here specifically to source lighting products for 14 new commercial building and luxury residential projects. I have already met with over 20 new suppliers and identified two potential partners offering smart street lights, solar lights, and decorative lighting products. I will initially purchase US$100,000 worth of smart street lights.”Driven by the Belt and Road Initiative, urban development in participating countries and regions are in full swing, fuelling a continuous surge in demand for high-efficiency and smart lighting products. Aigerim Beisekina, Supply Manager of Karelz.kz from Kazakhstan, said: “This is our first time visiting the twin lighting fairs, to find reliable suppliers for a solar-powered stadium and sports lighting for three international schools currently under construction in Kazakhstan. Through the Click2Match business matching platform, we have identified three potential suppliers from the Chinese Mainland and plan to purchase lighting equipment valued between US$600,000 and US$900,000.”During the fairs, multiple professional events were held, including the Asian Lighting Conference and the Smart Lighting Solutions Forum. Designers and industry representatives from different regions shared market trends, application cases and technological developments, providing forward-looking market insight for the industry.EXHIBITION+ model sustains post-fair business opportunitiesUnder the hybrid EXHIBITION+ model, the twin lighting fairs combined in-person sourcing with online meetings via the HKTDC’s Click2Match smart business-matching platform and hktdc.com sourcing platform. Click2Match will be available until 30 April to facilitate discussions between exhibitors and buyers around the world.Photo download:  https://bit.ly/42m6sqDThe 3rd Smart Lighting Expo and the 17th Hong Kong International Lighting Fair (Spring Edition), organised by the Hong Kong Trade Development Council (HKTDC), successfully concluded today at the Hong Kong Convention and Exhibition Centre, attracted some 13,000 buyers from 114 countries and regions for on-site visits and sourcing.The newly launched “Light Lab” adopted a series of scenario-based and immersive designs, integrating lighting products directly into landscape, sports, cultural and artistic application settings, enabling buyers to better understand product features and practical applications.At the Spring Lighting Fair, the featured “Hall of Aurora” brought together 120 international and premium lighting brands, attracting numerous global buyers.The Shanghai Pudong Intelligent Lighting Association also returned to the Smart Lighting Expo for the third consecutive year, presenting the “Intelligent Ecosystem & IoT Supply Chain Zone”.As for the Spring Lighting Fair, exhibitors include the Xiamen Pavilion, and newly participating Changzhou Zouqu District Pavilion and Zhejiang Pavilion, further broadening industry exchange.The two fairs gathered numerous renowned brands and industry leaders, including Absen (photo), an LED display provider featured at the NBA All-Stars Games, the FIFA Qatar World Cup and Qatar Doha World Expo, and a Guinness World Record holder; and Shanghai Sansi, which supplies over 60% of the display screens in Times Square, New York.During the fairs, the HKTDC arranged various matching activities to connect buyers and exhibitors. The photo shows buyer Powermep from the UAE in discussion with an exhibitor.During the fairs, the HKTDC organised a buying mission to Zhongshan for the first time, visiting several lighting factories and participating in business matching meetings, strengthening exchange and cooperation within the Zhongshan lighting supply chain.‍The Smart Lighting Solution Forum was held on 21 April. Industry experts shared developments in smart home lighting systems and human-centric lighting for home entertainment as well as discussion of the eco-system of health and connected lighting supply chains.As part of the city’s mega-event economy, the Hong Kong Tourism Board (official exhibition promotion partner) arranged special “Cheung Po Tsai” Victoria Harbour night cruises during the fairs to enhance the business travel experience of convention and exhibition visitors.WebsitesHong Kong International Lighting Fair (Spring Edition): hklightingfairse.hktdc.com/tcSmart Lighting Expo: smartlightingexpo.hktdc.com/tcHKTDC Mediaroom: http://mediaroom.hktdc.com/enMedia enquiriesHKTDC’s Communications & Public Affairs Department:Stanley So Tel: (852) 2584 4049 Email: stanley.hp.so@hktdc.orgNavin Law Tel: (852) 2584 4525  Email: navin.cm.law@hktdc.orgSerena Cheung Tel: (852) 2584 4272 Email: serena.hm.cheung@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

GA Ventures Ltd 宣布正式推出 FastX:新一代全球交易交易所

開曼群島喬治敦, 2026年4月23日 - (亞太商訊 via SeaPRwire.com) - GA Ventures Ltd今日宣布正式推出FastX。這是一款專為專業及活躍交易者打造的下一代交易所,旨在提供機構級工具的同時,確保用戶無需放棄對資產的託管或控制權。FastX將於 5 月 5 日在全球上線,交易者可直接訪問fastx.co進入平台。FastX結合了深厚的on-chain流動性、多資產perpetual futures市場以及先進的copy-trading引擎,旨在架起傳統金融與去中心化數位資產生態系統之間的橋樑。透過利用blockchain技術,該平台實現了在全球主要去中心化網絡上的低延遲交易鏡像,同時讓用戶完全掌控自己的錢包和風險。「FastX由交易員為交易員而建,」FastX首席執行官Adelene表示。「我們的職業生涯遍佈華爾街交易台和加密市場,見證了同樣問題的重演:透明度極低的執行、利益錯位,以及要求用戶盲目外包決策的copytrading系統。FastX是我們的答案--一個去中心化、透明的基礎設施層,交易員保留託管權,技術則是用來增強而非取代他們的優勢。」FastX擁有一支由資深交易員組成的團隊,他們在頂級華爾街機構和領先的加密交易公司擁有超過50年的綜合經驗。FastX 從底層構建為一個decentralised protocol。用戶連接自己的錢包,始終保持self-custody,並透過smart contracts在on-chain執行交易,而非依賴中心化經紀商或託管交易所。發布時,FastX將提供:- 深厚的on-chain流動性:涵蓋廣泛的perpetual市場,旨在以極窄的價差和最小的滑點支持大額頭寸。- 快速直觀的交易界面:透過fastx.co直接訪問,允許交易員插入首選錢包並在幾分鐘內開始交易。- 透明的關聯計劃與積分系統:與社區分享平台費用的重要部分,獎勵幫助增長流動性和交易量的交易員及合作夥伴。FastX的核心功能是其下一代copytrading系統。與在單一場所鏡像訂單且存在不可預測延遲的傳統社交交易產品不同,FastX的引擎旨在跨主要去中心化交易所路由和同步跟單交易,並將這些功能疊加在FastX自身的流動性之上。該copytrading體驗旨在:- 最小化Lead Trader與Follower執行之間的延遲。- 緩解結構性風險,如滑點、去同步和明顯的操縱行為。- 發揮去中心化優勢,例如透明的on-chain業績記錄和可編程的風險控制,而不會使平台變成一個中心化的黑匣子。「copytrading 長期以來一直被定型為一場等待發生的盲目、自主的災難,」Adelene 補充道。「FastX 採取了相反的立場。我們利用技術帶來更多的透明度--on-chain 記錄、內置風險參數,以及盡可能減少搶跑和執行博弈的基礎設施。隨著時間的推移,我們的目標是在此基礎上疊加 AI 驅動的智能,使平台用戶能從高級分析和風險管理中獲益,而不僅僅是『跟隨並期待』。」FastX 目前由深耕全球加密交易生態系統的天使投資人網絡提供種子輪資金。這些支持者擁有共同的願景,即下一代市場將建立在開放、可驗證的軌道上,交易員理應獲得更好、更透明的工具來表達和管理風險。GA Ventures和FastX正在組建一個由資深交易員、market makers和技術專家組成的強大顧問委員會,以指導交易所進入下一階段的增長。作為一個decentralised protocol,FastX不託管用戶資金,也不作為傳統經紀商運營。所有頭寸、清算和費用流在on-chain均清晰可見,讓交易員在所有市場條件下都能對系統行為進行清晰、可驗證的洞察。「我們的願景很簡單,」Adelene表示。「我們希望專業級的 perpetuals和智能copytrading存在於它們應有的地方:透明的去中心化基礎設施,而不是黑匣子。5月5日推出 FastX是第一步。從這裡開始,我們將繼續提供更快的執行、更智能的工具和AI增強的copytrading,幫助交易員在 24/7 的市場中生存並蓬勃發展。」交易員可以透過 https://fastx.co 瞭解更多信息並訪問交易所。關於 GA Ventures LtdGA Ventures Ltd註冊於開曼群島,專注於為專業交易員和成熟的市場參與者構建去中心化金融基礎設施和工具。公司支持的產品優先考慮在快速發展的數位資產市場中實現self-custody、透明度和穩健的風險管理。Media ContactBrand: FastX Perpetuals Exchange (GA Ventures Ltd)Email: support@fastx.coContact: Ella HuangWebsite: https://fastx.co/ Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Sisel International Appoints Pamela Ferry as General Manager of Australia and New Zealand to Support Regional Expansion

SPRINGVILLE, UT, Apr 23, 2026 - (ACN Newswire via SeaPRwire.com) - Sisel International�today announced that it has appointed Pamela Ferry as General Manager of Australia and New Zealand as the company accelerates its expansion and transitions to full market operations across the region.Ferry brings more than 20 years of experience in the global direct selling industry, with a focus on international market expansion, distributor growth, and leadership development, including experience supporting the relaunch of underperforming markets and driving renewed growth. Throughout her career, she has held leadership roles focused on building strong teams, developing field leaders, and fostering long-term organizational success. An experienced presenter, trainer, and events professional, Ferry is recognized for her ability to connect with audiences and translate strategy into practical field execution. Her strengths in relationship building and education position her to play a key role in developing Sisel's distributor network and establishing a strong foundation in the region.The appointment comes at a pivotal stage as Sisel expands into the Australian market, with a focus on building infrastructure, enabling�distributor growth, and introducing its science-driven wellness solutions to new audiences. Ferry will lead efforts to develop market operations, strengthen field support, and drive sustainable growth across Australia and New Zealand."Australia represents an important opportunity for Sisel as we continue our international expansion," said Tom Mower Jr., CEO and Co-Founder of Sisel International. "Pamela brings not only deep industry experience, but a proven ability to develop leaders and build strong distributor networks. Her leadership will be instrumental as we establish a long-term presence in the region."About Sisel International Sisel International is a global health and wellness company dedicated to developing high-quality, science-driven products designed to support healthier living. Co-founded by Tom Mower Sr. and led by CEO Tom Mower Jr., Sisel creates supplements, personal care, home care, and wellness solutions formulated without harmful or unnecessary ingredients. Guided by its founding principles, the company is committed to innovation, safety, and quality while empowering individuals to pursue health, longevity, and personal success worldwide.Media Contact:Sisel InternationalMarketing TeamEmail:�marketing@sisel.netWebsite: www.sisel.netSOURCE: Sisel International Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

FastX Launching, a New Generation Global Trading Exchange

NEW YORK, Apr 23, 2026 - (ACN Newswire via SeaPRwire.com) - FastX today announces the official launch of its platform, a next-generation exchange built for professional and active traders who require institutional‑grade tools without surrendering custody or control of their assets. FastX goes live globally on 5 May, with traders able to access the platform directly at fastx.co.FastX combines deep on‑chain liquidity, multi‑asset perpetual futures markets, and an advanced copy-trading engine designed to bridge the gap between traditional finance and the decentralized digital asset ecosystem. By leveraging blockchain technology, the platform delivers low‑latency mirroring of trades across major decentralized networks worldwide—while keeping users in full control of their own wallets and risk."FastX was created by traders for traders," said Adelene, Chief Executive Officer of FastX. "We've spent our careers on Wall Street desks and in crypto markets, and we've seen the same problems repeat: opaque execution, misaligned incentives, and copytrading systems that ask users to blindly outsource decisions. FastX is our answer—a decentralised, transparent infrastructure layer where traders keep custody, and technology works to augment, not replace, their edge."Backed by a team of veteran traders with more than 50 years of combined experience across top Wall Street institutions and leading crypto trading firms, FastX is built from the ground up as a decentralised protocol. Users connect their own wallets, maintain self‑custody at all times, and interact with smart contracts that execute trades on‑chain, rather than relying on a centralised broker or custodial exchange.At launch, FastX will offer:Deep, on‑chain liquidity across a wide range of perpetual markets, designed to support serious position sizes with tight spreads and minimal slippage.A fast, intuitive trading interface accessible directly via fastx.co, allowing traders to plug in with their preferred wallet and start trading in minutes.A transparent affiliate and points system that shares a meaningful portion of platform fees with the community and rewards traders and partners who help grow liquidity and volume.The flagship feature of FastX is its next‑generation copytrading system. Unlike traditional social trading products that mirror orders on a single venue with unpredictable delays, FastX's engine is designed to route and synchronise copy trades across major decentralised exchanges, layering those capabilities on top of FastX's own liquidity.The result is a copytrading experience that aims to:Minimise latency between lead and follower execution.Mitigate structural risks such as slippage, desync, and obvious forms of manipulation.Exploit decentralised advantages, such as transparent on‑chain track records and programmable risk controls, without turning the platform into a centralised black box."Copytrading has always been typecast as a blind, autonomous disaster waiting to happen," Adelene added. "FastX takes the opposite stance. We use technology to bring more transparency, not less—on‑chain track records, built‑in risk parameters, and infrastructure that reduces front‑running and execution games wherever possible. Over time, our goal is to layer AI‑driven intelligence on top of this foundation so that users can benefit from advanced analytics and risk management, rather than just 'follow and hope'."FastX is currently seed‑funded by a network of angels deeply embedded in the global crypto trading ecosystem. These backers share a common view that the next generation of markets will be built on open, verifiable rails and that traders deserve better, more transparent instrumentation for expressing and managing risk. FastX is assembling a strong advisory board of experienced traders, market makers, and technologists to guide the exchange through its next phase of growth.As a decentralised protocol, FastX does not take custody of user funds and does not operate as a traditional broker. All positions, liquidations, and fee flows are visible on‑chain, giving traders clear, verifiable insight into how the system behaves under all market conditions."Our vision is simple," said Adelene. "We want professional‑grade perpetuals and intelligent copytrading to live where they belong: on transparent, decentralised infrastructure, not in a black box. Launching FastX on 5 May is the first step. From here, we'll continue to ship faster execution, smarter tooling, and AI‑enhanced copytrading that helps traders survive and thrive in 24/7 markets."Traders can learn more and access the exchange at https://fastx.co.About FastXFastX focuses on building decentralised financial infrastructure and tools for professional traders and sophisticated market participants. The company backs products that prioritise self‑custody, transparency, and robust risk management in rapidly evolving digital asset markets.Media ContactBrand: FastX Perpetuals ExchangeContact: Ella HuangWebsite: https://fastx.co/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

聚力佈局築牢根基 數智賦能穩健前行 海通恒信2025年經營成效亮眼

香港, 2026年4月23日 - (亞太商訊 via SeaPRwire.com) - 近年來,融資租賃行業在國家戰略引導下持續提質增效、穩步擴容,行業綜合實力顯著提升,為實體經濟高質量發展、產業結構優化調整、區域協調發展作出了重要貢獻。海通恒信(1905.HK)作為行業領先的數智化融資租賃公司之一,依託國泰海通證券集團的強大戰略協同與資源支撐,於近期發佈其2025年度業績,數據顯示,2025年公司實現收入總額68.20億元,年度溢利14.25億元;截至2025年末,公司資產總額達1,077.56億元,權益總額204.19億元,資產規模穩步夯實,用扎實的數據與亮眼的實踐,展現了數智化轉型與穩健經營的雙重成效。值得關注的是,海通恒信始終堅守回報股東的初心,以持續穩定的分紅表現,贏得了市場與投資者的廣泛認可。2025年,公司完成向股東派發現金股息2次,合計人民幣6.75億元,充分彰顯了其對自身長期發展的堅定信心。強化重點區域佈局 提升客戶層級築牢基本盤在業務佈局層面,2025年,海通恒信深度踐行國家區域發展戰略,聚焦核心經濟地帶與高能級城市,覆蓋核心城市周邊都市圈,依託全國21家分公司及各屬地團隊,深入挖掘屬地業務機會,形成了覆蓋長三角、珠三角、京津冀、成渝陝及長江中游五大重點區域的業務佈局。截至2025年末,公司五大重點區域生息資產餘額占比超過80%,聚焦性持續增強,特別是長三角地區優勢突出,新增業務投放占比近45%,同比增長34%,年末生息資產餘額占比超過36%,較年初提升約8個百分點,逐步建立了具有區域產業特色的差異化競爭優勢,為區域產業升級提供了有力支撐。與此同時,2025年,海通恒信不斷推動客戶層級提升,聚焦價值貢獻突出的核心客群,充分發揮「鏈主」企業輻射效應,橫向延伸挖掘重點客戶的綜合金融需求,縱向穿透核心企業上下游,積累更多紮根產業的優質客戶。截至2025年底,海通恒信的重點客戶持續積累、客戶層級顯著提升,2025年國央企客戶新增業務投放占比達到近60%,較2024年上升12個百分點,業務穩健性進一步增強,資產結構進一步優化,有效降低了經營風險,為公司持續健康發展提供了堅實保障。科技驅動轉型升級 完善風控體系守護高質發展海通恒信加速推動數智化轉型全面落地,以科技賦能重構業務模式、提升運營效能,公司已于業務全鏈條應用多款AI智能工具,建成公司級管理駕駛艙,強化決策支持的可視化呈現與量化分析,並將數智賦能全面覆蓋租前、租中、租後各關鍵環節,顯著提升運營效率與科學決策能力。憑藉在金融科技與業務融合方面的領先實踐,公司榮獲第六屆金融科技應用與服務大會「領軍企業獎」及「創新突破企業獎」,彰顯了行業對其數智化轉型成果與創新能力的高度認可,也奠定了其在數智化融資租賃領域的引領地位。2025年,海通恒信持續加強風險防控,堅守合規經營底線,制定發佈了風險偏好管理辦法,修訂核心風控指標,進一步完善了全面風險管理體系;推動基於大數據分析的風險模型與審批體系建設,提升全流程風險管控能力;持續優化風險管理信息系統,深化金融科技在風險管理中的應用,提升風險前瞻預警和主動防範能力,築牢資產質量防線。報告期內,公司資產質量總體穩定,年末不良資產率為1.16%,較上年末下降0.01個百分點,不良資產率和不良資產餘額實現雙降,各項資產質量指標均保持在安全可控水平;年末不良資產撥備覆蓋率為304.71%,穩定在300%以上,風險抵禦能力充足,充分體現了公司卓越的風險管控水平,為公司穩健經營保駕護航。綜合來看,2025年,海通恒信憑藉精准的區域佈局、優質的客群結構、領先的數智化能力以及堅實的風險防控體系,在複雜的市場環境中逆勢突圍,取得了亮眼成績。未來,海通恒信將繼續立足租賃本源,深入踐行「一個國泰海通」理念,深化數智化轉型,優化區域與客群佈局,提升綜合競爭力,為服務國家戰略注入更強金融動能。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Akkodis Named a Leader in ISG Provider Lens(TM) Digital Engineering Services 2026 Reports

Zurich, Apr 23, 2026 - (ACN Newswire via SeaPRwire.com) - Akkodis, a global leader in digital engineering consulting and part of the Adecco Group has been named a "Leader" by Information Services Group (ISG) in the ISG Provider Lens™ Digital Engineering Services 2026 reports, recognizing the company's strength across critical engineering and technology domains in Europe and the United States.Image: Akkodis named leader in ISG Digital Engineering Services 2026. Source: AkkodisAkkodis earned Leader status in the following quadrants:Augmented Design and R&D Services (Europe)Intelligent Operations and Connected Experiences (Europe)Integrated Platform and Application Services (Europe and U.S.)Leadership in augmented design & R&D servicesISG highlights Akkodis' expertise in end‑to‑end product development, including systems architecture, Model-based Systems Engineering (MBSE) integration, unified tool chains and multi‑domain engineering. The company's digital twin methodologies support deep physical-digital integration for safety‑critical products. By integrating engineering and digital toolchains, Akkodis accelerates agile product development from concept to lifecycle management across automotive, aerospace, rail and industrial sectors.ISG also recognizes Akkodis' leadership in software-defined vehicle (SDV) engineering, with capabilities spanning hardware-in-the-loop (HIL) automation, telemetry pipelines, cloud‑scale validation and AI‑supported analytics. This has been successfully showcased through the Akkodis SDV Academy where clients accelerate advanced driver‑assistance systems (ADAS) and SDV verification while addressing engineering talent gaps. Expertise in embedded systems, sensor fusion and real‑time software reinforces Akkodis' position across mobility, industrial and defense applications.Advancing intelligent operations & connected experiencesISG recognizes Akkodis for advancing industrial intelligence and transforming factory and mission-critical operations. Through smart commissioning frameworks, digital twins and advanced simulation tools, the company helps clients accelerate digital factory planning, reduce layout risks and improve overall equipment effectiveness (OEE). Akkodis also supports predictive quality and maintenance through acoustic sensing, physics-based AI and data-driven diagnostics. Its operations capabilities (including ruggedized hardware engineering, over-the-air (OTA) lifecycle management and industrial asset health solutions), have been applied across industries and asset-intensive environments requiring reliability, safety compliance, environmental resilience and long-term continuity.Strength in Integrated Platform & Application ServicesAkkodis' digital solutions advance AI‑led autonomous engineering by accelerating validation, enhancing quality and enabling compliance‑by‑design at scale. In Europe, ISG highlights Akkodis' Unified AI Platform, powered by AI-Core, alongside its deep expertise in cloud, hybrid and sovereign architectures, including AWS, Azure and sovereign deployments, which helps organizations balance agility with security, compliance and data residency requirements.In the U.S., ISG cites Akkodis' leadership in cloud‑native, MACH‑aligned modernization. Its AI‑enabled development frameworks embed intelligence into workflows, accelerating modernization and enabling personalized digital experiences. DevSecOps, compliance‑by‑design models and a secure, modular AI‑Core platform, enable Akkodis to provide scalable, cloud‑native innovation and flexible integration across modern enterprise and platform ecosystems."We are proud to receive this recognition from ISG which underscores the depth of Akkodis' global digital engineering expertise and our ability to combine AI‑driven engineering, cloud‑agnostic platforms and compliance‑by‑design at global scale to help clients innovate with Akkodis Intelligence across dynamic and complex environments," said Jo Debecker, President & CEO of Akkodis.Shirish Madhukar Kulkarni, Lead Analyst, ISG, said, "Akkodis uniquely combines deep engineering expertise with AI‑led digital twins and scalable platforms to enable faster product innovation, resilient operations, and connected, data‑driven experiences." Srinivasan P N, Senior Lead Analyst, ISG added, "Akkodis' leadership is rooted in four decades of European engineering excellence, where systems engineering, validation depth and software defined innovation converge through Akkodis Intelligence to deliver trusted, AI enabled digital engineering at scale."Media contactsAnne FriedrichSVP, Global Head of Communications, AkkodisM. +4915174633470E. anne.friedrich@adeccogroup.comLisa BushkaVP, External Communications, AkkodisM. +18604630770E. lisa.bushka@adeccogroup.comAbout AkkodisAkkodis is a global digital engineering consulting company that enables organizations to innovate and accelerate by applying technology to redefine how processes and products are developed, powered and optimized. With deep expertise across AI, data, cloud, edge and software engineering, we offer best-in-class technology consultancy. Through our strong, scalable delivery models and specialized talent, we provide end-to-end solutions, from strategy and consulting through implementation. Our commitment to Akkodis Intelligence helps businesses connect the exponential power of technology with the irreplaceable strengths of human thinking and collaboration. Part of the Adecco Group and headquartered in Switzerland, Akkodis brings together 40,000 engineers and digital experts in over 30 countries, with services that span Consulting, Solutions and Academy. With deep experience across the world's major industries, Akkodis empowers businesses to solve complex challenges and achieve sustainable impact.  akkodis.com | LinkedIn | Instagram | Facebook | XAbout the Adecco GroupThe Adecco Group is the world's leading talent company. Our purpose is making the future work for everyone. Through our three global business units - Adecco, Akkodis and LHH - across 60 countries, we enable sustainable and lifelong employability for individuals, deliver digital and engineering solutions to power transformation and empower organisations to optimise their workforces. The Adecco Group leads by example and is committed to an inclusive culture, fostering sustainable employability, and supporting resilient economies and communities. The Adecco Group AG is headquartered in Zurich, Switzerland (ISIN: CH0012138605) and listed on the SIX Swiss Exchange (ADEN). www.adeccogroup.comAbout ISGISG (Information Services Group) is a leading global technology research and advisory firm. A trusted business partner to more than 900 clients, including more than 75 of the world's top 100 enterprises, ISG is committed to helping corporations, public sector organizations, and service and technology providers achieve operational excellence and faster growth. The firm specializes in digital transformation services, including automation, cloud and data analytics; sourcing advisory; managed governance and risk services; network carrier services; strategy and operations design; change management; market intelligence and technology research and analysis. Founded in 2006, and based in Stamford, Conn., ISG employs more than 1,600 digital-ready professionals operating in more than 20 countries-a global team known for its innovative thinking, market influence, deep industry and technology expertise, and world-class research and analytical capabilities based on the industry's most comprehensive marketplace data. For more information, visit www.isg-one.com.SOURCE: Akkodis Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

港股迎來創新藥新貴 邁威生物差異化創新突圍

香港, 2026年4月23日 - (亞太商訊 via SeaPRwire.com) - 全球ADC藥物市場正經歷爆發式增長,2024年市場規模突破250億美元,其中前五大商業化產品的年度銷售額均突破10億美元,Padcev更是以近26億美元的成績證明了靶向Nectin-4 ADC的廣闊前景。與此同時,中國創新藥企不再滿足於本土市場,紛紛將目光投向海外。在這一輪出海浪潮中,邁威生物憑藉差異化的管線設計、積極的對外授權策略以及新興市場的商業化落地,逐步展現出清晰的全球化路徑。邁威生物成立於2017年,是一家具備從藥物發現到商業化銷售全產業鏈能力的中國創新製藥公司。公司已於2022年1月在上海證券交易所科創板上市(股票代碼:688062),此次赴港上市旨在構建「A+H」雙融資平臺,進一步打開國際資本通道,為海外商業化創造更便利的條件。核心產品獲FDA多項認定,國內外臨床試驗啟動截至目前,邁威生物擁有4款已上市產品及10款候選藥物,覆蓋腫瘤、免疫、骨科、眼科等領域。其中,核心產品9MW2821(靶向Nectin-4 ADC)在多個適應症上展現出全球領先的臨床開發進度。在尿路上皮癌領域,該產品是在中國開發的同類靶點ADC中進展最快的,全球範圍內僅次於已上市的Padcev;其聯合特瑞普利單抗的一線療法III期試驗正在推進中,有望於2027年提交新藥上市申請(NDA)。在宮頸癌領域,9MW2821更是全球首款進入關鍵III期試驗階段的靶向Nectin-4 ADC,該III期臨床試驗已於2024年9月啟動,預計2027年完成。針對三陰性乳腺癌,9MW2821精准聚焦拓撲異構酶抑制劑ADC經治後的耐藥患者這一差異化賽道,已在中國開展II期試驗,並於2025年8月在美國啟動I期研究,計畫後續開展全球多中心II期或III期臨床試驗。目前,9MW2821已累計獲得美國FDA授予的多項快速通道認定及孤兒藥資格認定,並獲中國國家藥監局授予兩項突破性療法認定,充分驗證了其全球同類最佳的潛力。除核心產品9MW2821外,邁威生物的ADC管線儲備同樣頗具看點。靶向B7-H3的7MW3711已在國內獲批聯合特瑞普利單抗及JS207等療法的Ib/II期研究,並獲FDA授予小細胞肺癌孤兒藥資格,初步臨床資料在肺癌、食管癌等實體瘤中顯示出良好安全性與抗腫瘤活性。另一款靶向CDH17的7MW4911則在中美雙軌並行,國內I期與美國I/II期臨床同步推進,精准聚焦高發消化道腫瘤。兩款產品的快速推進不僅豐富了公司ADC產品矩陣,更凸顯了其在差異化靶點佈局與全球臨床開發上的創新執行力。超20億美元對外授權,驗證管線全球價值通過對外授權將早期管線的價值變現,同時加速已上市產品的商業化放量,邁威生物已形成清晰的商業閉環。2025年,公司總收入達到6.59億元人民幣,同比增長230.0%。其中對外授權收入4.09億元,收入占比62%。主要授權合作包括:授予齊魯製藥在大中華區獨家開發及商業化邁粒生®(長效G-CSF)的權利,獲得首付款及里程碑付款;授予Disc在除大中華區及東南亞以外的全球範圍內獨家許可9MW3011(抗TMPRSS6單抗)的權利,潛在里程碑金額最高達4.125億美元,並已達成II期試驗里程碑;授予Calico在除大中華區以外的全球獨家開發及商業化9MW3811(靶向IL-11單抗)的權利,潛在里程碑金額最高近6億美元;授予Kalexo Bio在全球範圍獨家開發、生產和商業化雙靶點siRNA候選藥物的權利,潛在里程碑金額最高可達10億美元,此外公司還有權獲得其雙位數A輪優先股股權。上述合作總潛在里程碑金額超過20億美元,不僅為公司帶來了即期現金流入,也證明了其創新管線的國際競爭力。通過精准選擇深耕細分領域的合作夥伴並實施對外授權,公司已將創新管線的價值推向全球舞臺;與此同時,依託自主研發夯實長期創新根基,邁威生物在早期價值變現與持續研發投入之間建立起良性迴圈,實現了全球化佈局與內生增長的雙重驅動,構建起可持續的創新發展範式。生物類似藥持續落地,商業化網路持續擴張在產品出海方面,邁威生物以生物類似藥作為切入新興市場的突破口。2025年8月,邁利舒®及邁衛健®在巴基斯坦獲批上市,成為巴基斯坦首個獲批的Prolia®及Xgeva®生物類似藥。此外,公司已與巴西、秘魯、沙特阿拉伯、菲律賓等多個國家的領先製藥公司簽訂合作協定,推動產品在當地的註冊與商業化。2025年12月,君邁康®(阿達木單抗生物類似藥)也在印尼獲批上市,並已與16個國家訂立海外合作協定。同時,公司自主研發的長效G-CSF邁粒生®於2025年5月獲批上市,是首個全球上市的採用白蛋白長效融合技術開發的G-CSF藥物,公司已將其在大中華區的獨家開發及商業化權利授予齊魯製藥。依託齊魯製藥在腫瘤領域成熟的銷售網路和強大的商業化能力,邁粒生®有望快速切入龐大的G-CSF市場,有效解決該領域大量未得到滿足的醫療需求,在競爭激烈的市場中佔據一席之地。這些海外上市進展表明,邁威生物不僅具備研發能力,更擁有將產品推向國際市場的註冊與商業化執行力。對於新興市場而言,高品質且具成本優勢的生物類似藥存在巨大未滿足需求,邁威生物的提前佈局有望在未來數年持續貢獻收入增量。為支撐海外商業化佈局,邁威生物始終堅持以國際標準構建品質體系。公司位於江蘇泰州的生產基地嚴格符合中國GMP標準及歐盟EMA GMP標準,而正在建設的上海金山大規模商業化生產基地同樣遵循歐盟EMA GMP標準設計。此外,公司的地舒單抗生產線已零缺陷通過哥倫比亞INVIMA的現場審計。基於此,邁衛健®(地舒單抗,120mg)和邁利舒®(地舒單抗,60mg)已成功實現海外商業化發貨。接軌國際的品質管制體系不僅為產品在新興市場的註冊與商業化奠定了堅實基礎,也確保了公司在全球供應鏈中的合規性與競爭力。結語邁威生物已構建起涵蓋差異化ADC管線、對外授權落地、生物類似藥海外上市及國際品質體系認證的全球化佈局,實現了自主研發、對外授權與海外商業化的協同驅動。此次赴港上市不僅是其資本戰略的關鍵一步,更將為其打開國際資本通道,加速海外臨床研究、全球註冊申報以及商業化網路拓展。在港股生物醫藥板塊估值處於歷史低位的當下,公司用扎實的管線與商業化成果,向國際投資者展示了中國創新藥的務實路徑。具備真正全球化能力的ADC新貴,值得長期關注。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Sinch Mailgun Report: Companies are Leaving Email Performance on the Table

SINGAPORE, Apr 23, 2026 - (ACN Newswire via SeaPRwire.com) - Sinch Mailgun, part of Sinch, has released its Email Impact Report 2026, introducing new industry benchmarks across 10 high-volume sending sectors and revealing a gap between email performance and execution.Based on insights from more than 400 billion emails sent in 2025 and a global survey of over 1,200 email senders, the report shows that while email remains a critical, high-performing channel, poor deliverability is leaving significant revenue on the table. Nearly 18% of emails fail to reach the inbox, putting up to a fifth of potential return on investment at risk for many organisations.78% of respondents say email is critical to business success. At the same time, the research highlights a growing disconnect between performance and execution, driven by gaps in measurement, deliverability practices and AI application.“APAC businesses rely heavily on email to drive sales, loyalty and customer experience but many are not set up to capture its full value,” said Ginger Kidd, Vice President Marketing & Communications APAC at Sinch. “What we see in this data reflects what’s happening locally: brands are investing in email and seeing strong returns, yet there is still a high number of messages that never reach inboxes. For instance, in a market as competitive and cost-conscious as Australia, marketers simply can’t afford for emails to get lost in inboxes. When budgets are under pressure, fixing deliverability is one of the fastest ways to unlock more value from the spend they already have.”AI adoption is widespread, but its impact remains uneven. Many teams focus on basic use cases such as content generation, while higher-impact applications such as optimisation, segmentation and deliverability remain underutilised. Organisations that use AI more effectively are significantly more likely to report improved email performance.Ginger Kidd said: "Across the diverse markets of APAC, we’re seeing a common theme: marketers are enthusiastically adopting AI, but the initial focus has primarily been on content creation. The true opportunity now lies in leveraging AI for smarter decision-making. For instance, who to send to, how often, and with what level of risk. This strategic shift is the key to ensuring every campaign improves performance, not just adds volume.“The most sophisticated teams are already using AI to predict which subscribers are at risk of disengaging, to fine-tune send times and to protect sender reputation. That’s where we’re seeing a real uplift in performance, not just faster content production.”Key findings of the report include:60% of companies measuring email ROI report returns above $10 for every $1 spentMore than 1 in 10 achieve returns as high as 40:146% say AI improves speed and efficiency41% of teams use AI to generate email content23% say AI has not improved their email programs49% report improved email performance year-over-year79% plan to maintain or increase investment in emailFewer than half of organisations can confidently measure email ROIAbout the reportThe Email Impact Report 2026 combines:Data from 400+ billion emails sent in 2025Insights from 1,200+ email senders globallyBenchmarks across 10 high-volume industriesRead more about the report here.About SinchSinch’s vision is to connect every business with every customer, everywhere in the world. With the industry’s most trusted foundation for intelligent customer communications, Sinch powers over 900 billion customer interactions annually for more than 200,000 customers across the globe. Leading global companies, including AI innovators, rely on Sinch to strengthen customer relationships and deliver seamless experiences across messaging, email and voice. Profitable since its founding in 2008, Sinch generated net sales of USD 3 billion (SEK 27 billion) in 2025 and has over 4,000 Sinchers in 60 countries, with headquarters in Stockholm. Sinch is listed on Nasdaq Stockholm (XSTO: SINCH). Visit us at sinch.com.About Sinch MailgunSinch Mailgun is the email infrastructure platform built for developers and businesses that demand reliable, high-performance delivery at scale. Trusted by companies worldwide, Mailgun powers transactional, marketing, and programmatic email through a developer-first API, advanced deliverability tools, and real-time analytics. As part of Sinch — the industry’s most trusted foundation for intelligent customer communications — Mailgun connects businesses to their customers through every send, at every scale. Visit us at mailgun.com.For more information, please contact:Tracey ChooCommunications Manager, APAC at SinchE-mail: tracey.choo@sinch.com Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Datavault AI 憑藉新獲頒專利及准予通知進一步擴充智慧財產權組合

賓夕法尼亞州費城, 2026年4月22日 - (亞太商訊 via SeaPRwire.com) - Datavault AI Inc.(「Datavault AI」或「本公司」) (納斯達克代碼:DVLT),作為人工智慧驅動的數據變現、憑證認證、數位互動及實物資產(「RWA」)代幣化技術的領導者,今日宣布獲得美國專利第12,596,819號,並收到另外兩項美國專利申請的准予通知。此里程碑直接延續了本公司於2025年12月獲頒兩項關於區塊鏈驅動內容授權及代幣化變現的基礎專利,進一步擴展了其強大的智慧財產權組合,其中以定義業界標準的碳信用額度代幣化專利為首。投資者重點摘要一項新頒發的專利及兩份准予通知,將保護範圍延伸至三大高價值平台:AI驗證的數據估值與變現、代幣化虛擬地點融資,以及數位資產與去中心化金融(DeFi)的自動化報稅準備——直接解決1099-DA合規挑戰。透過量子抗性加密與區塊鏈不可篡改性,強化了公司的 Sumerian® 加密錨點、DataValue®、DataScore® 及 Information Data Exchange® (IDE®) 技術,為日益增長的代幣化合約與授權交易管道奠定基礎。此舉正值首個完整的 IRS 1099-DA 報稅季結束之際,期間據報出現諸多營運障礙——包括 Coinbase、Kraken 及 Gemini 的資料遲交問題——這充分顯示市場對 Datavault AI 自動化、代幣化稅務解決方案的明確需求。已實現的應用場景包括代幣化大宗商品(銅、黃金、貴金屬)、農業/基因組/醫療保健數據資產、NIL 數位孿生、資金支持的虛擬生物科技市場,以及智慧稅務自動化——這些功能皆能原生整合至該公司的邊緣 GPU 機隊與 HPC 基礎設施。此技術直接支持 Datavault AI 2026 年至少 2 億美元的營收目標,加速金融科技、醫療保健、生物科技、能源、農業、體育娛樂及 Web3 領域的商業化進程,並開拓新的授權與合作機會。最新專利保護範圍美國專利第 12,596,819 號 - 「數據估值與安全商業化變現平台的方法與系統」(已核准):涵蓋端到端的許可制平台,包含自願參與的數據貢獻、AI驅動的自動化估值、在Datavault®中的區塊鏈代幣化儲存,以及透過開放式交易所進行交易並具備靈活的補償途徑(銷售、授權、獎勵、慈善捐贈)。美國專利申請號 17/842,220 - 「虛擬地點資金籌措系統與方法」(准予通知):保護特定組織虛擬地點的資金籌措、驗證及代幣化運作,包括多幣種捐款、整合式活動與資產代幣化、與投資組合對應的廣告,以及針對資料貢獻者的補償機制。美國專利申請號 17/507,459 - 「報稅表製作平台與方法」(准予通知):涵蓋針對客戶與員工的自動化報稅表製作,包含針對數位資產及 DeFi 活動的專用代幣化報稅處理、後端表單處理,以及對不斷演變稅法條文的動態調整——精準解決困擾首個 1099-DA 報稅季的對帳負擔與透明度缺口。市場背景與利多因素這些專利申請使 Datavault AI 處於三個快速擴張市場的交匯點。代幣化實體資產的鏈上價值已突破 300 億美元(RWA.xyz 2025 年數據),波士頓諮詢集團(BCG)與 ADDX 預測全球市場規模將於 2030 年前超過 16 兆美元。全球數據貨幣化市場預計將從 2024 年的 75.3 億美元成長至 2033 年的 188 億美元(年複合成長率 10.7%,SkyQuest Technology)。這項新的報稅專利問世之際,正值美國納稅人面臨國稅局(IRS)1099-DA表數位資產經紀商申報制度實施後的首個完整報稅季——其中總收入申報自2025年1月1日開始,特定交易的成本基礎申報則於2026年1月1日生效——而業界針對經紀商遲報以及跨錢包/鏈/DeFi對帳等問題的摩擦,早已廣為人知。對投資者的影響與戰略展望總體而言,已獲頒的專利及獲准的申請案,擴大了智慧財產權的涵蓋範圍,涵蓋將原始資料轉化為代幣化、可交易資產的創新技術,並能實現虛擬環境與數位資產組合的透明化資金籌措、變現及自動化稅務處理。預期這些技術將與 Datavault AI 計劃中的邊緣 GPU 機群及高效能運算基礎設施無縫整合,從而加速 AI 估值處理與代幣化合約的執行。「取得這項已核發專利,並收到另外兩項申請的准予通知,證實了我們在將無形數據轉化為可驗證、可變現資本方面的領導地位,以及在協助組織以完全透明且包含用戶補償的方式為虛擬世界提供資金與營運方面的優勢,」Datavault AI 創辦人暨執行長納撒尼爾·T·布拉德利(Nathaniel T. Bradley)表示。「這些專利申請深化了我們的競爭護城河,並加速了我們在數據資產、實體資產及數位資產稅務申報市場中搶佔重要市佔率的進程——這將直接推動我們達成 2026 年 2 億美元的營收目標,並擴展代幣化合約的業務管道。」若欲進一步了解 Datavault AI 的成長策略、商業化路線圖,以及透過代幣化與授權釋放數據及智慧財產權價值的長期願景,建議投資人觀看近期由 Tech Edge 主持、納斯達克(Nasdaq)對執行長納撒尼爾·布拉德利(Nathaniel Bradley)的專訪,該影片現已上線:https://vimeo.com/1176174810  關於 Datavault AI Inc.Datavault AI™(納斯達克代碼:DVLT)是 Web 3.0 環境中以人工智慧驅動的數據體驗、資產估值及變現領域的先驅。該公司基於雲端的平台透過其聲學科學與數據科學兩個部門,提供全面的解決方案。Datavault AI 的聲學科學部門擁有 WiSA®、ADIO® 及 Sumerian® 等專利技術,專注於空間與多聲道無線高解析度聲音傳輸。數據科學部門則運用 Web 3.0 及高效能運算技術,為體育娛樂、生物科技、教育、金融科技、房地產、醫療保健、能源等各產業提供體驗式數據感知、估值及安全變現服務。Information Data Exchange® (IDE®) 是一項由納斯達克金融基礎設施(Nasdaq Financial Infrastructure)驅動的代幣交易技術。本公司擁有並營運多項交易所,包括國際元素交易所(IEE)、運動畫刊交易所(SIx)、紐約互動廣告交易所(NYIAX)及美國政治交易所(APE)。本公司總部位於賓夕法尼亞州費城。更多資訊請瀏覽 https://www.dvlt.ai 。前瞻性陳述:本新聞稿包含《1933年證券法》(經修訂)第27A條、《1934年證券交易法》(經修訂)第21E條,以及《1995年私人證券訴訟改革法》所定義之「前瞻性陳述」。本新聞稿中除歷史事實陳述以外的所有陳述,包括關於本公司未來營運、財務狀況、前景、計畫、目標、預期及意圖之陳述,均屬前瞻性陳述。諸如「預期」、「相信」、 「可能」、「估計」、「預期」、「意圖」、「或」、「計劃」、「潛在」、「預測」、「預估」、「應」、「目標」、「將」、「會」等詞彙及類似表述,旨在識別前瞻性陳述,儘管並非所有前瞻性陳述均包含此類識別詞彙。本新聞稿中的前瞻性陳述包括但不限於以下內容:(i) 美國專利申請號 17/842,220、美國專利申請號 17/507,459 及任何相關外國或延續申請的最終核發、範圍、有效性及可執行性; (ii) 本公司已獲專利及專利申請中技術的商業價值、市場採用情況及營收貢獻,包括 DataValue®、DataScore®、Information Data Exchange® (IDE®)、Sumerian® Crypto Anchors 以及 Datavault® 平台; (iii) 本公司能否達成 2026 年至少 2 億美元的營收目標;(iv) 本公司代幣化合約、授權協議及戰略合作夥伴關係的進展; (v) 實體資產代幣化、數據變現及數位資產稅務申報市場的規模、成長與時機;(vi) 本公司預期部署的邊緣 GPU 機隊與高效能運算基礎設施之整合與表現;以及 (vii) 因應美國國稅局 1099-DA 表格申報要求所衍生的自動化稅務申報解決方案需求。這些前瞻性陳述係基於管理層當前的預期與假設,並受重大風險、不確定性及其他因素影響,可能導致實際結果與所表達或暗示者存在重大差異。此類風險包括但不限於:美國專利商標局在重新審查時頒發的專利範圍較原核准範圍更窄,或駁回已核准的專利主張;本公司專利及專利申請中技術的商業化進程延遲或失敗;本公司吸引及留住客戶、被授權人及交易所合作夥伴的能力;來自現有及新興技術的競爭; 網路安全、區塊鏈協議及量子運算風險;影響數位資產申報的美國聯邦及州稅法變更,包括對 1099-DA 表格制度的修改;影響數位資產、證券、資料隱私及代幣化實體資產的監管發展; 本公司能否以可接受的條款籌集額外資金;宏觀經濟及資本市場狀況;以及本公司截至 2025 年 12 月 31 日止財政年度之 10-K 表年度報告、後續 10-Q 表季度報告、 以及向美國證券交易委員會(「SEC」)提交的其他文件中討論之「風險因素」章節所載之其他風險因素,該等文件的副本可於 SEC 網站 www.sec.gov 免費取得。除適用法律要求外,本公司無義務且明確聲明不承擔任何責任,無論基於新資訊、未來事件、情況變更或其他原因,均不對任何前瞻性陳述進行更新或修訂。投資者及證券持有人應注意,切勿過度依賴此等前瞻性陳述,該等陳述僅反映本新聞稿發布當日的狀況。本公司不保證將實現其預期目標。本新聞稿不構成出售任何證券之要約,亦不構成購買任何證券之要約邀請。任何關於潛在收購、處分、合資企業、戰略聯盟、授權交易或類似安排之前瞻性陳述,均須待最終協議之協商、簽署及完成,並須滿足慣常之交割條件;且無法保證任何此類交易將按預期條款、預期時間完成,或能否完成。產業與市場數據:本新聞稿包含產業、市場及競爭地位數據,包括統計數據、預測及推算,該等數據係基於或源自獨立產業出版物、第三方研究、調查及報告,其中包含歸因於 RWA.xyz、波士頓諮詢集團(Boston Consulting Group)、ADDX、SkyQuest Technology 及美國國稅局(U.S. Internal Revenue Service)之數據。本公司並未獨立核實任何此類第三方資訊的準確性或完整性,且不就其可靠性作出任何明示或暗示的陳述或保證。此類行業出版物及預測本質上受制於假設、方法論限制及不確定性,基於該等數據所作的推算、估計及判斷可能無法被證實為準確。實際市場規模、增長率以及本公司在這些市場中的地位,可能與本文所述數據存在重大差異。商標、商號、服務標誌及著作權:Datavault AI™、DataValue®、DataScore®、Information Data Exchange®、IDE®、Datavault®、WiSA®、ADIO® 及 Sumerian® 均為 Datavault AI Inc. 於美國及/或其他司法管轄區的商標、服務標誌或註冊商標。本新聞稿亦提及其他公司所擁有的商標、服務標誌、商號及著作權,包括 Coinbase、Kraken、Gemini 及 Nasdaq 所擁有的相關標識。僅為方便起見,本新聞稿中提及的某些商標、服務標誌、商號及著作權可能未標示 ™、®、© 或 SM 符號,但本公司將在適用法律允許的最大範圍內,主張其對自身商標、服務標誌、商號及著作權的權利。使用或展示其他方的商標、服務標誌、商號或著作權,並非意在亦不暗示本公司與任何該等第三方存在關係,或獲得其背書或贊助。媒體聯絡人:marketing@dvlt.ai 投資人聯絡:Edward Barger投資人關係副總裁ebarger@dvlt.ai | ir@dvlt.ai 消息來源:Datavault AI Inc Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Datavault AI Further Expands IP Portfolio with New Patent Issuance and Notices of Allowance

PHILADELPHIA, PA, Apr 22, 2026 - (ACN Newswire via SeaPRwire.com) - Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a leader in AI-driven data monetization, credentialing, digital engagement, and real-world asset ("RWA") tokenization technologies, today announced the issuance of U.S. Patent No. 12,596,819 and Notices of Allowance on two additional U.S. patent applications. This milestone builds directly on the Company's December 2025 issuance of two foundational patents for blockchain-driven content licensing and tokenized monetization - further expanding its robust intellectual property portfolio headlined by the industry-defining Carbon Credit Tokenization Patent.Key Highlights for InvestorsOne newly issued patent and two Notices of Allowance extend protection across three high-value platforms: AI-validated data valuation & monetization, tokenized virtual location funding, and automated tax return preparation for digital assets and DeFi-directly addressing 1099-DA compliance challenges.Reinforces the Company's Sumerian® Crypto Anchors, DataValue®, DataScore®, and Information Data Exchange® (IDE®) technologies with quantum-resistant encryption and blockchain immutability, underpinning a growing pipeline of tokenization contracts and licensing deals.Arrives as the first full IRS Form 1099-DA filing season closes amid reported operational hurdles-including late deliveries by Coinbase, Kraken, and Gemini-demonstrating clear demand for Datavault AI's automated, tokenized tax solutions.Enabled use cases include tokenized commodities (copper, gold, precious metals), agricultural/genomic/healthcare data assets, NIL digital twins, funded virtual biotech marketplaces, and intelligent tax automation-integrating natively with the Company's edge GPU fleet and HPC infrastructure.Directly supports Datavault AI's 2026 revenue target of at least $200 million, accelerates commercialization across fintech, healthcare, biotech, energy, agriculture, sports & entertainment, and Web3, and opens new licensing and partnership opportunities.Scope of the Latest ProtectionsU.S. Patent No. 12,596,819 - "Method and System for Data Valuation and Secure Commercial Monetization Platform" (issued): Covers an end-to-end permissioned platform spanning opt-in data contribution, AI-driven automated valuation, blockchain-tokenized storage in the Datavault®, and trading on open exchanges with flexible compensation pathways (sales, licenses, rewards, charitable contributions).U.S. Patent Application No. 17/842,220 - "System and Method for Funding a Virtual Location" (Notice of Allowance): Protects the funding, authentication, and tokenized operation of organization-specific virtual locations, including multi-currency donations, integrated event and asset tokenization, portfolio-aligned advertising, and compensation mechanisms for data contributors.U.S. Patent Application No. 17/507,459 - "Platform and Method for Preparing a Tax Return" (Notice of Allowance): Covers automated tax return preparation for clients and employees, with specialized tokenized return handling for digital asset and DeFi activity, back-end form processing, and dynamic adjustment to evolving tax codes-precisely targeting the reconciliation burdens and visibility gaps plaguing the inaugural 1099-DA season.Market Context & TailwindsThe filings position Datavault AI at the convergence of three rapidly expanding markets. Tokenized real-world assets have already surpassed $30 billion in on-chain value (RWA.xyz 2025 data), with Boston Consulting Group and ADDX projecting the global market to exceed $16 trillion by 2030. The global data monetization market is forecast to grow from $7.53 billion in 2024 to $18.8 billion by 2033 (10.7% CAGR, SkyQuest Technology). The new tax-preparation patent arrives precisely as U.S. taxpayers navigate the first full season under the IRS Form 1099-DA digital asset broker reporting regime-where gross proceeds reporting began January 1, 2025, and basis reporting for certain transactions took effect January 1, 2026-amid well-documented industry friction around late broker filings and cross-wallet/chain/DeFi reconciliation.Investor Implications & Strategic OutlookCollectively, the issued patents and allowed applications extend IP coverage around innovations that transform raw data into tokenized, tradable assets and enable transparent funding, monetization, and automated tax handling of virtual environments and digital asset portfolios. These technologies are expected to integrate seamlessly with Datavault AI's anticipated edge GPU fleet and high-performance computing infrastructure, accelerating AI valuation processing and tokenization contract execution."Securing this issued patent and receiving Notices of Allowance on two additional applications validates our leadership in turning intangible data into verifiable, monetizable capital, and in enabling organizations to fund and operate virtual worlds with full transparency and user compensation," said Nathaniel T. Bradley, Founder and Chief Executive Officer of Datavault AI. "These filings deepen our competitive moat and accelerate our path to capturing meaningful share in the data asset, real-world asset, and digital asset tax-preparation markets-directly fueling our $200 million 2026 revenue target and expanding pipeline of tokenization contracts."For additional insight into Datavault AI's growth strategy, commercialization roadmap, and long-term vision for unlocking value from data and intellectual property through tokenization and licensing, investors are encouraged to view the recent Nasdaq interview with CEO Nathaniel Bradley, hosted by Tech Edge and now available at https://vimeo.com/1176174810About Datavault AI Inc.Datavault AI™ (NASDAQ:DVLT) is a pioneer in AI-driven data experiences, valuation, and monetization of assets in the Web 3.0 environment. The Company's cloud-based platform delivers comprehensive solutions across its Acoustic Sciences and Data Sciences divisions. Datavault AI's Acoustic Sciences division features WiSA®, ADIO®, and Sumerian® patented technologies for spatial and multichannel wireless, high-definition sound transmission. The Data Science Division harnesses Web 3.0 and high-performance computing to enable experiential data perception, valuation, and secure monetization across industries, including sports & entertainment, biotech, education, fintech, real estate, healthcare, energy, and more. The Information Data Exchange® (IDE®) is a token exchange technology powered by Nasdaq Financial Infrastructure. The Company owns and operates exchanges, including International Elements Exchange (IEE), Sports Illustrated Exchange (SIx), New York Interactive Advertising Exchange (NYIAX), and American Political Exchange (APE). The Company is headquartered in Philadelphia, PA. Learn more at https://www.dvlt.ai.Forward-Looking Statements: This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact contained in this press release, including statements regarding the Company's future operations, financial position, prospects, plans, objectives, expectations, and intentions, are forward-looking statements. Words such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would," and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements in this release include, but are not limited to, statements regarding: (i) the ultimate issuance, scope, validity, and enforceability of U.S. Patent Application No. 17/842,220, U.S. Patent Application No. 17/507,459, and any related foreign or continuation applications; (ii) the commercial value, market adoption, and revenue contribution of the Company's patented and patent-pending technologies, including DataValue®, DataScore®, the Information Data Exchange® (IDE®), Sumerian® Crypto Anchors, and the Datavault® platform; (iii) the Company's ability to achieve its 2026 revenue target of at least $200 million; (iv) the Company's pipeline of tokenization contracts, licensing arrangements, and strategic partnerships; (v) the size, growth, and timing of the markets for tokenized real-world assets, data monetization, and digital-asset tax preparation; (vi) the integration and performance of the Company's anticipated edge GPU fleet and high-performance computing infrastructure; and (vii) the demand for automated tax-preparation solutions arising from IRS Form 1099-DA reporting requirements.These forward-looking statements are based on management's current expectations and assumptions and are subject to significant risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed or implied. Such risks include, among others: the U.S. Patent and Trademark Office issuing claims narrower than those allowed or rejecting allowed claims on reexamination; delays or failures in commercializing the Company's patented and patent-pending technologies; the Company's ability to attract and retain customers, licensees, and exchange partners; competition from existing and emerging technologies; cybersecurity, blockchain protocol, and quantum-computing risks; changes in U.S. federal and state tax law affecting digital-asset reporting, including modifications to the Form 1099-DA regime; regulatory developments affecting digital assets, securities, data privacy, and tokenized real-world assets; the Company's ability to raise additional capital on acceptable terms; macroeconomic and capital-markets conditions; and the other risk factors discussed under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, and in subsequent Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and other filings made with the U.S. Securities and Exchange Commission (the "SEC"), copies of which are available free of charge on the SEC's website at www.sec.gov.Except as required by applicable law, the Company undertakes no obligation, and expressly disclaims any duty, to update or revise any forward-looking statement, whether as a result of new information, future events, changed circumstances, or otherwise. Investors and security holders are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. The Company gives no assurance that it will achieve its expectations. This release does not constitute an offer to sell, or the solicitation of an offer to buy, any security. Any forward-looking statements regarding potential acquisitions, dispositions, joint ventures, strategic alliances, licensing transactions, or similar arrangements are subject to the negotiation, execution, and consummation of definitive agreements and the satisfaction of customary closing conditions, and no assurance can be given that any such transaction will be completed on the terms contemplated, on the timing anticipated, or at all.Industry and Market Data: This press release contains industry, market, and competitive position data, including statistics, forecasts, and projections, that are based on or derived from independent industry publications, third-party research, surveys, and reports, including data attributed to RWA.xyz, Boston Consulting Group, ADDX, SkyQuest Technology, and the U.S. Internal Revenue Service. The Company has not independently verified the accuracy or completeness of any such third-party information and makes no representation or warranty, express or implied, as to its reliability. Industry publications and forecasts of this nature are inherently subject to assumptions, methodological limitations, and uncertainties, and projections, estimates, and beliefs based on such data may not prove to be accurate. Actual market size, growth rates, and the Company's position within these markets may differ materially from the figures presented herein.Trademarks, Trade Names, Service Marks and Copyrights: Datavault AI™, DataValue®, DataScore®, Information Data Exchange®, IDE®, Datavault®, WiSA®, ADIO®, and Sumerian® are trademarks, service marks, or registered trademarks of Datavault AI Inc. in the United States and/or other jurisdictions. This press release also refers to trademarks, service marks, trade names, and copyrights owned by other companies, including those of Coinbase, Kraken, Gemini, and Nasdaq. Solely for convenience, certain of the trademarks, service marks, trade names, and copyrights referred to in this press release may be listed without the ™, ®, ©, or SM symbols, but the Company will assert, to the fullest extent under applicable law, its rights to its own trademarks, service marks, trade names, and copyrights. The use or display of other parties' trademarks, service marks, trade names, or copyrights is not intended to and does not imply a relationship with, or endorsement or sponsorship by, the Company of any such third party.Media Contact:marketing@dvlt.aiInvestor Contact:Edward BargerVP Investor Relationsebarger@dvlt.ai | ir@dvlt.aiSOURCE: Datavault AI Inc Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

中國燃氣攜手中信建設、中信銀行簽署戰略合作協議

香港, 2026年4月22日 - (亞太商訊 via SeaPRwire.com) - 國內具有領先地位的城市燃氣營運商中國燃氣控股有限公司(「中國燃氣」或「集團」;股票編號:384)宣佈與中信建設有限責任公司(「中信建設」)及中信銀行股份有限公司(「中信銀行」)簽署戰略合作協議,三方將基於「資源共享、優勢互補、利益共用、互利共贏」的原則,構建「產、建、融」三位一體的生態式協同模式,進一步支持中國燃氣儲能及生物質能源等新業務發展,共同深耕全球能源基礎設施及綠色低碳產業。中國燃氣、中信建設及中信銀行正式簽署三方戰略合作協議此次合作是各方積極響應國家「十五五」規劃、深度參與「一帶一路」建設的重要舉措。根據協議,三方將建立全面戰略合作夥伴關係,在海外能源基礎設施建設、第三方項目聯合開發、產業園區業務、綠色金融及各類融資合作等領域展開深度合作,確立了「生態式協同」的閉環合作模式:即由中國燃氣作為商業模式主導方,負責項目策劃、技術方案與運營;中信建設作為工程建設實施方,發揮屬地資源調配與施工管理優勢;中信銀行作為金融服務提供方,解決投融資需求。三方將聚焦於多項核心領域展開深度合作,共同應對全球氣候變化及能源安全挑戰,包括:1)三方將重點聚焦欧洲、東南亞、中亞及北亞等潛力地區,共同推動能源基礎設施的開發與建設;2)圍繞中國燃氣於海內外主導開發的產業園區及新型城鎮化項目,三方將實現資源融合;3)三方將共同努力落實「綠色發展」戰略,並在投融資領域開展深度聯動。為把握全球能源轉型與國家「雙碳」目標機遇,集團正加快發展以儲能為核心的新能源業務及生物質能源業務兩大新增長極。在儲能領域,集團搶抓電力市場改革與新型電力系統建設的戰略機遇,持續深耕市場、優化佈局,呈現出「核心區域集中發力、海外市場重點突破」的態勢。另一方面,集團積極佈局生物質業務,實現多點開花,此前已與奇瑞汽车旗下得壹能源及億緯鋰能等多家龍頭企業及地方政府達成合作,共同推進零碳園區建設與產業清潔化升級。此次三方合作,將進一步助力集團開拓海内外市場,聚焦「儲能+生物質能」兩大新增長極,推動集團健康、可持續發展。集團主席兼總裁劉明輝先生表示:「中國燃氣經過二十餘年的發展,已構建起以天然氣為核心,融合LNG、LPG、生物質能源及新能源技術應用的全業態發展格局。當前,集團正加速全球化戰略,在歐洲、東南亞、中亞及北亞等地區已形成清晰的業務佈局。此次與中信建設、中信銀行達成三方協議,標誌著我們從單純的業務出海升級為『產業主導、工程賦能、金融助力』的集群式出海。通過與合作方金融與實業雙引擎的深度協同,我們將以更強的抗風險能力和全產業鏈優勢,為全球能源的可持續發展貢獻中國燃氣解決方案。」有關中國燃氣控股有限公司中國燃氣控股有限公司(「中國燃氣」,股票代號:384)是一家領先的燃氣運營服務商,主要於中國從事投資、建設、經營城市燃氣管道基礎設施,向居民及工商業用戶輸送天然氣和液化石油氣,建設和經營車船用天然氣加氣站。目前中國燃氣在全國已擁有662個城鎮的管道燃氣專營權項目、32個天然氣長輸管道項目、485座壓縮/液化天然氣汽車與船用加氣站,並擁有120個液化石油氣分銷項目。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

萬利集團收購綠燃控股有限公司多數股權

吉隆坡,2026年4月22日 - (亞太商訊 via SeaPRwire.com) - 萬利集團(以下簡稱「萬利」或「集團」)之上市實體 CBL International Limited(以下簡稱「公司」或「CBL」)(美國納斯達克交易所代碼:BANL),亞太地區知名燃油供應服務商,今日宣佈收購英屬維爾京群島註冊公司綠燃控股有限公司(「綠燃」)50.5%的多數股權。CBL的全資子公司作為《股份出售及購買協定》(簡稱「SPA」)的直接簽約方,而CBL並非該協議的簽約方,因此CBL向賣方提供公司擔保,以確保其子公司履行SPA下的付款義務。綠燃在馬來西亞經營兩項互補業務:可持續航空燃料(SAF)和生物燃料的原料貿易,以及船舶生物燃料供應並提供傳統燃料油加注服務。其原料貿易部門持有需的國際認證資格,以進行SAF及生物燃料生產所需原材料的採購和交易,並擁有成熟的供應商與客戶網路。至於燃料油加注業務方面,綠燃持有當地政府發出的許可證,可於馬來西亞水域供應傳統船用燃料及生物燃料。此次戰略投資符合全球日益重視環境、社會和治理(ESG),以及海事、航空領域監管要求持續強化所帶來的趨勢。CBL的財務資源及船用燃料物流運營專長,預計將助力綠燃業務的擴張,使其能進一步擴大原料貿易規模,並探索向馬來西亞SAF相關生產企業供應原材料的業務。馬來西亞可持續燃料的基礎設施投資持續增加。該國已有新的商業規模SAF生產設施投入運營,並有更多專案正規劃中。這些發展進一步突顯該地區對原料的潛在需求。在燃料油加注業務方面,綠燃所持的供應資格使集團得以在馬來西亞主要港口(包括巴生港) 進一步發展傳統燃料和生物燃料的供應能力。巴生港是全球輸送量前十的港口之一。上述能力將依託CBL現有的燃料油加注服務,支持航運業邁向低碳船用燃料轉型。CBL集團主席兼行政總裁謝威廉博士評論道:「此次收購是在可持續能源供應鏈上採取穩健拓展的一步,並充分利用了我們在船用燃料服務方面的核心優勢。 我們期待與綠燃團隊合作,支持這些業務按照市場發展實現負責任增長。」此次交易預計將增強CBL在不斷演變的海洋與能源領域的長期定位,同時不會改變公司對現有加燃料服務業務的核心專注。關於萬利集團萬利集團成立於2015年,以 CBL International Limited(納斯達克:BANL)在納斯達克股票市場上市。我們致力於為客戶提供一站式燃油供應服務,被業內稱為燃油供應服務商。截至2026年4月17日,我們主要通過當地實體供應商為船舶提供燃油加注服務,遍佈澳大利亞、比利時、中國、香港、印度、日本、韓國、馬來西亞、模里裘斯、荷蘭、巴拿馬、菲律賓、新加坡、臺灣、泰國、土耳其和越南,共覆蓋超過70個港口。 集團積極推動可持續燃料的使用,並已取得ISCC EU 和ISCC Plus認證,以及EcoVadis銀牌。如欲瞭解更多信息,請到集團網站 https://www.banle-intl.com 瀏覽。前瞻性聲明本公告中的某些陳述並非歷史事實,而是前瞻性陳述。 前瞻性陳述一般使用"相信"、"可能"、"可以"、"將要"、"估計"、"繼續"、"預期"、"打算"、"期望"、"計劃"、"應該"、"將會"、"未來"、"展望"、"潛力"、"專案"等類似詞語來預測或表達未來事件或趨勢或不屬於歷史事項的陳述,但不使用這些詞語並不意味著陳述並非前瞻性。 這些前瞻性陳述包括但不限於對其他績效指標的估計和預測,以及對市場機會的預測。 這些資訊涉及已知和未知的風險和不確定性,並基於各種假設(無論本新聞稿中是否指明)以及BANL管理層的當前預期,而非對實際業績的預測。 這些前瞻性陳述僅供說明目的,不得被任何投資者作為且不得被依賴為對事實或可能性的擔保、保證、預測或確鑿陳述。 實際事件和情況難以或不可能預測,也會與假設不同。 許多實際事件和情況不在BANL的控制範圍內。 一些重要因素可能導致實際結果與任何前瞻性陳述存在實質性差異,包括國內外商業、燃料價格及關稅、市場、金融、政治和法律環境的變化。 公司沒有義務公開更新或修改任何前瞻性陳述來反映隨後發生的事件或情況或預期的變化,除非法律要求。 儘管公司認為該等前瞻性陳述中表達的預期合理,但不能向您保證此類預期最終正確無誤。 公司提醒投資者實際結果可能與預期結果存在重大差異,並鼓勵投資者細閱公司的註冊聲明和向SEC提交的其他檔所載可能影響其未來業績的其他因素。CBL INTERNATIONAL LIMITED(註冊於開曼群島的有限責任公司)如需更多信息,請聯繫:CBL International Limited電郵:investors@banle-intl.com Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

GMG Appoints New Chief Production Growth Officer and Provides Update on Global Production Plans

Brisbane, Queensland, Australia--(ACN Newswire via SeaPRwire.com - April 22, 2026) - Graphene Manufacturing Group Ltd (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to announce that Stuart Watson — former global Head of Technical Development for Rio Tinto Ltd. (ASX: RIO), one of the largest mining and mineral production companies in the world, has joined GMG as Chief Production Growth Officer.Stuart has over 30 years of global leadership experience in metals and mining and oil and chemicals, including 20 years at Rio Tinto, across operations, sales and marketing, mergers and acquisitions, and technology development and innovation. Career highlights include:Leading and delivering multiple major transformation programs valued over US$5 Billion and merger and acquisition deals valued at US$1 Billion.Directing US$1 Billion in global technology and research & development spend to create breakthrough growth options and projectsBuilding high-performing global teams across Asia, Europe, and North AmericaStuart has a Master of Business Administration (MBA) - Henley Management College, UK; is a Chartered Engineer - Institute of Chemical Engineers (IChemE), has a Masters of Engineering, Chemical Engineering (First Class Honours) — Imperial College, University of London and Ecole Nationale Supérieure d'Ingénieurs de Génie Chimique (ENSIGC), Toulouse, France.Craig Nicol, CEO & Managing Director of the Company, commented "We welcome Stuart to the GMG team - he is a great addition to the Senior Executive Team for both executive leadership and delivery capability. I will enjoy working with Stuart to expand our production across our graphene and graphene products around the world."Jack Perkowski, Non-Executive Chairman and Director of the Company, commented: "On behalf of the board I welcome Stuart to the team and look forward to the progress around expanding our production capability into North America."Operations UpdateGMG is focused on delivering its Gen 2.0 Graphene Production Project (the "Gen 2.0 Project") by end of June 2026 — which is expected to produce at least 10 tonnes per annum of graphene at its headquarters in Richlands, Queensland, Australia.Once the Gen 2.0 Project is commissioned and operating. GMG plans to replicate and establish other production plants around the world to enable scaled production for potential sales, diversify and lower production risks, and in the end, reduce operating costs by locating the plant in countries with lower operating costs, including low cost natural gas — one of GMG's key production input costs.Currently, GMG is planning three potential expansion projects — two in North America (potentially one in US and one in Canada) in addition to an expansion production project in Australia. GMG proposes to mature these projects and expand production in line with sales for all of its products.The expansion program for GMG includes the following 5 production plants:Graphene Production (from natural gas)Coating Blend Plant (for the graphene coating THERMAL-XR®)Lubricant Blend Plant (for the graphene lubricant additive G® LUBRICANT)Graphene Slurry Plant (for the SUPA G Lithium-Ion Battery Additive)Battery Assembly Plant (for the Graphene Aluminium Ion Battery)Figure 1To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/293781_d1c07d1d84356a2d_001full.jpgAbout GMG:GMG is an Australian based clean-technology company which develops, makes and sells energy saving and energy storage solutions, enabled by graphene manufactured via in house production process. GMG uses its own proprietary production process to decompose natural gas (i.e. methane) into its natural elements, carbon (as graphene), hydrogen and some residual hydrocarbon gases. This process produces high quality, low cost, scalable, 'tuneable' and low/no contaminant graphene suitable for use in clean-technology and other applications.The Company's present focus is to de-risk and develop commercial scale-up capabilities, and secure market applications. In the energy savings segment, GMG has initially focused on graphene enhanced heating, ventilation and air conditioning ("HVAC-R") coating (or energy-saving coating) which is now being marketed into other applications including electronic heat sinks, industrial process plants and data centres. Another product GMG has developed is the graphene lubricant additive focused on saving liquid fuels initially for diesel engines.In the energy storage segment, GMG and the University of Queensland are working collaboratively with financial support from the Australian Government to progress R&D and commercialization of graphene aluminium-ion batteries ("G+AI Batteries"). GMG has also developed a graphene additive slurry that is aimed at improving the performance of lithium-ion batteries.GMG's 4 critical business objectives are:Produce Graphene and improve/scale cell production processesBuild Revenue from Energy Savings ProductsDevelop Next-Generation BatteryDevelop Supply Chain, Partners & Project Execution CapabilityFor further information please contact:Craig Nicol, Chief Executive Officer & Managing Director of the Company at craig.nicol@graphenemg.com, +61 415 445 223Leo Karabelas at Focus Communications Investor Relations, leo@fcir.ca, +1 647 689 6041Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this news release.Cautionary Note Regarding Forward-Looking StatementsThis news release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian and U.S. securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends", "believes" "expects" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or will "potentially" or "likely" occur. This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, statements as to GMG's focus on, and the timing and production expectations of, the Gen 2 Project, intentions regarding the number, purpose and location of expansion projects, intentions to de-risk and develop commercial scale-up capabilities, GMG's focus in the energy savings segment, GMG's intentions for the use of graphene lubricant additive on saving liquid fuels, expectations for R&D and commercialization of G+AI Batteries, GMG's ability to improve the performance of lithium-ion batteries and GMG's critical business objectives.Such forward-looking statements are based on a number of assumptions of management, including the patent and potential market size of G® LUBRICANT. Additionally, forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of GMG to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation that GMG does not receive or receive on a timely basis the fully signed consent notice from the and the risk factors set out under the heading "Risk Factors" in the Company's annual information form dated November 4, 2025 available for review on the Company's profile at www.sedarplus.ca.Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/293781 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com